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35 _
Hypertensive Disorders in Pregnancy

In some mystenous way the presence of chononic villi in certain women mates vasospasm and hypertension Moreover to effect a cure
the chononic villi must be expelled or surgically removed The vasospastic hypertensive state and related pathological changes somehow
induced by the presence of chononic villi may not be so great that pregnancy need be termmated prematurely (Pntchard, 1978)
Pregnancy may induce hypertension in previously normotensive women or aggravate hypertension in women who have
underlying hypertension Generalized edema, proteinuna, or
both, often accompany hypertension induced or aggravated by
pregnancy Convulsions also may develop in association with
hypertension, especially if hypertension is ignored
Hypertensive disorders complicating pregnancy are common and form one of the great tnad, along with hemorrhage
and infection, that continues to be responsible for a large number of maternal deaths in the United States Kaunitz and colleagues (1985) reported that 20 percent of 2,067|»aternal deaths
from 1974 to 1978 were caused by hypertensivs^diseases With
improved prenatal care and a rational approach tVthe management of hypertensive disorders complicating pregnancy, dra-

matic declines in maternal mortality rates have been reported
more recently (Lehmann and colleagues, 1987, Rochat and coworkers, 1988, Sachs and associates, 1987) Hypertensive disorders are also an important cause of perinatal mortality and
severe morbidity
How pregnancy per se incites or aggravates hypertensive
vascular disease remains unsolved despite decades of intensive
research, and these disorders remain among the most important
unsolved problems in obstetncs The large toll of maternal and
infant lives that may be taken by hypertension induced or aggravated by pregnancy is most often preventable Good prenatal supervision followed by appropriate treatment will
ameliorate many cases sufficiently that the outcomes for both
fetus-infant and mother are satisfactory

GENERAL CONSIDERATIONS
CLASSIFICATION AND
DIFFERENTIAL DIAGNOSIS
TERMINOLOGY
The unsatisfactory term toxemia of pregnancy has been applied
variably to any or all disorders in which hypertension, proteinuna, or edema was present d u n n g pregnancy or the puerpenum, and to other disorders, as well The Amencan College of
Obstetricians and Gynecologists (1986) proposed the following
definitions and classification of hypertension that develop during pregnancy or the puerpenum Hypertension is defined as a
diastolic blood pressure of at least 90 mm Hg or a systolic
pressure of at least 140 mm Hg, or a nse in diastolic pressure of
at least 15 mm Hg or in systolic pressure of 30 mm Hg The
blood pressure readings cited must be obtained on at least two
occasions 6 hours or more apart Preeclampsia is the development of hypertension with proteinuna, edema, or both, induced by pregnancy after the 20th week of gestation, and
sometimes earlier when there are extensive hydahdiform
changes in the chononic villi (see Chap 31, p 544) Eclampsia is
diagnosed when convulsions, not caused by anv coincidental
neurological disease such as epilepsy, develop in a woman who
also has clinical cntena for preeclampsia Superimposed preeclampsia or eclampsia is defined as preeclampsia or eclampsia
that develops in a woman with chronic hypertensive vascular or

renal disease Chronic hypertensive disease is defined as persistent
hypertension, of whatever cause, antedating pregnancy o- detected before the 20th week of gestation in the absence of hydahdiform mole or extensive molar change, or hypertension
that persists beyond 6 weeks postpartum
Unfortunately, not all women can be categorized neatly as having
one of these syndromes Earlier, the Committee on Terminology of
the Amencan College of Obstetncians and Gynecologists (Hughes,
1972) sought to improve the diagnosis of preeclampsia It defined
gestational hypertension as elevated blood pressure that develops
dunng the latter half of pregnancy or dunng the first 24 hours
following delivery It is not accompanied by other evidence for
preeclampsia or chronic underlying hypertension, and it disappears within 10 days of delivery It is unclear whether this is mild
or incipient preeclampsia forestalled by delivery or if it is a marker
for latent chronic hypertension, but we agree with Chesley (1985)
that it is probably the latter If so, then it is certainly inappropnately
classified Gestational edema is characterized by abnormal fluid retention that regresses after delivery, hypertension never developing Rarely, so-called gestational proteinuria exceeds 300 mg per day
m the absence of hypertension, edema, renal infection, or other
known renovascular disease These terms are not used by many
teaching centers in the United States
Because of the confusion that has ansen from these classifications of hypertensive disorders complicating pregnancy, we
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hypertension. Villar and colleagues (1988) reported that 31 percent of young primigravidas with a 15 mm Hg rise in diastolic
blood pressure developed pregnancy-induced hypertension.
For those without such a rise, the incidence was 15 percent. For
women in whom the systolic pressure rose 30 mm Hg or more,
42 percent developed pregnancy-induced hypertension, compared to an incidence of 17 percent in women without such a
rise. If both systolic and diastolic pressure increased as defined,
then 56 percent developed pregnancy-induced hypertension,
PREGNANCY-INDUCED HYPERTENSION
compared to only 15 percent if there had not been a preceding
elevation. Midpregnancy blood pressure elevations more likely
As shown in Table 35-1, pregnancy-induced hypertension is
forecast future chronic hypertension (Chesley and Sibai, 1988).
divided into three categories: (1) hypertension alone, (2) preAlthough the diagnosis of preeclampsia has traditionally
eclampsia, and (3) eclampsia. The diagnosis of preeclampsia is
required the identification of pregnancy-induced hypertension
based on the development of hypertension plus proteinuria or
plus proteinuria or generalized edema, many authorities concur
of edema that is generalized and overt, or both. Eclampsia is
that edema, even of the hands and face, is such a common
characterized typically by the abnormalities just cited with the
finding in pregnant women that its presence should not validate
addition of convulsions that are precipitated by the pregnancythe diagnosis of preeclampsia any more than its absence should
induced hypertension. Only rarely does preeclampsia develop
preclude the diagnosis. Indeed, Robertson (1971) reported that
earlier than 20 weeks gestation, and then usually in cases of
one third of women developed generalized edema by the 38th
hydatidiform mole or appreciable molar degeneration (see
week of pregnancy, and he was unable to show a significant
Chap. 31, p. 544). As emphasized by Chesley (1985), preeclampstatistical correlation between edema and hypertension. In ansia is almost exclusively a disease of nulliparous women. Alother study, Friedman and Neff (1976) identified perinatal morthough it more commonly affects the woman who is at the
tality for women with edema alone to be 30 percent lower than
extremes of reproductive age, that is, teenagers or those older
for the general population. Thus, the edema of preeclampsia is
than 35 years, preeclampsia in the latter usually reflects
pathological and not dependent, and it usually involves the face
pregnancy-aggravated hypertension. Pregnancy-induced hyand hands and persists even after arising. A useful indicator of
pertension is occasionally seen in the multipara with multifetal
nondependent edema is the woman's complaint that her rings
pregnancy or fetal hydrops. Pregnancy-aggravated hypertenhave become too tight.
sion is common in multiparas with vascular diseases, including
Proteinuria is an important sign of preeclampsia and Cheschronic essential hypertension and diabetes mellirus, or those
ley
(1985)
rightfully concluded that the diagnosis is questionable
with coexisting renal disease.
in its absence. Proteinuria is defined as 300 mg or more of
urinary protein during a 24-hour period or 100 mg per dL or
DIAGNOSIS
more in at least frvo random urine specimens collected 6 hours
The diagnosis of pregnancy-induced hypertension is usually or more apart. The degree of proteinuria may fluctuate wideT^"
straightforward and made when the blood pressure is 140/90 mm over any 24-hour period, even in severe cases. Therefore, a
Hg or greater. Although it has been accepted in the past that an single random sample may fail to detect significant proteinuria.
The combination of proteinuria and hypertension during
increase of 30 mm Hg systolic or 15 mm Hg diastolic over
pregnancy
markedly increases the risk of perinatal mortality.
baseline values on at least two occasions 6 or more hours apart
r
McCartney
and co-workers (1971), in their extensive study of
be considered as possibly diagnostic for pregnancy-induced h y
pertension, these vague criteria have little clinical value. Such renal biopsy specimens obtained from hypertensive pregnant
findings, however, may increase the risk for pregnancy-induced women, invariably found that proteinuria was present when
the glomerular lesion considered to be characteristic of preeclampsia was evident. It is important to recognize, however,
that both proteinuria and alterations of glomerular histology
develop late in the course of pregnancy-induced hypertension.
TABLE 35-1. CLASSIFICATION OF HYPERTENSIVE DISORDERS
Actually, preeclampsia becomes evident clinically only near the
COMPLICATING PREGNANCY
end of an often protracted, covert pathophysiological process .
Pregnancy-induced hypertension
that
may begin 3 to 4 months before hypertension develops.
Hypertension that develops as a consequence of pregnancy, and reThe
fact that perinatal mortality is increased by maternal
gresses postpartum
hypertension is evident from an analysis of data collected from
1. Hypertension without proteinuria or pathological edema
the Collaborative Perinatal Project conducted by the National
2. Preeclampsia—with proteinuria and/or pathological edema
a. Mild
Institute of Neurologic and Communicative Disorders and
b. Severe
Stroke (Friedman and Neff, 1976). From this 13-year prospective
3. Eclampsia—proteinuria and/or pathological edema along with
study, 38,636 pregnancies were selected for analysis because
convulsions
they satisfied the following criteria: (1) antepartum care before
Pregnancy-aggravated hypertension
the 28th week of pregnancy, (2) singleton fetus, (3) four or more
Underlying hypertension worsened by pregnancy
antepartum visits, and (4) date of last menstrual period known.
1. Superimposed preeclampsia
In Table 35-2 the fetal death rate for these pregnancies is pre2. Superimposed eclampsia
sented in relation to the presence or absence of hypertension,
Coincidental hypertension
proteinuria, or both. Hypertension alone, defined by diastolic
Chronic underlying hypertension that antecedes pregnancy or persists
blood pressure of 95 mm Hg or greater, was associated with a
postpartum
threefold rise in the fetal death rate. Worsening hypertension,
have made the modifications shown in Table 35-1. Our principal reason was to separate hypertension that is in some way
induced by pregnancy from hypertension that merely coexists
with it. At the same time it needs to be emphasized that chronic
underlying hypertension will increase the frequency and intensity of superimposed preeclampsia.

35 HYPERTFNSIVE DISORDERS IN PREGNANCY
TABLE 35-2. FETAL DEATH RATE PER 1,000 BIRTHS ANALYZED
ACCORDING TO DIASTOLIC PRESSURE AND PROTEINURIA
COMBINATIONS
Diastolic Blood
Pressure
(mm Hg)

None

Trace

r+

<65
65-74
75-84
85-94
95-104
105 +

15 5a
93
62
87
19 2a
20 5a

136
81
74
93
17 4a
27 9 a

62
56
62
23 6a
26 7a
62 6a

—a

55 8
68 8 a

22 3
115 3a
125 2 a

143a
111 a

86

95

129

23 2 a

42 0 a

57a

Total

Proteinuria

2+

3+

4+

Totat

—

—

32 9 a
19 2 a

41 5

—
__
—
—

136
88
68
102
25 2
41 5a

—

a

P< 0 01
Modified from Friedman and Nefi In Lmdheimer Katz and Zuspan (eds) Hypertension in Pregnancy New York Wiley 1976

655

TABLE 35-3. INDICATORS OF SEVERITY OF
PREGNANCY-INDUCED HYPERTENSION
Abnormality

Mild

Severe

Diastolic blood pressure
Proteinuria
Headache
Visual disturbances
Upper abdominal pain
Oliguria
Convulsions
Serum creatinine
Thrombocytopenia
Hyperbilirubinemia
Liver enzyme elevation
Fetal growth retardation
Pulmonary edema

< 100 mg Hg
Trace to 1 +
Absent
Absent
Absent
Absent
Absent
Normal
Absent
Absent
Minimal
Absent
Absent

110 mm Hg or higher
Persistent 2+ or more
Present
Present
Present
Present
Present (eclampsia)
Elevated
Present
Present
Marked
Obvious
Present

especially if accompanied by proteinuria, was more ominous
Conversely, proteinuna without hypertension had little overall
influence on the frequency of fetal death
In an evaluation of the causes of perinatal deaths in this
same study population, Naeye and Friedman (1979) concluded
that 70 percent of the excess deaths were due to three disorders
large placental infarcts, markedly small placental size, and
abruptio placentae They further stated, "All three [disorders]
display microscopic placental lesions [that] are the consequence
of reduced uteroplacental perfusion
" Uteroplacental perfusion is considered in detail on page 671
When the blood pressure nses appreciably during the latter
half of pregnancy it is dangerous, to the fetus especially, not to
take action simply because proteinuna has not yet developed
As Chesley (1985) emphasizes, 10 percent of eclamptic seizures
develop before overt proteinuna Thus, from pathophysiological and epidemiological perspectives it is clear that hypertension
is the sine qua non of preeclampsia and that from the moment
blood pressure begins to nse, both mother and fetus are at
increased nsk Once the blood pressure exceeds 140/90 mm Hg,
pregnancy-induced hypertension is diagnosed and the woman,
treated accordingly Proteinuna is a sign of worsening hypertensive disease, specifically preeclampsia, and when it is overt
and persistent, the maternal and fetal nsks are increased even
more

Proteinuna is an important indicator of severity, since, as
discussed, it usually develops late in the course of the disease
Certainly, persistent proteinuna of 2+ or more, or 24-hour
unnary excretion of 4 g or more, is indicative of severe preeclampsia With severe renal involvement, glomerular filtration
may be impaired and the plasma creatinine concentration become abnormally high, or it may begin to nse
Epigastnc or nght upper quadrant pain is presumed to
result from hepatocelluar necrosis and edema that stretches
Glisson's capsule The charactenshc pain frequently is accom
panied by elevation of serum liver enzymes, and usually
prompts definitive therapy Rarely, the pain presages liver rupture, or more correctly, catastrophic rupture of an hepatic subcapsular hematoma
Thrombocytopenia is charactenshc of worsening preeclampsia and is probably caused by microangiopathic hemolysis engendered by severe vasospasm Whatever the cause
evidence of gross hemolysis from hemoglobmemia, hemoglobi
nuna, or hyperbilirubinemia is indicative of severe disease
Other factors indicative of severe hypertension most often
are seen in association with pregnancy-aggravated hyperten
sion These factors include cardiac dysfunction with pulmonary
edema as well as fetal growth retardation
The more profound the frequency and intensity of these
aberrations, the more severe the disease and the greater the
need for pregnancy termination

SEVERITY OF PREGNANCY-INDUCED
HYPERTENSION

ECLAMPSIA

The seventy of pregnancy-induced hypertension is assessed by
the frequency and intensity of those abnormalities shown in
Table 35-3 At the ouset it is appreaated that many women
have clmical syndromes that are somewhere between those two
extremes Importantly, the differentiation between mild and
severe preeclampsia cannot be rigidly pursued since apparently mild disease may rapidly become severe.
Blood pressure alone is not always a dependable indicator
of seventy For example, an adolescent woman may have 3 +
proteinuna and convulsions while her blood pressure is 140/85
mm Hg, whereas most women with blood pressures as high as
180/120 mm Hg do not have seizures Convulsions usually are
preceded by an unrelenting severe headache or visual disturbances, thus, these symptoms are considered ominous

In neglected or, less often, fulminant cases of pregnancy induced hypertension, eclampsia may develop The seizures are
grand mal and may first appear before labor, dunng labor, or
postpartum Any seizure that develops more than 48 hours
postpartum is more likely to be the consequence of some other
lesion of the central nervous system However, we have en
countered otherwise typical eclampsia up to 10 days postpar
rum (Brown and colleagues, 1987).

COINCIDENTAL (CHRONIC) HYPERTENSION
All chronic hypertensive disorders, regardless of their cause, pre
dispose to the development of supenmposed preeclampsia or
eclampsia These disorders can create a difficult problem or
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diagnosis and management in women who are not seen for
prenatal care until after midpregnancy. The diagnosis of coincidental or chronic underlying hypertension is suggested by the
following: (1) hypertension (140/90 mm Hg or greater) antecedent to pregnancy, (2) hypertension (140/90 mm Hg or greater )
detected before the 20th week of pregnancy (unless there is
gestational trophoblastic disease), or (3) persistent hypertension
long after delivery. Additional historical factors that help support the diagnosis of coincidental hypertension are multiparity
and hypertension complicating a previous pregnancy other than
the first one.
When the woman is not seen until the latter half of pregnancy, the diagnosis of chronic hypertension may be difficult to
make, because blood pressure usually decreases during the second and early third trimester in chronically hypertensive
women. Thus, a woman with chronic vascular disease who is
seen for the first time at 20 weeks frequently will have a normal
blood pressure. During the third trimester, however, the blood
pressure returns to its former hypertensive level, presenting a
diagnostic problem: is this chronic (coexistent) hypertensive disease or is it pregnancy-induced hypertension?
There are many diseases and syndromes associated with
underlying hypertension that may be encountered during pregnancy. Sims (1970) proposed the modified classification presented in Table 35-4. As is true for the general population of the
same age group, essential hypertension is the cause of underlying vascular disease in more than 90 percent of pregnant
women. McCartney (1964) studied renal biopsies from women
with "clinical preeclampsia," and found chronic glomerulonephritis in 21 percent of the nulliparas and in nearly 70 percent of
the multiparas. Fisher and co-workers (1969), however, did not
confirm a high prevalence of chronic glomerulonephritis in their
own patients.
It must be remembered that chronic hypertension causes
morbidity whether the woman is pregnant or not. Specifically,
chronic hypertension may lead to premature cardiovascular deterioration and cause cardiac decompensation and cerebrovas-

TABLE 35-4. UNDERLYING CHRONIC HYPERTENSIVE
DISORDERS UPON WHICH PREECLAMPSIA MAY
BE SUPERIMPOSED
Hypertensive diseases
Essential familial hypertension
(hypertensive vascular disease)
Renovascular hypertension
Coarctation of the aorta
Primary aldosteronism
Pheochromocytoma
Renal and urinary tract disease
Glomerulonephritis (acute and chronic)
Nephrotic syndrome
Chronic renal insufficiency
Pyelonephritis
Lupus erythematosus
Scleroderma
Periarteritis nodosa
Acute renal failure
Tubuler necrosis
Cortical necrosis
Polycystic kidney disease
Diabetic nephropathy
Modified from Sims: Am J Obstet Gynecol 107:154, 1970.

cular accidents. Intrinsic renal damage also may result from
chronic hypertensive disease, but more commonly in young
women, hypertension develops as the result of underlying renal
parenchymal disease. Dangers specific to pregnancy complicated by chronic hypertension include the risk of pregnancyaggravated hypertension, which may develop in as many as 20
percent of these women. Additionally, the risk of abruptio placentae is increased substantively, and may be as high as 5 to 10
percent. Moreover, the fetus of the woman with chronic hypertension is at increased risk for growth retardation and intrauterine death.

PREGNANCY-AGGRAVATED HYPERTENSION
In some women with preexisting chronic hypertension there is
worsening of hypertension, typically in later pregnancy. Such
pregnancy-aggravated hypertension may be accompanied by
proteinuria or pathological edema and is then termed superimposed preeclampsia. Frequently, superimposed preeclampsia has
an onset earlier in pregnancy than pure preeclampsia, and it
tends to be quite severe in many cases. Fetal growth retardation
commonly accompanies these syndromes.
Diagnosis includes documentation of chronic underlying
hypertension. Pregnancy-aggravated hypertension is characterized by at least a 15 mm Hg increase in diastolic or a 30 mm Hg
rise in systolic blood pressure, and preeclampsia is accompanied by proteinuria or pathological edema, or both. Indicators of
severity shown in Table 35-3 also are used to further characterize these disorders.

INCIDENCE OF PREGNANCY-INDUCED
HYPERTENSION
Pregnancy-induced hypertension most often affects nulliparous
women. Older women, who accrue an increasing incidence of
chronic hypertension with advancing age, are at greater risk of
pregnancy-aggravated hypertension or superimposed preeclampsia. Thus, women at either end of the reproductive age
in the past have been considered more susceptible. For example, Duenhoelter and colleagues (1975) observed that very
young teenage nulligravidas were at appreciably greater risk for
preeclampsia. This traditional view is not supported by Guzick
and associates (1987) who reported that younger-age women
did not have a higher incidence of pregnancy-induced hypertension when parity was considered. Spellacy and associates
(1986) reported that women over 40 had a threefold (9.6 versus
2.7 percent) increased incidence of hypertension compared to
control women aged 20 to 30 years. Hansen (1986) reviewed
several studies and reported a two- to threefold increase in the
incidence of preeclampsia in nulliparas over 40 compared to
those 25 to 29 years old.
The incidence of preeclampsia is commonly cited to be
about 5 percent, although remarkable variations are reported.
The incidence is influenced by parity, it is related to racial—and
thus to generic—predisposition, and environmental factors may
have a role. From 1983 through 1986, 13 percent of 49,992
women who were delivered at Parkland Hospital were identified as having pregnancy-induced or aggravated hypertension
(Cunningham and Leveno, 1987). Almost 70 percent were
nulliparous, but only half of these had proteinuria and thus
preeclampsia according to Chesley. The effects of parity were
striking, since nearly 20 percent of nulliparas had hypertension
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antepartum, intrapartum, or in the puerperium, compared to an
incidence of 7 percent in multiparas.
Racial and genetic factors are important since they contribute to the incidence ot underlying chronic hypertension.
We analyzed pregnaricy outcomes of 5,622 nulliparas delivered at Parkland Hospital in 1986, and 18 percent of white, 20
percent of Hispanic, and 22 percent of black women had hypertension complicating pregnancy (Cunningham and Leveno, 1987). Again, about half of these women had preeclampsia defined as proteinuric hypertension. The incidence
of hypertension in multiparas during pregnancy was 6.2 percent in white, 6.6 in Hispanic, and 8.5 percent in black
women, reflecting the increased incidence of underlying hypertension in blacks. Slightly more than half of these muciparous women with hypertension also had proteinuria and
thus superimposed preeclampsia.
The tendency for preeclampsia-eclampsia is inherited.
Chesley and Cooper (1986) studied the sisters, daughters,
granddaughters, and daughters-in-law of eclamptic women delivered at the Margaret Hague Maternity Hospital during the
49-year period 1935 to 1984. They concluded that preeclampsiaeclampsia is highly heritable and that the single-gene model,
with a frequency of 0.25, best explained their observations;
however, multifactorial inheritance also was considered possible (see Chap. 32, p. 574).
Although Chesley (1974) disagrees, some have concluded
that socioeconomically advantaged women have a lesser incidence of preeclampsia, even after racial factors are controlled.
Regardless, when a socially affluent woman develops preeclampsia, it can be as severe and life-threatening as preeclampsia in a ghetto teenager.
In general, eclampsia is preventable, and it has become less
common in the United States, since most women now receive
"prenatal care. For example, in the seventeenth edition of
Williams Obstetrics, the incidence of eclampsia at Parkland Hospital was cited to be 1 in 700 deliveries for the past 25-year
period. For the 4-year period 1983-1986 the incidence was 1 in
1,150 deliveries. During this same time, there were proportionally more nulliparous women delivered at our hospital, and this
should favor an increased incidence of eclampsia rather than the
decrease noted.

THEORIES ABOUT THE CAUSE OF
PREGNANCY-INDUCED HYPERTENSION
Any satisfactory theory must take into account the following
observations: pregnancy-induced or -aggravated hypertension
is very much more likely to develop in the woman who (1) is
exposed to chorionic villi for the first time, (2) is exposed to a
superabundance of chorionic villi, as with twins or hydatidiform mole, (3) has preexisting vascular disease, or (4) is genetically predisposed to hypertension developing during
pregnancy. While chorionic villi are essential, they need not
support a fetus nor be located within the uterus.
The possibility that immunological as well as endocrine and
genetic mechanisms are involved in the genesis of preeclampsia
is intriguing. The risk of pregnancy-induced hypertension is enhanced appreciably in circumstances where formation of blocking antibodies to antigenic sites on the placenta might be impaired, such as during immunosuppressive therapy to protect a
renal transplant during pregnancy; where effective immunization by a previous pregnancy is lacking, as in first pregnancies;
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or where the number of antigenic sites provided by the placenta
is unusually great compared to the amount of antibody, an
example of which is multiple fetuses (Beer, 1978). Strickland
and associates (1986) provided data that do not lend strong
support to "immunization" by a previous pregnancy. They analyzed the outcomes of 29,484 pregnancies at Parkland Hospital
and reported that pregnancy-induced hypertension was only
slightly decreased (22.3 versus 25.4 percent) in women who had
previously aborted and now were having their first baby. However, supporting the immunization concept is the observation
that preeclampsia develops in multiparous women impregnated
by a new consort (Feeney and Scott, 1980) or in those pregnant
as the result of donor insemination (Need and colleagues, 1983).
As summarized by Chesley (1974), everyone from allergist
to zoologist has proposed a theory and suggested "rational
therapy" based upon that theory. Some schemes proposed
included mastectomy, oophorectomy, renal decapsulation,
trephination, alignment of the woman with the earth's magnetic field, and a myriad of medical regimens. Everything
from watermelon season to infestation with a worm (Hydatoxi
lualba) has been claimed to be of importance. The interested
reader is urged to examine the scholarly and entertaining review of various theories provided by Chesley (1978) in his
elegant book, Hypertensive Disorders in Pregnancy.
As discussed above, the tendency to develop preeclampsia
is inherited. Cooper and Liston (1979) examined the possibility
that susceptibility to preeclampsia is dependent upon a single
recessive gene. They calculated the expected first-pregnancy
frequencies of daughters of women with eclampsia; daughtersin-law served as controls. The frequencies calculated by them
and those actually observed by Chesley and co-workers (1968)
in daughters and daughters-in-law of women with eclampsia
are in remarkably close agreement. Subsequently, Chesley and
Cooper (1986) reanalyzed Chesley's extensive data and concluded that the single-gene hypothesis fits well, but multifactorial inheritance cannot be excluded.
Preeclampsia may be more common among indigent
women; however, in the early 1900s eclampsia was believed to
be most common in middle- and upper-class women. Indeed,
that observation led to the ready acceptance of the hypothesis
that dietary restriction of protein accounted for the reduction in
the incidence of eclampsia in Germany during World War I.
Although there are suggestions that dietary deficiencies might
cause preeclampsia, this hypothesis also lacks supportive data.
Since pregnancy "depletes" a woman nutritionally, preeclampsia might be expected to be more common in multiparous
women compared to nulliparas; however, the opposite is true.
Moreover, in a number of studies in which dietary supplementation was provided, no reduction in the frequency of hypertension was demonstrated (see Chap. 14, p. 263). Zlatnik and
Burmeister (1983) provided convincing evidence that the incidence of preeclampsia is not related to the level of dietary protein. Calcium deficiency has been implicated by some; however,
appropriate clinical trials have not been done to test this hypothesis (Belizan and colleagues, 1988).
Carefully controlled epidemiological studies of pregnancy
have been conducted in Aberdeen, Scotland, where for many
years the relevant data have been available for most deliveries.
Baird (1969) found that the incidence of preeclampsia did not
differ significantly among the five social classes ranging from
the professional and well-to-do (class I) through the unskilled
laborers (class V), except for some slight increase in class III
(skilled manual occupations).
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rich foam cells Zeek and Assail (1950) extended these observations and concluded that in preeclampsia there is a
pathognomonic lesion of the uteroplacental vessels that they
termed acute atherosis Most investigators are now in accord
that there is a lesion, but they do not necessarily agree on its
prease nature Using electron microscopic studies of artenes
at the uteroplacental implantation site, DeWolf and co-

workers (1975) reported that early preeclamptic changes include endothelial damage, insudation of plasma constituents
into the vessel wall, proliferation of myointimal cells, and medial necrosis They also found that lipid accumulates first m
the myointimal cells and then in macrophages Robertson and
colleagues (1986) recently provided a careful review of these
microscopic \ascular findings

CLINICAL ASPECTS OF PREECLAMPSIA
CLINICAL FINDINGS
The two especially important signs of preeclampsia—
hypertension and proteinuria—are abnormalities of v\ hich the
pregnant woman is usually unaware By the time svmptoms
such as headache, visual disturbances, or epigastric pain de
velop, the disorder is most always severe Hence the impor
tance of prenatal care in the early detection and management of
preeclampsia becomes obvious

BLOOD PRESSURE
The basic derangement in preeclampsia is arteriolar vasospasm,
and it is not surprising, therefore, that the most dependable
warning sign is an increase in blood pressure The diastolic
pressure is probably a more reliable prognostic sign than the
systolic, and any diastolic pressure of 90 mm Hg or more that
persists is abnormal The fifth Korotkoff sound is used

WEIGHT GAIN
A sudden increase m weight may precede the development of
preeclampsia, and indeed, excessive weight gain in some
"women is the first sign Weight increase of about 1 pound per
week is normal, but when weight gam exceeds much more than
2 pounds m any given week, or 6 pounds in a month de\el
oping preeclampsia must De suspected enaractenstic ot pre
eclampsia is the suddenness ot the excessive weight gain rather
than an increase distributed throughout gestation Sudden and
excessive weight gam is attributable almost entirely to abnormal
fluid retention and is demonstrable, as a rule, before visible signs
of nondependent edema, such as, swollen eyelids and puffiness
of the fingers In cases of fulminating preeclampsia or eclampsia,
fluid retention may be extreme, and m such women a weight gain
of 10 pounds or more within a week is not unusual

PROTEINURIA
The degree of proteinuria vanes greatly in preeclampsia not
only from case to case but also in the same woman from hour to
hour The variability points to a functional (vasospasm) rather
than an organic cause In early preeclampsia proteinuria may
be minimal or entirely lacking In the most severe forms protein
una is usually demonstrable and may be as much as 10 g per L
Proteinuna almost always develops later than hypertension and
usually later than excessive weight gain

HEADACHE
Headache is unusual in milder cases but is increasingK frequent
in more severe disease It is often frontal but may be occipital
and it is resistant to relief from ordinary analgesics In women

who develop eclampsia, severe headache almost invariably
precedes the first convulsion.

EPIGASTRIC PAIN
Epigastric or right upper quadrant pain often is a symptom of
severe preeclampsia and may be indicative of imminent convulsions. It may be the result of stretching of the hepatic capsule, possibly by edema and hemorrhage (p 667)

VISUAL DISTURBANCES
A spectrum of visual disturbances, ranging from slight blurnng
of vision to scotomata to partial or complete blindness, may
accompany preeclampsia These probably develop as the result
of vasospasm, ischemia, and petechial hemorrhages within the
occipital cortex (Brown and colleagues, 1988) In some women,
visual symptoms may arise from retinal artenolar spasm, ischemia, and edema, and m rare cases, retinal detachment (p 670)
In general, the prognosis for such detachments is good, and the
retina usually reattaches spontaneously within a few weeks
after delivery Hemorrhages and exudates are extremely rare m
preeclampsia and when present, are almost invariably due to
underlying chronic hypertensive vascular disease

IMMEDIATE PROGNOSIS
The prognosis for the mother and fetus is dependent to a considerable extent on the gestational age of the fetus, whether
improvement follows hospitalization, when and how delivery is
accomplished, and whether eclampsia supervenes
The perinatal mortality rate is vanably increased for pregnancies complicated by pregnancy-induced hypertension, as
with the other hypertensive disorders It is dependent pnmanly
upon the time of onset and the seventy of the disease Much of
the loss is the consequence of prematurity, either from spontaneous labor or because of induced preterm delivery necessitated
by severe preeclampsia

PROPHYLAXIS AND EARLY TREATMENT
EARLY DETECTION
Because women are usually asymptomatic and seldom notice
the signs of incipient preeclampsia, its early detection demands
careful observation at appropriate,intervals, especially in
women known to be predisposed to preeclampsia Major predisposing factors are (1) nulhpanty, (2) familial history of
preeclampsia-eclampsia, (3) multiple fetuses, (4) diabetes, (5)
chronic vascular disease, (6) renal disease, (7) hydatidiform
mole, and (8) fetal hydrops

35: HYPERTENSIVE DISORDExRS IN PREGNANCY
Rapid weight gain any time during the latter half of pregnancy, or an upward trend in the diastolic blood pressure, even
fohile still in the normal range, is worrisome. Every woman
should be examined at least weekly during the last month of
pregnancy and every 2 weeks during the previous 2 months. At
these visits, the woman is weighed and careful blood pressure
measurements made. Furthermore, all women should be advised verbally and preferably also by means of suitable printed
mstructions to report immediately any ot the well-known symp~
toms or signs ot preeclampsia, such as headache, visual disturbances, and puhiness ot hands or face. The reporting of any
#
such symptoms calls tor an immediate examination to confirm
or exclude preeclampsia.

Weight Gain
Obstetricians in the past often attempted to limit maternal
weight gain to about 20 pounds, or even less, in the belief that
preeclampsia could thereby be prevented. The total weight
gained during pregnancy, however, probably has no relation to
preeclampsia unless a large component of the gain is edema.
Stringent restriction of weight gain is more likely to be detrimental rather than beneficial to both mother and fetus. The
physician's scale, unfortunately, does not distinguish between
the accumulation of edema fluid and the normal deposition of
fetal and maternal tissue.

DIURETICS AND SODIUM RESTRICTION
Natriuretic drugs, such as chlorothiazide and its congeners,
have been severely overused in the past. Although diuretics
have been alleged to prevent the development of preeclampsia,
the results of several studies cast doubt on their real value. The
women studied by Kraus and associates (1966) took either a
placebo or 50 mg of hydrochlorothiazide daily during at least
the last 16 weeks of gestation. The incidence of preeclampsia
was 6.67 percent in primigravid women given hydrochlorothiazide, as well as in those who took the placebo. Moreover, the
frequency of hypertension was not altered in multiparous
women. Collins and colleagues (1985) reviewed the results of
nine such studies that included more than 7,000 women, and
they concluded that perinatal mortality was not improved when
diuretics were given to prevent preeclampsia. The failure of
natriuretic drugs in the prevention of preeclampsia also raises
serious doubt about the efficacy of rigid dietary sodium restriction.
Thiazide diuretics and similar compounds are not used in
the treatment or prophylaxis of preeclampsia at Parkland Hospital. While there is no clear evidence that they are of any value,
there is evidence that these drugs can reduce renal perfusion as
measured by creatinine clearance and more importantly, probably reduce uteroplacental perfusion as cited above (Gant and
colleagues, 1975). Thiazides can induce serious sodium and
potassium depletion, hemorrhagic pancreatitis, and severe
thrombocytopenia in some newborns.

OTHER DRUGS
Wallenburg and co-workers (1986) reported their experiences in
which they gave either 60 mg of aspirin or placebo to primigravid women at 28 weeks gestation. These women were judged
to be at high risk for developing preeclampsia because they
were abnormally sensitive to infused angiotensin II. The reduced incidence of preeclampsia in the treated group was attributed to suppression of thromboxane synthesis by platelets,
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with .subsequent endothelial prostacyclin dominance. In a group
of women with prior bad pregnancy outcomes due to hypertension and placental insufficiency, Beaufils and colleagues (1985)
reported that early prophylactic treatment with dipyridamole
and aspirin reduced their recurrence. They also attributed these
results to the antiplatelet actions of these drugs. Although these
reports seem encouraging, more extensive investigations to confirm these observations are necessary before they can be recommended for clinical practice. Currently the National Institutes of
Health is sponsoring a multicenter study designed to investigate this hypothesis.

OBJECTIVES OF TREATMENT
The basic management objectives for any pregnancy complicated by pregnancy-induced hypertension are (1) termination of
the pregnancy with the least possible trauma to the mother and
the fetus, (2) birth of an infant who subsequently thrives, and
(3) complete restoration of the health of the mother. In certain
cases of preeclampsia, especially in women at or near term,
these three objectives may be served equally well by careful
induction of labor. Therefore, the most important information
that the obstetrician has for the successful management of
pregnancy, and especially pregnancy that becomes complicated
by hypertension, is precise knowledge of the age of the fetus
(see Chap. 14, p. 260).

AMBULATORY TREATMENT
Ambulatory treatment has no place in the management of
pregnancy-induced or pregnancy-aggravated hypertension. Excluding young nulliparas, some women whose systolic blood
pressure does not exceed 135 mm Hg and whose diastolic pressure does not exceed PD mm Hg, and in whom proteinuria is
absent, may be managed tentatively at home as long as trie
disease does not become more severe and tetal growth retardation is not suspected. Bed rest throughout the greater part ot tne
day is essential. Moreover, these women should be examined
twice weekly rather than once weekly, and they should oe
instructed in detail about reporting symptoms. With minor elevations of blood pressure, the response to this regimen is often
immediate, but the woman must be cooperative and the obstetrician wary.

HOSPITAL MANAGEMENT
The indication for hospitalization of women with pregnancyinduced hypertension is a sustained elevation in systolic blood
pressure of 140 mm Hg or above or a diastolic pressure of 90 mm
Hg or above. For an intelligent continuing appraisal of the severity of the disease, upon admittance to the hospital, a systematic study should be instituted that includes the following:
1. An appropriate history and general physical examination followed by daily search for the development of
signs and symptoms such as headache, visual disturbances, epigastric pain, and rapid weight gain
2. Weight measurement on admittance and every 2 days
thereafter
3. Urine test for protein on admittance and subsequently at
least every 2 days
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MANAGEMENT OF PREECLAMPSIA
For over a century the phrase "toxemia of pregnancy" was used to describe hypertensive disorders
complicating pregnancy. The term was also used for
a variety of other poorly understood conditions, including hyperemesis gravidarum and acute yellow
atrophy of the liver. Because of this ambiguity, the
following classification is now preferred.
Classification of Hypertensive Disorders
in Pregnancy
I.

Pregnancy-induced hypertension
A. Preeclampsia
1. Mild
2. Severe
B. Eclampsia

II. Chronic hypertension preceding pregnancy (any
etiology)
IN. Chronic hypertension (any etiology) with superimposed pregnancy-induced hypertension
A. Superimposed preeclampsia
B. Superimposed eclampsia
It is apparent that virtually all of the hypertensive
diseases that occur during pregnancy are included
in this clinical classification, proposed in 1971. The
original outline has been modified here by the use
of the term "pregnancy-induced hypertension." The
Committee on Terminology of the American College
pf Obstetricians and Gynecologists has established
standard definitions for each of these conditions (1).
Hypertension is defined as a diastolic blood pressure
ofat least 90 mm Hg or a systolic pressure ofat least
14(Tmm Hg, or a rise in the former of at least 15 mm
Hg or in the latter of 30 mm Hg. These blood pressures must be manifested on at least two occasions
fr hours or more apart. Preeclampsia is the develop-

ment of hypertension with proteinuria (presence of
300 mgor more of protein in a 24-hour urine collection or a protein concentration of 1 g or more per
liter in at least two random urine specimens collected
6 hours or more apart) or edema (a generalized accumulation of fluid of greater than 1 + pitting edema
after 12 hours of bed rest or weight gain of 5 pounds
or more in 1 week), or both, induced by pregnancy
after the 20th week of gestation, and sometimes
earlier, when there are extensive hydatidiform changes
in the chorionic villi (2). Another rare event may be
the development of a typical preeclamptic finding
in the absence of any previous hypertension, which
may be the consequence of a rare autoimmune response caused by the presence of the lupus anticoagulant. This lupus anticoagulant may be present,
in fact, without any of the diagnostic features of lupus
erythematosus or without a previous history of
thrombotic episodes (3). Preeclampsia is regarded
as mild unless one or more of the following signs or
symptoms are present, in which case it is classified
as severe:
• Blood pressure readings, with the patient at bed
rest, ofat least 160 mm Hg systolic pressure or 110
mm Hg diastolic pressure on two occasions at least
6 hours apart (in practice, however, one should
not wait 6 hours between blood pressure readings
of greater than 110 mm Hg diastolic pressure
before diagnosing severe pregnancy-induced
hypertension and taking appropriate action)

2
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• Proteinuria levels ofat least 5 g in a 24-hour urine
collection (or 3+ to4 + based on semiquantitative
assay)

H33

• Oliguria (24-hour urinary output of less than
400-500 ml)
• Cerebral or visual disturbances such as altered
consciousness, headache, scotomata, or blurred
vision
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• Pulmonary edema or cyanosis
• Epigastric or right upper quadrant pain, presumably caused by stretching of Glisson's capsule (occasionally the pain precedes hepatic rupture, an
uncommon but catastrophic complication)
• Impaired liver function of unclear etiology
• Thrombocytopenia, postulated to be caused by
platelet adherence to collagen exposed at sites of
disrupted vascular endothelium (4)
Eclampsia is the occurrence of convulsions, not
caused by any coincidental neurologic disease such
as epilepsy, in a woman whose condition also meets
the criteria for preeclampsia Chronic hypertension
is defined as the presence of persistent hypertension,
of whatever cause, before the 20th week of gestation in the absence of hydatidiform mole or extensive molar change, or persistent hypertension beyond
6 weeks postpartum Superimposed preeclampsia
or eclampsia is defined as the development of preeclampsia or eclampsia in a woman with chronic
hypertensive vascular or renal disease (2)

Pathophysiology
Effects on the Mother
Although numerous theories and opinions have
been advanced to explain the etiology of pregnancyinduced hypertension, virtually all authorities agree
on these common features 1) the disease process
is characterized by hypertension and various degrees
of impaired tissue perfusion, and 2) for some unique
and as yet unexplained reason, a pnmigravida has
the highest risk of developing pregnancy-induced
hypertension
There are many potential consequences of pregnancy-induced hypertension for the mother, most
effects, however, can be categorized as cardiovascular, hematologic, and regional perfusion abnormalities
CARDIOVASCULAR EFFECTS

The primary characteristic of preeclampsia is an elevation in blood pressure Blood pressure is the product of cardiac output and peripheral resistance In
a normal pregnancy, the cardiac output increases by
30-50%, this increase is maintained in patients with
preeclampsia (5) The elevation in blood pressure
seen in pregnancy-induced hypertension is, therefore, probably the direct result of a change in
peripheral vascular resistance
The exact reasons for increased vascular resistance
remain a mystery, some pioneering work (6), how-

ever has led investigators to examine the pressor effects ot angiotensin II in pregnancy A relative refractory response to the pressor effects of angiotensin I!
in late normal pregnancy has been observed Additional studies (7) have indicated that preeclamptic
patients lose their pregnancy-associated refractoriness to angiotensin II Further work (8) has reported
that women predisposed to pregnancy-induced
hypertension become progressively more sensitive
to the pressor effects oi infused angiotensin II after
18 weeks of gestation This increased sensitivity to
the pressor effects of angiotensin II, and possibly to
other pressor agents as well, often results in alterations of regional perfusion, which may lead to the
other physiologic changes observed with pregnancyinduced hypertension, such as changes in the hematologic system
HEMATOLOGIC EFFECTS

The most frequent hematologic consequence of
pregnancy-induced hypertension is the constriction
of plasma volume, which can result in decreased
regional perfusion and could subject the woman to
hypovolemic shock if antepartum or postpartum
hemorrhage occurs These patients are not hypovolemic but are volume constricted Thus, the vascular system is not underfilled but is constricted by
the pressor effects noted above This observation is
clinically substantiated by the observation of a rising hematocrit as the severity and duration of pregnancy-induced hypertension increases
Thrombocytopenia is the most frequent coagulation abnormality that occurs in women with pregnancy-induced hypertension (4) The frequency and
severity of this condition is increased with earlier
onset or in patients with chronic hypertension and
superimposed preeclampsia The thrombocytopenia
itself is probably a manifestation of microangiopathic
hemolytic anemia This entity is characterized by
hemolytic anemia accompanied by bizarre red
blood cell morphology and consumption of platelets
and other coagulation factors It is likely to be the
consequence of endothelial damage resultmgfrom
the arteriolar spasm that accompanies pregnancyinduced hypertension This syndrome is a variation
of disseminated intravascular coagulation, but the
full picture of disseminated intravascular coagulation is usually not observed
REGIONAL PERFUSION ABNORMALITIES

Renal blood flow is reported to decrease in women
with pregnancy-induced hypertension This decrease
in renal plasma flow averages 20%, and glomerular
filtration rates decrease by,an average of 32% (9)
There is evidence that hepatic blood flow and perfu-

20 ml of a 50% magnesium sulfate solution, one-half
(5 g) of which is injected deeply in the upper outer
quadrant of each buttock (10 gtotal dose). Thereafter,
10 ml of a 50% magnesium sulfate solution (5 g) is
injected intramuscularly into alternate buttocks
every 4 hours (14). Another method of administering magnesium sulfate involves a similar 4-g intravenous loading dose followed by continuous intravenous infusion of 1-3 g/h, depending on the intensity of the patellar reflex. For the administration of
magnesium sulfate to continue, the patient should
have 1) a patellar reflex; 2) urine flow greater than
25 ml/h; and 3) respiration greaterthan 12/min (15).
If magnesium levels are obtained, they should be 4-8
mg/dl. Magnesium toxicity most often can be reversed by the slow intravenous administration of 10%
calcium gluconate and nasal oxygen. In instances
in which toxicity cannot be reversed with calcium
gluconate, respiration must be supported until magnesium levels in plasma are reduced.

fusion to the extremities are reduced, but a consensus is lacking in these areas of research.
Usually cerebral blood flow is unaltered by pregnancy-induced hypertension (10). It is important to
note that hydralazine and magnesium sulfate appear
to increase cerebral blood flow and oxygen consumption in women with pregnancy-induced hypertension, whereas barbiturates are reported to increase cerebrovascular resistance and decrease cerebral blood flow and oxygen consumption (11).
Effects on the Fetus
The decrease in maternal-placental perfusion that
accompanies maternal vascular spasm in pregnancyinduced hypertension is believed to account for the
increased perinatal morbidity and mortality associated with this disease process. Although several
methods have been used to measure uteroplacental
perfusion, all methods thus far used have revealed
a decrease of approximately 50-70% in uteroplacental blood flow in women with pregnancy-induced
hypertension (12).
The use of diuretics and antihypertensive agents
does not result in improved uteroplacental blood
flow in women with pregnancy-induced hypertension
(12). The failure to increase uteroplacental blood flow
and to lower perinatal mortality is probably the result of diuretics further decreasing plasma volume.
Similarly, antihypertensive therapy in patients with
pregnancy-induced hypertension has failed to improve
outcome, probably because uteroplacental blood
flow is directly related to uterine arterial blood pressure, which may be reduced by this treatment (13).

Antihypertensive therapy consists of the intermittent intravenous administration of hydralazine (14).
In a patient with a diastolic blood pressure of 110 mm
Hg, 5 mg of hydralazine is given intravenously and
blood pressure is monitored every 5 minutes. The
goal of therapy is to reduce diastolic blood pressure
to the range oi 90-100 mm Hg.
Vaginal delivery usually can be accomplished by
initiating labor with intravenous oxytocin. Relatively
rapid labor may ensue in patients with severe preeclampsia. The final decision for a vaginal versus an
abdominal delivery, however, is based on an evaluation of all maternal and fetal indications. Diuretics
and hyperosmotic agents should not be used.
For a patient who has mild pregnancy-induced
hypertension with an immature fetus, the goal of
therapy should be to 1) retard the hypertensive
process so as not to endangerthe mother orthefetus,
2) allow time for the fetus to mature and increase the
potential for neonatal survival, and 3) allowthecervix to ripen and therefore increase the probability
for a vaginal delivery. Therapy forthese patients can
be conducted by either ambulatory management or
hospitalization. Ambulatory management is acceptable for patients who are compliant, who can have
frequent office visits including laboratory assessments, and who can perform some form of adequate
blood pressure monitoring at home. Hospitalization
should be required for noncompliant patients and
those who show unsatisfactory progress as outpatients. In either situation, the following regimen
should be recommended:

Clinical Management
In the past, essential management included preventing convulsions, controlling blood pressure, and
delivering the baby. This is still the best approach if
preeclampsia occurs when the fetus is mature. When
the fetus is immature, delivery should be effected if
there is severe preeclampsia, fetal growth retardation, or fetal distress. If, however, a patient has mild
preeclampsia and the fetus is immature and apparently healthy, ambulatory or hospital management
without delivery is acceptable (Table 1).
When delivery is indicated, the prevention or treatment of convulsions involves the use of parenteral
magnesium sulfate, which may be given either intramuscularly or intravenously. One method of administration is as follows. A 20-ml injection of a 20%
magnesium sulfate solution (4g) is given intravenously over'? minutes? This is immediately fo!' )wed by

• Ambulation with modified bed rest in the lateral
decubitus position
3

TABLE 1. CLINICAL MANAGEMENT OF PATIENTS WITH PREGNANCY INDUCED HYPERTENSION
Therapy

Clinical Condition
Expectant

Mild pregnancy-induced hypertension
and immature fetus
Compliant patient and improvement

1) Ambulatory management
a See patient twice a week
b Fetal surveillance*
c Bed rest
d Educate about increasing severity of the disease
e Weight daily
f Home blood pressure monitoring

Noncompliant patient or lack of improvement

2) Hospitalization
a Urine protein daily
b Fetal surveillance*
c Regular diet
d No salt restriction
e Weight daily
f Blood pressure four times a day

Severe pregnancy-induced hypertension and
immature fetus in the presence of fetal growth
retardation or fetal jeopardy

Definitive
1) Prevent convulsions (magnesium sulfate)
2) Control blood pressure (hydralazine)
3) Deliver by vaginal or cesarean birth, depending upon
fetal and maternal conditions

Severe pregnancy-induced hypertension and
mature fetus

Definitive
1) Prevent convulsions (magnesium sulfate)
2) Control blood pressure (hydrazalme)
3) Deliver by vaginal or cesarean birth, depending upon
fetal and maternal conditions

* Fetal surveillance is defined as tests of fetal well being including but not limited to fetal movement charts contraction stress tests nonstress tests and
biophysical profiles

•

R E F E R E N C E S

Regular diet

• B l o o d pressure measurements

four times daily
HughesHC (ed) Obstetnc-GynecologicTerminology
Philadelphia, F A Davis Company, 1972, pp 422-423

• W e i g h t and urine protein recorded t w o or three
times w e e k l y

Pntchard JA, MacDonald PC, Cant NF (eds) Williams
Obstetrics, 17 ed Norwalk, Connecticut, AppletonCentury Crofts, 1985, p 525
Branch DW Scott JR, Kochenour NK,etal Obstetric
complications associated with the lupus anticoagulant
N Engl J Med 313(21) 1322-1326, 1985
Pntchard JA Cunningham FG, Mason RA Coagula
tion changes in eclampsia Their frequency and pathogenesis Am J Obstet Gynecol 124(8) 855-864, 1976

• Creatinine clearance r e c o r d e d w e e k l y
•

Fetal surveillance

•

Serial sonography
A patient is considered a c a n d i d a t e for i n d u c t i o n

of labor if she has reached 37 weeks of gestation, the
fetus is mature, and the c o n d i t i o n of t h e cervix is
favorable She is also a candidate for i n d u c t i o n if her
diastolic b l o o d pressure c o n t i n u e s to rise despite
conservative m a n a g e m e n t

A patient w i t h

Assail NS, Holm LW, Parker HR Systemic and regional hemodynamic alterations in toxemia Circulation
30(2 Suppl) 53-62, 1964

mild

p r e g n a n c y - i n d u c e d hypertension may be f o l l o w e d
beyond 37 weeks of gestation if fetal evaluation is

Abdul-Kanm R, Assail NS Pressor response to angiotonin in pregnant and nonpregnant women Am J
Obstet Gynecol 82(2) 246-251, 1961

n o r m a l a n d the c o n d i t i o n of t h e cervix is unfavorable I n d i v i d u a l i z e d t r e a t m e n t is necessary
4
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APPENDIX 5
UTAH VITAL STATITSTIC SUMMARY

UTAH'S VITAL STATISTICS SUMMARY
UTAH DEPARTMENT OF HEALTH
BUREAU OF VITAL RECORDS & HEALTH STATISTICS
CENTER FOR HEALTH STATISTICS

TECHNICAL REPORT NO. 164
DECEMBER 1992

FINAL VITAL STATISTICS, JANUARY 1 - DECEMBER 31, 1991
UTAH'S INFANT MORTALITY RATES DROPPED TO AN ALL-TIME LOW OF 6.2 PER THOUSAND LIVE BIRTHS IN 1991, THE LOWEST IN
UTAH'S HISTORY. THIS WAS A DECREASE OF 16 PERCENT FROM THE PREVIOUS RECORD LOW RATE OF 7.4 IN 1990. THE NUMBER OF
INFANT DEATHS DECREASED BY MORE THAN 18 PERCENT FROM 269 IN 1990, TO 222 IN 1991. THE PROVISIONAL RATE IN THE UNITED
STATES WAS 8.9 IN 1991, A DECREASE BY TWO PERCENT FROM 9.1 THE PREVIOUS YEAR. THIS ALSO WAS THE LOWEST RATE EVER
RECORDED FOR THE UNITED STATES.
THERE WERE 36,016 LIVE BIRTHS TO UTAH'S RESIDENTS IN 1991. THIS IS A DECREASE OF LESS THAN ONE PERCENT BELOW THE
36,253 IN 1990. THE CRUDE BIRTH RATE, THE NUMBER OF RESIDENT LIVE BIRTHS PER 1,000 RESIDENTS, ALSO DECREASED BY LESS
THAN ONE PERCENT, FROM 21.0 IN 1990 TO 20.3 IN 1991. THE PROVISIONAL BIRTH RATE NATIONALLY WAS 16.2 IN 1991, A THREE
PERCENT DECLINE FROM THE RATE OF 16.7 IN 1990.
BOTH THE NUMBER AND RATE OF BIRTHS TO UNMARRIED WOMEN INCREASED BETWEEN 1990 AND 1991. IN 1991, THERE WERE 5,195
INFANTS BORN TO UNMARRIED WOMEN, AN INCREASE OF ALMOST SIX PERCENT ABOVE THE 4,910 IN 1990. THE RATE OF BIRTHS TO
UNMARRIED WOMEN INCREASED BY ALMOST SEVEN PERCENT FROM 135.4 IN 1990 TO 144.2 PER THOUSAND LIVE BIRTHS IN 1991. THIS
IS THE SEVENTEENTH CONSECUTIVE YEAR THIS RATE HAS INCREASED IN UTAH, FROM 38.0 IN 1974 TO 144.2 THIS PAST YEAR.
NATIONALLY, THERE WERE 270.8 BIRTHS TO UNMARRIED WOMEN FOR EVERY 1,000 LIVE BIRTHS IN 1989, THIS WAS FIVE PERCENT HIGHER
THAN THE 257.1 IN 1988.
THE NUMBER AND RATIO OF INDUCED ABORTIONS TO UTAH'S RESIDENTS DECREASED BETWEEN 1990 AND 1991. IN 1991, THERE WERE
3,759 ABORTIONS REPORTED TO RESIDENTS OF THE STATE. ALTHOUGH MOST OF THESE OCCURRED IN-STATE, 111 WERE REPORTED TO HAVE
OCCURRED IN OTHER STATES. IN 1990, THERE WERE 4,159 ABORTIONS REPORTED TO RESIDENTS OF UTAH, WITH 99 OF THESE OCCURRING
IN OTHER STATES. THE NUMBER OF ABORTIONS DECREASED BY ALMOST TEN PERCENT, AND THE ABORTION RATIO DECREASED BY NINE
PERCENT, FROM 114.7 TO 104.4 PER 1,000 LIVE BIRTHS. NATIONALLY, PRELIMINARY DATA FOR 1989, THE LATEST YEAR AVAILABLE,
SHOW THERE WERE 345.6 ABORTIONS FOR EVERY ONE THOUSAND LIVE BIRTHS, WHICH IS A DECREASE OF ABOUT TWO PERCENT FROM THE
352 REPORTED IN 1988.
IN 1991, THERE WERE 9,576 DEATHS TO RESIDENTS OF UTAH, AN INCREASE OF FIVE PERCENT COMPARED WITH THE 9,135 IN 1990.
THE CRUDE MORTALITY RATE INCREASED BY ALMOST TWO PERCENT, TO 5.4 PER 1,000 POPULATION, COMPARED WITH 5.3 THE PREVIOUS
YEAR. THE PROVISIONAL MORTALITY RATE NATIONALLY FOR 1991, 8.5 DEATHS PER 1,000 POPULATION, DECEASED BY SLIGHTLY MORE
THAN ONE PERCENT FROM THE RATE OF 8.6 IN 1990.
IN 1991, ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND AIDS RELATED DEATHS BECAME THE 12TH LEADING CAUSE OF DEATH
FOR RESIDENTS OF UTAH, MOVING UP FROM THE 16TH PLACE IN 1990. THE NUMBER OF DEATHS INCREASED BY 24 PERCENT FROM 58 TO
72 SINCE 1990. NATIONALLY, AIDS ROSE FROM THE 11TH LEADING CAUSE IN 1990, TO THE 9TH LEADING CAUSE IN 1991. THE NUMBER
OF AIDS RELATED DEATHS NATIONALLY INCREASED FROM AN ESTIMATED 24,120 IN 1990, TO 29,850 IN 1991, ALSO A 24 PERCENT
INCREASE FOR THE YEAR.
TABLE 1
FINAL VITAL STATISTICS, RESIDENTS: UTAH AND UNITED STATES, 1990-91

UUMBER
EVENTS
LIVE BIRTHS
DEATHS
NATURAL INCREASE
MARRIAGES
DIVORCES
BIRTHS TO UNMARRIED WOMEN
LOW BIRTH WEIGHT, <2,500 GRAMS
INDUCED ABORTIONS
FETAL DEATHS
INFANT DEATHS
NEONATAL
POSTNEONATAL
POPULATION IN MILLIONS

X
(

1991

1990

\

36,253
J
9,125^/

RATES
REVISED
1991
1990

U. S. RATES
PROVISIONAL
1990
1991

20.3

21.0

16.2

5.3

8.5

19,427
8,950
4,910
2,070
4,159

5.4
14.9
11.0

15.7
11.2

5.2

7.7
9.4

4.7

4.7

144.2
60.5
104.4

135.4
57.1
114.7

270.8
70.4
345.6

198
222
109
113

189
269
137
132

5.5
6.2
3.0
3.1

5.2
7.4
3.8
3.6

N.A.
N.A.
N.A.
N.A.

1.775

1.729

36,016

N^g>76
^

-\

^\\

'

—
19,472
8,700
5,195
2,179
3,759

4.9

--

16.7
8.6
8.1
9.8

8.9
5.4
3.4

7.5
9.1
5.7
3.3

252.2

249.5

NOTES: POPULATIONS ARE REVISED ESTIMATES BASED ON CENSUS OF POPULATION ON APRIL 1, 1990. ALL
PREGNANCY OUTCOME RATES AND RATIOS ARE PER 1,000 LIVE BIRTHS. INDUCED ABORTIONS AND FETAL DEATHS
ARE DEFINED AS RATIOS. FOR THE U.S., THE RATES FOR BIRTHS TO UNMARRIED WOMEN AND LOW BIRTI
WEIGHT AND THE RATIOS FOR ABORTIONS AND FETAL DEATHS ARE FINAL FOR 1989. N.A. IS NOT AVAILABLE.

TABLE 2
ESTIMATED POPULATION, BIRTHS, DEATHS, NATURAL INCREASES, MARRIAGES, DIVORCES AND ANNULMENTS
BY HEALTH DISTRICT AND COUNTY OF RESIDENCE: UTAH, 1991
HEALTH
DISTRICT/
COUNTY OF
RESIDENCE

NUMBER

RATE

NUMBER

RATE

NATURAL
INCREASE

NUMBER

RATE

NUMBER

RATE

1,775,100

36,016

20.3

9,576

5.4

26,440

19,472

11.0

8,700

4.9

110,700
37,100
71,900
1,700

2,382

581
213
361
7

5.2
5.7
5.0
4.1

1,801

1,342

12.1

505

242

6.5

1,278

1,082

18

18

15.0
10.6

316
179
136
1

2.9
4.8
1.9

25

21.5
19.4
22.8
14.7

53,750
6,000
11,600
1,350
16,900
15,700
2,200

910
89
210
15
305
261
30

16.9
14.8
18.1
11.1
18.0
16.6
13.6

435
58
80
17
147
111
22

8.1
9.7
6.9

20.8

12.6

46
70
9
863
118
11

7.7
6.0
6.7
7.5
5.0

192
28
41
8
43
69
3

3.6
4.7
3.5
5.9
2.5
4.4

10.0

475
31
130
-2
158
150
8

1,117

DAVIS

195,000

3,760

19.3

730

3.7

3,030

1,099

5.6

983

5.0

SALT LAKE

747,000

14,782

19.8

4,089

5.5

10,693

10,251

13.7

4,063

5.4

SOUTHEASTERN
CARBON
EMERY
GRAND
SAN JUAN

50,300
20,600
10,200
6,800
12,700

961
343
205
88
325

19.1
16.7
20.1
12.9
25.6

338
151
59
59
69

6.7
7.3
5.8
8.7
5.4

623
192
146
29
256

8.1
8.6
6.6

210
108
30
53
19

4.2
5.2
2.9
7.8
1.5

SOUTHWEST
BEAVER
GARFIELD
IRON
KANE
WASHINGTON

87,600
4,850
4,100
21,500
5,250
51,900

1,635

18.7
15.9
18.5
20.8
17.0
18.2

668
48
53
120
40
407

7.6
9.9

12.5

5.6
7.6
7.8

967
29
23
328
49
538

1,091

77
76
448
89
945

43
29
152
51
816

8.9
7.1
7.1
9.7
15.7

482
26
13
117
21
305

5.5
5.4
3.2
5.4
4.0
5.9

SUMMIT

16,600

282

17.0

61

3.7

221

271

16.3

72

4.3

TOOELE

27,200

479

17.6

140

5.1

339

229

8.4

133

4.9

UINTAH BASIN
DAGGETT
DUCHESNE
UINTAH

36,600

19.4
17.1
19.2
19.6

207
7
79
121

5.7

374
50
102
222

8.0
9.6

144
0
40
104

3.9

6.2
5.2

504
5
167
332

10.2
71.4

12,800
23,100

711
12
246
453

3.1
4.5

UTAH COUNTY

272,000

6,776

24.9

1,165

4.3

5,611

1,600

5.9

1,028

3.8

10,700

186

17.4

59

5.5

127

112

10.5

47

4.4

18.8
14.0
19.0

1,103

2,049

1,581

1,030

43

49

1,067

6.6
6.4
6.6

1,026

6.1
0.7
6.3

16.2

2,165,000

8.5

1,187,000

4.7

TOTAL
BEAR RIVER
BOX ELDER
CACHE
RICH
CENTRAL UTAH
JUAB
MILLARD
PIUTE
SANPETE
SEVIER
WAYNE

WASATCH
WEBER-MORGAN
MORGAN
WEBER
UNITED STATES

700

167,650
5,650
162,000
252,177,000

BIRTHS

DIVORCE &
ANNULMENTS

ESTIMATED
POPULATION
1 JULY 1991

718
1,639

3,152

79
3,073
4,111,000

DEATHS

36

MARRIAGES

8.7
7.1

12.9

- -

405
177
67
77
84

51.1

11.3

6.6

2,006

1,532

9.4
8.7
9.5

1,946,000

2,371,000

9.4

4

- -

- -

- -

NOTES: FOR UTAH, RATES ARE PER 1,000 POPULATION; HOWEVER, THEY ARE NOT COMPUTED FOR LESS THAN SEVEN VITAL EVENTS. MARRIAGES ARE RECORDED
FOR COUNTY OF OCCURRENCE, WHILE DIVORCES ARE RECORDED FOR COUNTY OF RESIDENCE. FOR THE UNITED STATES ALL FREQUENCIES AND RATES ARE FOR
1991 AND ARE PROVISIONAL.

INFANT MORTALITY--TOTAL, NEONATAL, POSTNEONATAL, OUT-OF-WEDLOCK, LOW WEIGHT BIRTHS AND ABORTIONS
BY HEALTH DISTRICT AND COUNTY OF RESIDENCE: UTAH, 1991

HEATLH
DISTRICT/
COUNTY OF
RESIDENCE
TOTAL
BEAR RIVER
BOX ELDER
CACHE
RICH

TOTAL
NUMBER
RATE

- INFANT MORTA LI 1 T
NEONATAL
BIRTH
TO 28 DAY s
NUMBER
RATE

POSTNEONATAL
28 DAYS
TO 1 YEAR
NUMBER
RATE

BIRTHS TO
UNMARRIED WOMEN
NUMBER
RATE

LOW BIRTH WEIGHT
UNDER
2,500 GRAMS
NUMBER
RATE

INDUCED
ABORTIONS
NUMBER
RATIO

222

6.2

109

3.0

113

3.1

5,195

144.2

2,179

60.5

3,759

104.4

12
6
6
0

5.0

7
3
4
0

2.9

5
3
2
0

--

203
85
117
1

85.2
118.4
71.4

140
58
80
2

58.8
80.8
48.8

124
29
95
0

52.1
40.4
58.0

112
16
19
1
35
38
3

123.1
179.8
90.5

51
1
9
1
15
22
3

56.0

42
2
7
1
20
9
3

46.2

4
0
0
0
4
0
0

--

16

4.3

12

3.2

4

- -

416

110.6

221

58.8

310

82.4

106

7.2

46

3.1

60

4.1

2,603

176.1

970

65.6

2,412

163.2

SOUTHEASTERN
CARBON
EMERY
GRAND
SAN JUAN

11
4
2
2
3

11.4

6
3
1
1
1

281
73
37
40
131

292.4
212.8
180.5
454.5
403.1

55
17
13
4
21

57.2
49.6
63.4

62
34
5
13
10

64.5
99.1

SOUTHWEST
BEAVER
GARFIELD
IRON
KANE
WASHINGTON

5
0
0
2
0
3

186
4
8
42
13
119

113.8

48.9

105.3
93.8
146.1
125.9

80
4
6
26
2
42

SUMMIT

0

20

70.9

TOOELE

1

UINTAH BASIN
DAGGETT
DUCHESNE
UINTAH

2
0
1
1

--

39

CENTRAL UTAH
JUAB
MILLARD
PIUTE
SANPETE
SEVIER
WAYNE
DAVIS
SALT LAKE

UTAH COUNTY
WASATCH
WEBER-MORGAN
MORGAN
WEBER
UNITED STATES

--

3
0
0
0
3
0
0

3
0
0
2
0
1

--

--

--

1
0
0
0
1
0
0

5
1
1
1
2
2
0
0
0
0
2

--

--

--

--

0

--

0

--

--

0

--

1

- -

114.8
145.6

42.9
49.2
84.3

64.6

33.3
65.6
34.5

147.7
30.8

7.3

44.4

12
0
1
4
2
5

10

35.5

96

340.4

58.0

98

204.6

33

68.9

57

119.0

135
0
41
94

189.9

77.4
85.4
75.1

38
2
14
22

53.4

166.7
207.5

55
0
21
34

3.2

469

69.2

330

48.7

205

30.3

1

--

19

102.2

12

64.5

14

11
0
11

3.5

70.6

387
2
385

122.8

211.2

222
5
217

70.4

3.6

653
4
649

207.2

3.9

5.5

13,800

3.4

1,094,169

270.8

284,391

70.4

1,396,658

345.6

1
0
1
0

--

5.8

17

2.5

22

3

--

2

--

23
0
23

7.3

12
0
12

3.8

7.5

36,600

8.9

22,640

1
0
0
1

--

|

56.9
48.6

75.3 J
125.3

NOTES: FOR UTAH, THE RATES AND RATIOS ARE PER 1,000 LIVE BIRTHS; HOWEVER, THEY ARE NOT COMPUTED FOR FEWER THAN SEVEN EVENTS. THE INDUCED
ABORTION TOTAL INCLUDES 111 EVENTS TO RESIDENTS OF UTAH WHICH OCCURRED OUT-OF-STATE. FOR THE UNITED STATES, FREQUENCIES AND RATES FOR
INFANT MORTALITY ARE FOR 1991 AND PROVISIONAL; FREQUENCIES AND RATES FOR BIRTHS TO UNMARRIED WOMEN AND LOW BIRTH WEIGHT AND THE FREQUENCY
AND RATIO FOR INDUCED ABORTIONS ARE FOR 1989 AND FINAL.

TABLE 4
DEATHS BY SELECTED CAUSES AND AGE, RESIDENTS: UTAH, 1991

038042-044
001-037.039-041
045-139
140-208
140-149
150-159
160-165

174-175
179-187
188-189
170-173,190-199
204-208
200-203
210-239
250
260-269
280-285
390-448
390-398.402,404-429
390-398
402,404410-414
410411-414
424415-423,425-429
401-403
430-438
434430,433,435-438
440441-448
480-487
480-486
487490-496
490-491
492493494-496
531-533
550-553,560
571580-589

740-759
760-779
767-769
760-766,770-779
780-799
E800-E949
E810-E825
E800-E807,E826-E949
E950-E959
E960-E978
E980-E999
RESIDUAL

CAUSE OF DEATH (9TH REV)

RATES

ALL
AGES

<1

1-4

5-14

15-24

25-34

35-44

45-54

55-64

65-74

75+

UNKNOWN

TOTAL. ALL CAUSES
SEPTICEMIA
ACQUIRED IMMUNODEFICIENCY SYNDROME
ALL OTHER INFECTIOUS AND PARASITIC
DISEASES
MALIGNANT NEOPLASMS
MALIGNANT NEOPLASMS OF LIP, ORAL
CAVITY AND PHARYNX
MALIGNANT NEOPLASMS OF DIGESTIVE
ORGANS AND PERITONEUM
MALIGNANT NEOPLASMS OF RESPIRATORY
AND INTRATHORACIC ORGANS
MALIGNANT NEOPLASMS OF BREAST
MALIGNANT NEOPLASMS OF GENITAL ORGANS
MALIGNANT NEOPLASMS OF URINARY ORGANS
MALIGNANT NEOPLASMS OF ALL OTHER
AND UNSPECIFIED SITES
LEUKEMIA
OTHER MALIGNANT NEOPLASMS OF
LYMPHATIC AND HEMATOPOIETIC TISSUES
BENIGN NEOPLASMS, CARCINOMA IN SITU
AND NEOPLASMS OF UNCERTAIN BEHAVIOR AND
OF UNSPECIFIED NATURE
DIABETES MELLITUS
NUTRITIONAL DEFICIENCIES
ANEMIAS
MAJOR CARDIOVASCULAR DISEASES
DISEASES OF HEART
RHEUMATIC FEVER AND RHEUMATIC HEART
DISEASE
HYPERTENSIVE HEART DISEASE, HYPERTENSIVE
HEART AND RENAL DISEASE
ISCHEMIC HEART DISEASE
ACUTE MYOCARDIAL INFARCTION
OLD MYOCARDIAL INFARCTION AND OTHER
FORMS OF CHRONIC ISCHEMIC HEART
DISEASE
OTHER DISEASES OF ENDOCARDIUM
ALL OTHER FORMS OF HEART DISEASE
HYPERTENSION WITH OR WITHOUT RENAL
DISEASE
CEROBROVASCULAR DISEASES
OCCLUSION OF CEREBRAL ARTERIES
ALL OTHER AND LATE EFFECTS OF
CEREBROVASCULAR DISEASE
ATHEROSCLEROSIS
OTHER DISEASES OF ARTERIES, ARTERIOLES
AND CAPILLARIES
PNEUMONIA AND INFLUENZA
PNEUMONIA
INFLUENZA
CHRONIC OBSTRUCTIVE PULMONARY DISEASES
AND ALLIED CONDITIONS
BRONCHITIS, CHRONIC AND UNSPECIFIED
EMPHYSEMA
ASTHMA
OTHER CHRONIC OBSTRUCTIVE PULMONARY
DISEASES AND ALLIED CONDITIONS
ULCER OF STOMACH AND DUODENUM
HERNIA OF ABDOMINAL CAVITY AND INTESTINAL
OBSTRUCTION WITHOUT MENTION OF HERNIA
CHRONIC LIVER DISEASE AND CIRRHOSIS
NEPHRITIS, NEPHROTIC SYNDROME, AND
NEPHROSIS
CONGENITAL ANOMALIES
CERTAIN CONDITIONS ORIGINATING IN THE
PERINATAL PERIOD
BIRTH TRAUMA. INTRAUTERINE HYPOXIA
BIRTH ASPHYXIA AND RESPIRATORY
DISTRESS SYNDROME
OTHER CONDITIONS ORIGINATING IN THE
PERINATAL PERIOD
SYMPTOMS, SIGNS AND ILL-DEFINED CONDITIONS
ACCIDENTS AND ADVERSE EFFECTS
MOTOR VEHICLE ACCIDENTS
ALL OTHER ACCIDENTS AW ADVERSE EFFECTS
SUICIDE
HOMICIDE AND LEGAL INTERVENTION
ALL OTHER INJURIES
ALL OTHER DISEASES

539.5
5.1
4.1

9,576
90
72

222
1
0

63
1
0

83
0
0

202
0
1

300
3
27

421
1
25

466
5
13

979
9
4

1,942
22
2

4,897
48
0

1
0
0

2.1
110.4

38
1,959

2
2

0
5

0
7

0
9

3
33

6
98

2
148

4
375

7
564

14
718

0
0

1.1
0.0
26.0

19

0

0

0

0

2

0

2

4

5

6

0

461

0

0

0

0

4

20

41

83

122

191

0

19.5
11.0
16.3
4.3

346
196
290
77

0
0
0
0

0
0
0
0

0
0
0
0

0
0
0
0

2
4
5
1

8
12
8
0

19
28
9
3

97
47
34
12

122
54
85
28

98
51
149
33

0
0
0
0

17.7
5.2

315
92

1
0

3
1

3
3

3
3

8
4

35
8

31
3

50
17

79
25

102
28

0
0

9.2

163

3.0

53

NOTES: MORTALITY RATES ARE PER 100,000 POPULATION.
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1
0
116
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35
3
2
307
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13

24

97
2
2
721
586

148
18
13
2,436
1,760
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7
1
0
19
11

14
0
0
48
39

0

1

0

1

4

19

28

0
0
0

0
5
4

2
21
6

4
54
29

21
149
90

26
353
208

68
1,022
468

0
0
0

0

0

1

15

25

59

145

554

0

0
1

0
1

1
4

1
15

1
35

5
71

13
175

47
595

0

0
0
0

1
1
0

0
1
1

0
5
0

0
7
1

1
17
1

4
43
4

10
100
9

34
514
46

1
0

0
0

1
0

0
0

5
0

6
0

16
0

39
2

91
5

468
65

0

100
389
387
2

0
3
3
0

0
2
2
0

1
1
1
0

0
0
0
0

3
6
5
1

2
8
8
0

3
6
6
0

8
17
17
0

20
55
55
0

63
291
290
1

o

24.1
1.1
4.1
1.8

428
19
73
32

0
0
0
0

0
0
0
0

1
0
0
1

2
0
0
2

2
0
0
2

2
0
0
1

11
0

165
5
31
8

208
10
36
9

o

4

37
4
5
5

17.1
2.1

304
37

0
0

0
0

0
0

0
0

0
0

1
0

6
3

23
1

121
6

153
27

o

3.0
4.7

53
83

0
0

0
0

0
0

0
0

0
0

0
12

2
14

3
21

14
20

34
16

6.0
5.4

106
96

1
60

0
10

0
4

0
2

2
6

3
4

1
6

6
1

21
2

72
1

0

3.4

61

59

1

1

0

0

0

0

0

0

0

0

323
25
18
3,660
2,749

0
0
0
2
1

0
0
1
5
5

1
0
0
4
1

0
0
0
2
1

3.0

53

0

0

0

6.8
90.4
45.3

121
1,604
805

0
0
0

0
0
0

0
0
0

45.0

799

0

0

3.8
50.9

68
903

0
1

0
5

2.8
38.8
3.5

50
689
62

0
1
0

35.3
4.1

627
72

5.6
21.9
21.8
0.1

18.2
1.4
1.0
206.2
154.9

o

o
0

0

0
0
0

0.3

6

6

0

0

0

0

0

0

0

0

0

0

3.1

55

53

1

1

0

0

0

0

0

0

0

0

9.6
26.1
14.6
11.5
15.9
3.4
2.2
60.2

171
463
259
204
282
61
39
1,069

66
10
1
8
0
3
2
11

1
27
12
16
0
5
0
4

1
38
19
19
4
10
0
11

3
89
72
17
64
13
4
12

4
78
53
25
55
11
15
26

4
59
34
25
68
11
9
47

6
30
19
11
28
3
6
40

4
29
12
17
22
3
1
89

13
26
16
10
22
0
1
167

69
77
21
56
19
1
1
662

IN 1987, THE NATIONAL CENTER FOR HEALTH STATISTICS BEGAN TO CODE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
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PREGNANCYRELATED
HYPERTENSION

JAMES M. ROBERTS, M.D.

CLASSIFICATION AND
DEFINITIONS
The hypertensive disorders of pregnancy
challenge the medical and obstetric skills of
the health care team. Decisions as to the
possible use and appropriate choice of pharmacologic agents require not only an understanding of the pathophysiology of the hypertensive disorders and a recognition of the
pharmacokinetic changes occurring during
pregnancy but also an appreciation of the
possible fetal effects of such therapeutic
agents. Obstetric management demands meticulous maternal observation and use of tests of
fetal-placental function and fetal maturity in
order to weigh maternal risks and the risks to
the infant of intrauterine versus extrauterine
existence.
Recent information has provided new insights into the pathophysiology of the hypertensive disorders of pregnancy and has suggested methods of evaluating and treating the
patient with these disorders.
The management of elevated blood pressure
and the impact of the disorder on the mother
and her fetus are quite different when hypertension antedates pregnancy from when the
appearance of elevated blood pressure signals
the onset of a specific pregnancy-related vasospastic condition. An attempt to differentiate these patients has led to several systems
of nomenclature and classification. The hypertensive disorders of pregnancy were for many
years called toxemias of pregnancy, a term that
originally even included hyperemesis gravidarum and acute yellow atrophy of the liver. This
term reflected the opinion that these disorders
had, as a common etiology, circulating toxins.
Failure to identify these toxins did not lead to
a revision of this terminology, signifying the
continuing confusion that has plagued the taxonomy of these disorders. This archaic terminology, which neither describes the disorders

nor clarifies their etiology, has rightly been
abandoned.
One of the difficulties in interpreting studies
of the hypertensive disorders of pregnancy is
the inconsistency of terminology (Rippman,
1969). Several systems of nomenclature are in
Use around the world. The system prepared by
the Committee on Terminology of the American College of Obstetricians and Gynecologists (Hughes, 1972), even though imperfect
like all such systems, has the advantage of
clarity and is available in published form to
investigators throughout the world. This classification is as follows:
Chronic hypertension
Preeclampsia-eclampsia
Preeclampsia superimposed upon chronic
hypertension
Transient hypertension
Unclassified
The various classifications are explained in the
following discussion.

Chronic Hypertension
Chronic hypertension is defined as hypertension that is present and observable prior to
pregnancy or that is diagnosed before the 20th
Week of gestation. The Committee has defined
hypertension as a blood pressure greater than
140/90 mm Hg. Hypertension diagnosed for
the first time during pregnancy that persists
beyond the 42nd day postpartum is also classified as chronic hypertension.

Preeclampsia-Eclampsla
The diagnosis of preeclampsia is determined
by increased blood pressure accompanied by
proteinuria, edema, or both. Blood pressure
must increase by at least 30 mm Hg systolic or
777
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15 mm Hg diastolic. If prior blood pressure is
not known, readings of 140/90 after 20 weeks
gestation are considered sufficiently elevated
for diagnosis of preeclampsia. This elevation
must be present at two measurements taken 6
hours apart.
Page and Christianson (1976) advocated the
use of mean arterial pressure during pregnancy. Mean pressures are determined by the
following relationship:
Mean arterial pressure =
Systolic BP + (2 x Diastolic BP)
3
which can be simplified for clinical use to:
Mean arterial pressure =
Diastolic pressure -f (16 x Pulse pressure)
The use of mean arterial pressure eliminates
confusion regarding the significance of diastolic
or systolic hypertension. For example, if one
regards a mean arterial pressure of 105 as
defining risk, this level may be associated with
diastolic "hypertension" (125/95) or systolic
"hypertension" (155/80). In addition, mean
blood pressures are much easier to deal with
statistically. The obvious disadvantage is that
obstetricians are not familiar with the use of
mean pressures. The Committee defines either
an increase in mean arterial pressure of 20 mm
Hg or, if a prior blood pressure is not known,
a mean arterial pressure of 105 mm Hg as
indicative of hypertension.
Proteinuria is defined as the excretion of 0.1
gm/liter of protein in a random specimen or
0.3 gm/liter in a 24-hour specimen. Interestingly, the Committee did not define the minimum amount of protein excreted in 24 hours
th&t can be considered diagnostic. On the basis
of usual urinary output, the minimum would
be about 0.3 gm/day. Edema is diagnosed as
clinically evident swelling, but fluid retention
may also be manifest as a rapid increase of
weight without evident swelling.
Preeclampsia has mild and severe forms.
Severe preeclampsia is diagnosed when the
following criteria are present:
1. Bk)od pressure of 160 mm Hg or more
systolic, or 110 mm Hg or more diastolic,
recorded on at least two occasions at least 6
hours apart, with the patient at bed rest.
2. Proteinuria of 5 gm or more in 24 hours
(3- or 4-plus on qualitative examination).
3. Oliguria (500 ml or less in 24 hours).
4. Cerebral or visual disturbances.
5. Epigastric pain.
6. Pulmonary edema or cyanosis.
Eclampsia is the occurrence of seizures in a

preeclamptic patient that cannot be attributed
to other causes.

Preeclampsia Superimposed Upon
Chronic Hypertension
There is ample evidence that preeclampsia
may occur in women already hypertensive and
that the prognosis for mother and fetus is much
worse than with either condition alone. The
Committee on Terminology recommends that
the diagnosis be made on the basis of increases
of blood pressure (30 mm Hg systolic and 15
mm Hg diastolic, or 20 mm Hg mean arterial
pressure) together with the appearance of proteinuria or generalized edema.

Transient Hypertension
Transient hypertension is the development
of elevated blood pressure during pregnancy
or in the first 24 hours postpartum without
other signs of preeclampsia or pre-existing
hypertension.

Unclassified Hypertension
Information about these disorders is insufficient for classification. This category should be
used for a minority of patients with hypertensive disorders of pregnancy.

Problems with Classification
The degree of blood pressure elevation that
constitutes gestational hypertension is contrcTversial. Because average blood pressure in
women in their teens to 2Us is 12U/6U mm HgT
the standard dennition ot hypertension—bloocT
' pressure greater than 14U/9U mm Hg—is
* judged by some investigators to be too high
XVartran, 1966). There is evidence that the
rate of perinatal mortality is increased irT
'women with blood pressures even lower than""
140/90 (Page, 1976)
^ There are also problems inherent in the use
of blood pressures measured in the first trimester to diagnose chronic hypertension or to
define basal blood pressure for the diagnosis
of preeclampsia. Blood pressure usually decreases early in pregnancy, reaching its nadir
at about the stage of pregnancy at which
women usually present for obstetric care (Fig.
41-1). The decrease averages 7 mm Hg for
diastolic and systolic readings. In some
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FIGURE 41-1. Mean blood pressure by gestational
age in 6,000 white women 25 to 34 years of age who
delivered single term infants (From Chnstianson
R Page EW Studies on blood pressure during
pregnancy Influence of parity and age Am J Obstet
Gynecol 125 509, 1976 Copyright 1976 by Amen
can College of Obstetricians and Gynecologists )
women, obviously, blood pressure decreases
more than 7 mm Hg, and in others, the early
decline and subsequent return of blood pressure to pre-pregnant levels in late gestation
will be sufficient to diagnose preeclampsia
There is evidence that women hypertensive
prior to pregnancy actually have a greater
decrease in blood pressure in early pregnancy
than do normotensive women (Chesley and
Annito, 1947) and thus are even more likely
to be erroneously diagnosed as preeclamptic
according to blood pressure criteria Also, the
diagnosis of chronic hypertension based on the
failure of blood pressure to return to normal
by 42 days postpartum can be in error In a
long-range prospective study by Chesley
(1956), many women who remained hyperten
sive 6 weeks postpartum were normotensive at
long-term follow-up
Even the triad of proteinuria, edema, and
hypertension are nonspecific signs, and their
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presence in pregnancy could be due to conditions other than preeclampsia Edema is a very
physiologic finding present in many normal
pregnant women The diagnosis of superimposed preeclampsia is especially difficult
Women fulfilling diagnostic criteria for superimposed preeclampsia may, indeed, have preeclampsia but in some of these women the
origin of signs may instead be renal disease,
either causing the hypertension or secondary
to it that may comcidentally worsen during
pregnancv Conversely, many women who actuall\ develop preeclampsia may not have the
condition diagnosed This is a special problem
in women receiving antihypertensive therapy,
in whom early stages of preeclampsia without
proteinuria may be masked by therapeutic
lowering of blood pressure Superimposed preeclampsia is especially difficult to diagnose in
the hypertensive woman with proteinuria at
the onset of pregnancy To aid in diagnosis,
investigators have suggested the use of increasing serum uric acid (Redman et al , 1976a)
and decreasing creatinine clearance (Roberts
and Perloff, 1977) as indicators of preeclampsia
Renal biopsy specimens from women clini
cally diagnosed as having preeclampsia (blood
pressure increase and proteinuria) demon
strate these diagnostic difficulties (Table 41-1)
(McCartney, 1964a) Of 62 women diagnosed
as preeclamptic in their first pregnancy, 70 per
cent had a glomerular lesion believed to be
characteristic of preeclampsia However, 24
per cent had evidence of chronic renal disease
not suspected previously Renal biopsies of
multiparous women with a clinical diagnosis of
superimposed preeclampsia demonstrate the
difficulty of diagnosing this condition Of 152
subjects, only 3 per cent had the characteristic
glomerular lesion, but 43 per cent had evidence
of pre existing renal or vascular disease
Preeclampsia has a clinical spectrum ranging
from mild to severe forms and then potentially"
to eclampsia Affected patients do not "catch ^
eclampsia but progress through this spectrum.
In most cases progression will be slow and the

TABLE 4 1 - 1 . Renal Biopsy Findings in Patients with Clinical Diagnosis of Preeclampsia
BIOPSY FINDINGS
Glomeruloendotheliosis

PRIMIGRAVIDAS
(N = 62)

70%

MULTIGRAVIDAS
(N = 152)

14%
(with or without
nephrosclerosis)

Normal histologic appearance
Chronic renal disease (chronic GTN chronic pyelonephritis)
Arteriolar nephrosclerosis

5%
25%
0

(Modified from McCartney CP Pitholo ic tl anatomy of acute hypertension of pregnancy
permission of the American He irt Associ uion Ine )

53%
21%
12%
Circulation 30(Suppl 1!) V7 1964 b\
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disorder may never proceed beyond mild preeclampsia. In others, the disease may progress
jnore rapidly, changing trom mild to severe
over days to weeks In the most serious cases,
progression may be fulminant, with mild preeclampsia evolving to severe preeclampsia or
eclampsia over hours to days In a series of
eclamptic women analyzed bv Chesley (1978)
25 per cent had evidence of only mild preeclampsia in the days preceding convulsions
Thus, for clinical management, we must accept
the fact that we are overdiagnosing the condition, because as will be discussed later, a major"
goal in managing preeclampsia is the preven-"
tion of eclampsia, primarily through timing ot
delivery It is also evident, however, that studles of preeclampsia will be confounded by
inclusion of women diagnosed as preeclamptic
who actually have another cardiovascular or
renal disorder Still another problem is that
some women with pregnancy-specific pathophysiologic changes identical to those present
in preeclampsia will not have the specific signs
of preeclampsia sufficient to satisfy the ACOG
definition (Gpodhn, 1986) These women are
nonetheless at increased risk, as are their infants (Weinstem, 1982, Killam et al , 1975),
and should be managed as is the more typical
preeclamptic patient

PREECLAMPSIA-ECLAMPSIA
In spite of the difficulty of making a clinical
diagnosis of preeclampsia, there is no question
that a disorder exists unique to pregnancy and
characterized by poor perfusion of many vital
organs, including the fetal-placental unit, and
completely reversible with the termination of
pregnancy Pathologic, pathophysiologic, and
prognostic findings clearly indicate that this
condition, which we will call preeclampsia * is
not merely an unmasking ot pre-existing, underlying hypertension Although this fact has
been well documented for many years, problems still arise owing to approaches in the
management of preeclampsia that are based
solely on principles useful in managing hypertension in nonpregnant individuals The successful management of preeclampsia requires
an understanding of the pathophysiologic

*It is tempting to use a new label to define this
vasospastic condition in pregnancy However because
there are already too many labels and because the diag
nosis of this pregnancy related condition can be made only
retrospectively i e when physiologic functions including
blood pressure return to normal after pregnancy we will
use preeclampsia realizing its limitations

changes in this condition and the recognition
that the signs of preeclampsia—increased
blood pressure, proteinuria and edema—are
only signs and not causal abnormalities The
etiology of preeclampsia-eclampsia is not completely understood; however, as Zuspan (1978)
has pointed out, we can manage the condition
very successfully using the information we do
have about its pathophysiology, prognosis, and
natural history

Clinical Presentation
The "Typical" Preeclamptic Patient
Preeclampsia occurs in about 7 per cent of
pregnancies not terminating in first-trimester
abortions It would be useful to be able to
identify the women at greatest risk In preeclampsia as with all diseases there are no truly
"typical" patients Epidemiologic findings do,
however, indicate that certain characteristics
are more common in women who develop
preeclampsia The most important is nulliparity Preeclampsia is primarily a disease of the
first pregnancy At least two-thirds of cases
occur in women during the first pregnancy not
terminating in a first-trimester loss
Preeclampsia is thought to be more common
in women of lower socioeconomic status In
his study of pregnant women in Aberdeen,
Scotland, nearly all of whom were delivered
in hospitals, Nelson (1955) found no relationship of preeclampsia-eclampsia to socioeconomic status In similar studies in Finland
(Vara et al , 1965) and Jerusalem (Davies
1970), no relationship was established between
this factor and the incidence of preeclampsia
It remains the current clinical impression of
most individuals caring for pregnant women in
the United States that preeclampsia is a disease
of lower-income women This impression ma\
be accurate, but it is undoubtedly confounded
by the relationship of preeclampsia to age,
race, and parity Eclampsia, on the other hand,
is clearly a disease of women of lower socioeconomic status (Nelson, 1955, Vara et al ,
1965, Davies, 1970) Eclampsia is preventable
by careful obstetric observation and delivery
for severe preeclampsia Therefore, the lack
of availability and utilization of good-quality
obstetric care to indigent women is undoubtedly a major factor in the increased incidence
of eclampsia It is interesting to note that in
past years the clinical impression was that
preeclampsia-eclampsia was a disease of
women of higher socioeconomic status (Chesley, 1978)
There is a relationship between the extremes
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of childbearing age and the incidence of
eclampsia and preeclampsia. Because most
pregnancies, particularly most first pregnancies, occur in young women, most cases of
preeclampsia-eclampsia occur in this age
group. However, studies of entire populations
in Aberdeen, Jerusalem, and Finland do not
indicate an increased incidence of preeclampsia in young women if parity is considered. In
all of these studies a higher incidence of preeclampsia was found in older women that was
not dependent on parity. The information from
the Collaborative Study in the United States
(Vollman, 1970) does suggest a higher incidence of preeclampsia in younger women, although Davies (1971) has pointed out the
deficiencies in this study. It is possible that the
incidence of preeclampsia may be greater in
young women in the United States but not in
other parts of the world; however, even if this
is true, increased incidence of the youngest
age groups in the Collaborative Study is not
nearly as great as that of older patients.
The relationship of preeclampsia and
eclampsia to race is equally difficult to evaluate. Data from both the U. S. Collaborative
Study and the Jerusalem study indicate a relationship to race (Vollman, 1970; Davies,
1970). The Jerusalem study revealed the strong
correlation of race and age during pregnancy.
In the Collaborative Study the incidence of
preeclampsia was higher in blacks, in whom
hypertension is generally more common. This
finding raises the question whether the incidence of preeclampsia is truly race-related or
whether the finding is an example of the difficulty in differentiating preeclampsia from unrecognized pre-existing chronic hypertension.
Chesley has stated that there is no difference
in incidence of preeclampsia between blacks
and Caucasians (unpublished observation cited
by Davies, 1971)
A characteristic oi preeclampsia-eclampsia
that is frequently overlooked is the tendency
of the condition to occur in daughters and
sisters of women with a history of preeclampsia. In Aberdeen, the incidence of proteinuric
preeclampsia was found to be four times higher
in sisters of women who had preeclampsia in
their first pregnancy than in sisters of women
who did not (Adams and Finlayson, 1961). In
a recent study of the same population the
incidence of preeclampsia was 15 per cent in
mothers but only 4 per cent in mothers-in-law
of preeclamptic women (Sutherland et al.,
1981). Chesley and Cooper (1986) evaluated
preeclampsia in the first pregnancy of sisters,
daughters, granddaughters, and daughters-inlaw of women who had been eclamptic. The
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incidence of preeclampsia in sisters was 37 per
cent, in daughters 26 per cent, in granddaughters 16 per cent, but in daughters-in-law only
6 per cent. These observed incidences fit
closely with inheritance of preeclampsia
through a single maternal gene with the frequency of the putative gene being 0.25.
Certain medical disorders also predispose to
preeclampsia. Diabetes is frequently complicated by preeclampsia, with the incidence
stated to be as high as 50 per cent of diabetic
pregnancies (Chesley, 1978). Preeclampsia is
also more common in women with hypertension antedating pregnancy. In several studies
the reported incidence is approximately 20 per
cent (Roberts and Perloff, 1977).
Certain conditions of pregnancy also increase the risk of preeclampsia. The incidence
is approximately 30 per cent in women with
twin pregnancies and is increased regardless of
parity. In a study by Bulfin and Lawler (1957)
the incidence was 70 per cent in primiparas
and 20 per cent in multiparas. Preeclampsia is
also present in 70 per cent of women with
large, rapidly growing hydatidiform moles and
occurs earlier than usual in gestation (Page,
1939). In fact, in cases of preeclampsia occurring before 24 weeks, hydatidiform mole
should be suspected and sought. An interesting
variant of preeclampsia occurs with fetal hydrops, although not with erythroblastosis uncomplicated by hydrops; the incidence is high
(approximately 50 per cent), and preeclampsia
is not confined to hydrops secondary to isoimmunization, occurring in one series in nine of
11 infants with hydrops of nonimmune etiology
(Scott, 1958). This condition may present early
in pregnancy and with severe signs and symptoms of preeclampsia. Proteinuria is massive,
and blood pressure elevation and edema are
marked. In spite of this severity, eclampsia is
a rare complication. Preeclampsia is also reported to be more common in pregnancies
complicated by polyhydramnios; however, if
the association of polyhydramnios with diabetes and multiple pregnancies is accounted for,
the relationship is not present (Jeffcoate and
Scott, 1959).

Signs of Preeclampsia
The diagnostic signs of preeclampsia usually
antedate symptoms. The usual sequence of the
appearance of the signs is edema, followed by
increased blood pressure and proteinuria; however, any order of appearance may occur
(Chesley, 1978).
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Edema
Fluid retention can be manifested as a rapid
gain in weight prior to demonstrable edema.
A gain of 5 lb in one week is cited as a warning
sign of preeclampsia. However, rapid weigh:
gain can occur in pregnancy without preeclampsia, and, in one group of women who
became eclamptic, only 10 per cent manifested
this rapid weight gain (Chesley, 1978). Edema
in preeclampsia is believed to be related in
part to sodium retention and is thus not limited
to dependent edema..Edema of the hands and
face is more likely associated with sodium
retention and is therefore a more reliable indicator of preeclampsia than is dependent^
edema, which may be due to primarily hydrostatic mechanisms. However, sodium retention
caused by altered glomerular tubular balance
due to postural decreases in glomerular filtration is common in normal pregnancy. Edema
of the hands and face occurs in 10 to 15 per
cent of women whose blood pressure remains
normal throughout pregnancy (Thomson et al.,
1967). Edema may be massive, especially in
severe~preeclampsia, rendering the patient vir~
r^tnally unrecognizable (Fig. 41-2). With such"
"patients it is important to remember that substantia} hypoalbuminuria may complicate preeclampsia and contribute to the edema. Therefore, edema is an early and common sign of
preeclampsia but is not diagnostic.
Blood Pressure Change
Increased blood pressure is required for the
diagnosis of preeclampsia. As discussed previously, however, the changes in blood pressure associated with normal pregnancy may
lead to misdiagnosis. In clinical practice the
possible impact of preeclampsia on mother and

fetus warrants such overdiagnosis. From a
pathophysiologic viewpoint, of primary importance is poor tissue perfusion secondary to
vasospasm, which is revealed more clearly by
blood pressure changes than by absolute blood
pressure (evefs. Even the relative increase of
blood pressure does not, however, always correlate well with decreased tissue perfusion and
subsequent damage. Eclampsia and maternal
or fetal death can occur in the patient with
only modest blood pressure elevation. In two
series, 20 per cent of women with eclampsia
never had a systolic blood pressure exceeding
MO mm Hg (Chesley, 1978; Dieckman, 1952).
Proteinuria
Among the diagnostic signs of preeclampsia,
proteinuria accompanied by hypertension is
the most reliable indicator of fetal jeopardy.
In two studies of preeclampsia, the perinatal
mortality rate tripled in women with proteinuria (McGillivray, 1958), and the amount of
proteinuria correlated with increased perinatal
mortality rate and the number of growth-retarded infants (Tervila et al., 1973). If only
eclampsia is considered—thus excluding cases
of chronic hypertension misdiagnosed as preEclampsia—the relationship of proteinuria to
perinatal mortality is even more striking. In
the series reported by Nelson (1955) from
Aberdeen, there were 15 neonatal deaths in
52 proteinuric women and no neonatal deaths
in 17 women who became eclamptic but did
not have proteinuria. In spite of the specificity
3nd fetal prognostic significance of proteinuria,
however, we must emphasize that eclampsia
Qan occur without proteinuria. In one series of
298 eclamptic patients, 41 per cent did not
have proteinuria (Naidoo and Moodley, 1980),

FIGURE 41-2. Facial edema in
severe preeclampsia. Markedly
-edematous facies of this severely preeclamptic woman (A)
are especiaffy evident wfien
compared with her appearance
6 weeks postpartum (B).
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and in a series of eclamptic patients reviewed
by Chesley (1978) 26 of 199 had either trace
(16) or no (10) proteinuria prior to seizures.

Retinal Changes
Important and consistent signs in preeclamptic patients are retinal vascular changes on
funduscopic examination. Localized or generalized changes occur in retinal arterioles in at
least 50 per cent of women with preeclampsia.
These retinal vascular changes are the clinical
sign that best correlates with renal biopsy
changes of preeclampsia (Pollak and Nettles,
1960). Localized retinal vascular narrowing is
visualized as segmental spasm, and the generalized narrowing is indicated by a decrease in
the ratio of arteriolar-venous diameter from
the usual 3:5 to 1:2 or even 1:3. It may occur
in all vessels or, in early stages, in single vessels
(Jaffe and Shatz, 1986). Preeclampsia does not
cause chronic arteriolar changes; thus the presence of arteriolar sclerosis detected by increased light reflex, copper wiring, or arteriovenous nickling indicates pre-existing vascular
disease. Finnerty (1956) described a characteristic "retinal sheen" in preeclamptic patients.
In the author's experience, this finding is present in many young patients, pregnant and
nonpregnant, male and female, and has not
been a useful sign.

Hyper-reflexia
Hyper-reflexia is a sign given a great deal of
clinical attention. Deep tendon reflexes are
increased in many women prior to seizures.
However, seizures can occur in the absence of
hyper-reflexia (Sibai et al., 1981), and many
young subjects are consistently hyper-reflexic
without being preeclamptic. Changes, or lack
of changes, in deep tendon reflexes are not
part of the diagnosis of mild forms of preeclampsia.

Symptoms of Preeclampsia
It is important to remember that the majority of women with early preeclampsia are
asymptomatic. This lack of symptoms is, in
fact, an important part of the rationale for
frequent obstetric visits in late gestation. In
most cases, increased blood pressure, increasing edema, and proteinuria antedate overt
symptoms.
The multitude of symptoms that can occur
secondary to preeclampsia—especially preeclampsia of increasing severity—are listed in
Table 41-2. Because preeclampsia is a disease
of poor perfusion to essentially all tissues, the
occurrence of symptoms related to many organ
systems is not surprising. Tightness of hands
and feet and paresthesias secondary to medial
or ulnar nerve compression occur because of
fluid retention. Although these are of concern
to the patient, who may be quite uncomfortable, they are not of prognostic significance.
Certain symptoms are, however, indicators of
the severity of the disease. Symptoms of hepatic capsular distention are particularly ominous. These include epigastric pain, "stomach
upset," and pain penetrating to the back.
Headache and mental confusion indicate poor
cerebral perfusion and may be precursors of
convulsions. Visual symptoms ranging from
scotomata to blindness indicate retinal arterial
spasm and edema. In evaluation of the patient
with preeclampsia, these signs of poor perfusion are as important indicators of the severity
of the disease as the easily quantifiable signs.
Other symptoms may also be present secondary to the complications of preeclampsia,
such as congestive heart failure and abruptio
placentae.
TABLE 41-2. Signs and Symptoms of
Preeclampsia-Eclampsia
Cerebral

Other Signs

Other signs that occur in preeclampsia less
commonly are indicators of involvement of
specific organs of the preeclamptic process.
Thus, patients with marked edema may have
ascites and hydrothorax, and those in congestive heart failure have the usual signs—increased neck vein distention, gallop rhythm,
and pulmonary rales. Hepatic capsular distention, manifested by hepatic enlargement and
tenderness, is particularly ominous, as is disseminated intravascular coagulation sufficient
to result in petechiae or generalized bruising
and bleeding.
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Visual

Gastrointestinal

Renal

Headache
Dizziness
Tinnitus
Drowsiness
Change in respiratory rate
Tachycardia
Fever
Diplopia
Scotomata
Blurred vision
Amaurosis
Nausea
Vomiting
Epigastric pain
Hematemesis
Oliguria
Anuria
Hematuria
Hemoglobinuria
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(Stallworth et al., 1981), but especially if nor^
mal variability was never evident, it should be
proven by fetal scalp blood sampling that decreased variability is not secondary to asphyxia. The woman with marked hepatic cap^
sular distention should undergo cesarean
delivery if vaginal delivery is not imminent.
Even several extra hours may be life-threatening, and none of the palliative therapies
prevents liver rupture.
Regional anesthesia offers its usual advantages for vaginal and cesarean delivery but
does carry the possibility of extensive sympatholysis with consequent decreased cardiac output, hypotension, and impairment of already
compromised uteroplacental perfusion. This
problem can be avoided by meticulous attention to anesthetic technique and volume expansion. Regional anesthesia is not a rational
means to lower blood pressure because it does
so at the expense of cardiac output. Likewise,
although analgesia with narcotics is not contraindicated and should be used when necessary, there is abundant evidence that attempting to manage or prevent eclampsia with
profound maternaf sedation is dangerous ancf
ineffective.
MONITORING OF MOTHER AND FETUS
MATERNAL MONITORING. There are two
goals for antepartum monitoring of th^
mother. The first is the early recognition of
the condition, because infants of mothers with
even mild preeclampsia are at increased risk^
and the second is to gauge the rate of progression of the condition, both to prevent eclampsia by delivery and to determine whether fetal
well-being can be safely monitored by the usual
intermittent observations. Ideally, identificaN
tion of early changes would allow intervention
prior to the advent of clinical symptoms. Hemodynamic, volume, and biochemical changes
appear to antedate the diagnostic clinical signs
of preeclampsia. In the past, lability of blood
pressure, which is a feature of preeclampsia,
was suggested as a predictor. However, neither
stimulation of sympathetic response by thQ
cold pressor test (Chesley and Valenti, 1958a)
nor second-trimester blood pressure "spikes"'
(Browne, 1933) were found to be specific
enough as predictors. More recently, higher
early second-trimester blood pressures were
measured in groups of women destined to have
diagnostic blood pressure increases in laterpregnancy (Gallery et aL, 1977). The overlap
of blood pressure levels between these women
and women who remained normotensive, however, was too large to regard this value as a

useful predictor for individual women. Higher
brachial artery blood pressure in the supine
than the lateral position is believed by some
investigators to predict the development of
sustained blood pressure increases in late pregnancy. Extensive studies of this phenomenon
do not support the earlier enthusiastic reports
(Kuntz, 1980). Recently, Sobel and co-workers
(1980) found that both men and nonpregnant
women had higher right arm blood pressure in
the supine position than in the left lateral
position, the difference being related to the
distance of the brachial artery above the heart.
However, the increased blood pressure response to angiotensin II (Gant et al., 1973;
Oney and Kaulhausen, 1982; Nakamura et al.,
1986) in women destined to have elevated
blood pressure in late pregnancy appears to be
an accurate predictor, but the test is neither
simple nor safe enough for extensive clinical
use. Changes in renal function, serum urate,
and PSP clearance (Gallery and Gyory, 1979a)
precede clinical signs of preeclampsia. Also, it
appears that decreased plasma volume (Arias,
1975) and subtle coagulation changes are also
predictors (Redman et a(., 1977a). The usefufness of these values as clinical predictors in
patient management remains to be confirmed.
At present, clinical management is dictated
by the overt clinical signs of preeclampsia.
Unfortunately, proteinuria—the most valid
clinical indicator of preeclampsia—is often a
late change, sometimes even preceded by seizures, and so is not a useful sign for early
recognition. Although rapid weight increase
and hand and face edema indicate the fluid
and sodium retention characteristic of preeclampsia, they are neither universally present
nor uniquely characteristic of preeclampsia.
These signs are, at most, a reason for closer
observation of blood pressure and monitoring
of urinary protein. Early recognition of preeclampsia is based primarily on diagnostic
blood pressure increases in the late second and
early third trimesters in relation to early pregnancy. Using blood pressure changes without
evidence of proteinuria as an indicator does,
undoubtedly, result in the diagnosis of preeclampsia in some normal women as well as in
some with underlying renal or vascular disease.
Because the goal of early diagnosis is to identify patients requiring more careful observation, however, overdiagnosis is preferable to
underdiagnosis.
Once the blood pressure changes diagnostic
of preeclampsia appear, an office examination
within 24 hours is mandatory, or with selected
patients, blood pressure and urinary protein
must be checked at home. These measures are
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directed at determining the rapidity of progression of the condition in order to ensure
that it is not following a fulminant course.
Frequency of subsequent observations is determined by these initial observations and the
ensuing clinical progression. If the condition
appears stable, weekly observations may be
appropriate. If it appears to be accelerating,
more frequent observations, perhaps in hospital, are required. The initial appearance of
proteinuria is an especially important sign of
progression and dictates frequent observation,
which is best accomplished in hospital.
If an increasing rate of deterioration is
noted, as determined by laboratory findings,
symptoms, and clinical signs, the decision to
continue the pregnancy is determined day by
day. Important clinical signs are blood pressure, urinary output, and fluid retention as
evidenced by daily weight increase. Laboratory
studies are performed at intervals of no more
than 48 hours. These include examination for
possible activation of the coagulation system
as determined by platelet count and fibrin split
products, evaluation of renal function as measured by urinary protein excretion and serum
creatinine and urate levels, and determination
of hepatic dysfunction as evidenced by increasing SGOT and SGPT. In addition, subjective
evidence of central nervous system involvement, such as headache, disorientation, and
visual symptoms, and the presence of hepatic
distention as indicated by abdominal pain and
liver tenderness are equally important indicators of worsening preeclampsia.
FETAL OBSERVATION. Tests to assess fetal
well-being provide information for determining whether the infant is safer in the uterus or
delivered. Since the perinatal mortality rate is
higher for infants of women with even mild
preeclampsia, it is mandatory to begin monitoring the fetal condition in any woman with
the clinical diagnosis of preeclampsia. If the
maternal condition is stable, weekly monitoring of the fetus appears to be adequate. The
etiology of fetal demise is apparently placental
insufficiency, and therefore biochemical indications of placental function such as serum
HPL concentration, and of fetal-placental
function such as urinary or serum estriol level
can be used (Fliegner, 1976). However, biophysical assessment of the fetus by observations of periodic changes in fetal heart rate
and activity and contraction stress testing are
more direct and accurate indicators of fetal
condition (Freeman, 1975). Unfortunately, no
test of fetal well-being is predictive when maternal condition is rapidly deteriorating. The
management of the fetus with intrauterine
growth retardation, a common complication of
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preeclampsia, is discussed in Chapter 31. Assessment of amniotic fluid for determination
of lung maturity aids in decision for delivery
of the fetus with severe intrauterine growth
retardation. Jeopardy of fetal well-being rather
than lung maturity is the fetal criterion for
determining delivery in a pregnancy with preeclampsia that is remote from term.
Antepartum Management in
Preeclampsia
There is little evidence that therapeutic efforts alter the underlying pathophysiology of
preeclampsia. Therapeutic intervention is palliative. At best, it may slow the progression of
the condition, but more likely, it merely allows
continuation of the pregnancy. Bed rest is a
usual and reasonable recommendation for the
woman with mild preeclampsia, although its
efficacy is not clearly established (Mathews,
1977). Prophylactic hospitalization with increased bed rest may reduce the incidence of
preeclampsia for women at high risk as identified by increased angiotensin sensitivity
(Hauth et al., 1976). It is unclear, however,
which of the several behavioral modifications
involved in hospital residence is important.
Anecdotal reports of clinical improvement
with bed rest must be tempered by the recognition of the unpredictable course of preeclampsia. Strict sodium restriction or diuretic
therapy has no role in the prevention or therapy of preeclampsia. In women with marked
sodium retention as manifested by significant
edema, modest sodium restriction may not
alter the course of the disease but may reduce
discomfort. Diuretics should not be given, because these patients already have decreased
plasma volume and further volume depletion
could adversely affect the fetus. Attempts to
modify the progression of the disease by volume expansion are not conclusive and require
more complete evaluation before they can be
considered part of routine antepartum management (Goodlin et al., 1978). The reduction
of prostacyclin production in tissues from preeclamptic women has prompted the prophylactic use of aspirin in doses (60 to 150 mg) found
to reduce thromboxane production while maintaining prostacyclin production. The results in
two studies of carefully screened very high-risk
patients, treated prior to the onset of clinically
evident disease, have been encouraging (Beaufils et al., 1986; Wallenburg et al., 1986).
Carefully controlled trials of the risk-to-benefit
ratio of this therapy are required before it can
be used in the general population of pregnant
women.
Prolonged expectant antepartum manage-
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ment of women with severe preeclampsia is
not practiced in most centers. With improvements in neonatal care, many investigators
regard delivery of women with severe preeclampsia beyond 30 weeks gestation to be in
the best interests of not only the mother but
also the fetus. Antihypertensive therapy is not
used, because it masks one important clinical
sign of disease progression and blood pressure
control does not improve fetal well-being. Diastolic pressure of 110 mm Hg and higher,
which puts the mother at increased risk of
cerebrovascular accident, indicates delivery
with control of blood pressure. When gestational age is critical (between 25 and 30
weeks), one might consider control of maternal
blood pressure along with meticulous observation of maternal and fetal condition. Delivery is then indicated by worsening maternal
symptoms, laboratory evidence of end organ
dysfunction, or deterioration of fetal condition. Whether this plan of action can effect a
decrease in perinatal morbidity and mortality
rates after 30 weeks gestation is not clear. The
use of this approach with even very immature
fetuses may only replace a nonviable neonate
with an extremely premature one, with the
attendant risks of long-range neurologic disability. Such an approach should therefore be
attempted only in centers equipped to provide
meticulous maternal observation and daily assessment of fetal and maternal condition.
Intrapartum Management in
Preeclampsia

The intrapartum management of women
with preeclampsia tests the obstetric and medical skills of the health care team. The severely
preeclamptic or eclamptic woman is acutely ill,
with functional derangements of many organ
systems. An appreciation of this situation and
the availability of methods of accurate maternal monitoring have reduced mortality rates
from 5 per cent in earlier series to 1 per cent
or less in recent series. Failure to recognize
and appropriately manage this grave condition
probably accounts for most deaths. Also, even
mildly preeclamptic women may experience an
acceleration of the process during labor. Delivery terminates the preeclamptic process, and
it is tempting to effect immediate delivery,
frequently by cesarean section. However,
physiologic abnormalities are not immediately
corrected by delivery, and adding surgical
stress to the abnormal physiologic state is not
desirable. It is possible to partially correct
many of these abnormalities, and it is imperative to attempt to do so prior to imposing

surgical stress. If the fetus can be monitored,
several hours of palliation with vaginal delivery
are preferable to the added maternal stress of
operative delivery.
Baseline information should be obtained to
determine renal function, coagulation status,
and liver function. Determination of serum
protein concentration indicates the choice of
appropriate fluid administration. Some investigators advocate the use of intensive cardiovascular monitoring, preferably with SwanGanz catheters or with central venous pressure
catheters in all severely preeclamptic and
eclamptic women (Chapter 19). Such a practice
is certainly indicated in oliguric patients whose
urinary output does not improve with a modest
fluid challenge. The major problems to be
managed are those of high blood pressure,
intravascular volume, and convulsions. Less
commonly, disseminated intravascular coagulation and myocardial dysfunction will require
treatment.
ANTICONVULSANTS
PROPHYLAXIS. The majority of seizures occur during the intrapartum and postpartum
periods, suggesting that these are the periods
in which the preeclamptic process is most likely
to accelerate. In many centers outside the
United States, anticonvulsant prophylaxis is
not used routinely, but rather is reserved for
the woman who seems clinically to be at risk
for seizures. It is not known whether the risk
for seizures is less in these centers than in
those in the United States. However, a recent
review of eclamptic patients from a major
United States center indicates the hazards of
this approach (Sibai et al., 1981). None of the
clinical signs and symptoms considered to be
prognostic of seizures was absolutely reliable.
Seventeen per cent of women who had seizures
did not have headache, 80 per cent did not
have epigastric pain, and 20 per cent had
normal deep tendon reflexes (Table 41-6). The
lack of absolute correlation with proteinuria is
consistent with the observations by Chesley
and Chesley (1943) 45 years ago that 24 per
cent of patients do not have proteinuria prior
to seizure.
The prophylactic use of anticonvulsant therapy, which is the approach strongly recommended by most United States investigators,
will protect most women at risk for seizures
only if therapy is elected for all women with a
blood pressure elevation diagnostic of preeclampsia whether or not there are other signs
and symptoms, including proteinuria. Because
this approach will certainly include many
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TABLE 41-6. Frequency of Symptoms
Preceding Eclampsia

SYMPTOM

PATIENTS IN W H O M
PRESENT
(%)

Headache
Hyper-reflexia
Proteinuria
Edema
Clonus
Visual signs
Epigastric pain

83
80
80
60
46
45
20

(Adapted from Sibai BM, Lipshitz J, Anderson GD. Dilts PV
Jr: Reassessment of intravenous MgS0 4 therapy in preclampsia^
eclampsia. Obstet Gynecol 57:199, 1981.)

women at no risk for seizure, the first requirement for anticonvulsant prophylaxis is that the
agent and its dosage must be extremely safe
for the mother. The other obvious requirement
is safety for the infant, not only as a fetus but
also when, as a neonate with appreciable blood
levels of the drug, it begins the complex adaptation to extrauterine life.
In the past, a staggering array of drugs and
combinations of dn\gs have been used as therapeutic and prophylactic agents for convulsions
(Studd, 1977). Zuspan (1978) and Pritchard
and Pritchard (1975), among others, have demonstrated the value of simplifying therapy by
reducing the number of agents administered.
Both reports advocate the use of magnesium
sulfate for anticonvulsant prophylaxis, which
is clearly the drug of choice for United States
obstetricians. Other anticonvulsant agents, primarily benzodiazepine derivatives, are used in
other parts of the world. Investigators worldwide agree with the principle of simplifying
therapy by avoiding polypharmaceutical regimens (Studd, 1977).
CHLORMETHIAZOLE
PINES. The use of large

AND

BENZODIAZE*

doses of diazepam was
advocated by some British investigators as an
effective means of terminating eclamptic seizures and preventing their recurrence (Studd,
1977). It is now evident that diazepam in these
dosages results in hypotonia, hypothermia, and
respiratory depression in a high proportion of
neonates (Cree et ai, 2973). These effects may
last for several days owing to the pharmacokinetics of benzodiazepine in the neonate. Lorazepam, a long-acting benzodiazepine derivative, has even more severe fetal effects
(Whitelaw et al., 1981). In spite of these findings, benzodiazepines continue to be the major
anticonvulsants used in many centers outside
the United States. The effects of these agents
on the neonate would appear to contraindicate
their use as prophylactic agents. Chlormethia-

807

zole (clomethiazole) has been advocated for
prophylactic use in preeclamptic women (Duffus et al., 1969). In one series in which this
drug was used in combination with diazoxide,
however, 13 of 21 infants were severely depressed (hypotonia, hypoventilation) for 24 to
36 hours after birth (Johnson, 1976).
MAGNESIUM SULFATE. Magnesium sulfate
offers considerable advantages over the preceding agents for prophylaxis in preeclamptic
women. Its pharmacokinetics during pregnancy is well established, as are its efficacy
and safety for mother and fetus.
Pharmacokinetics, Mechanism of Action,
and Maternal Side Effects, The volume of
distribution of magnesium is greater than that
of sucrose, indicating that the distribution of
this ion goes beyond extracellular fluid, also
entering bones and cells (Chesley, 1979). Magnesium circulates largely unbound to protein
and is almost exclusively excreted in urine. It
is reabsorbed in the proximal tubule by a
process limited by transport maximum (Tmax)
and its excretion increases as filtered load
increases above the transport maximum (Massey, 1977). Inpatients with normal renal function, the half-time for excretion is about 4
hours (Chesley, 1979). Because excretion depends on delivery of a filtered load of magnesium that exceeds the Tmax, the half-time of
excretion is prolonged in women with decreased glomerular filtration rate. The clinically significant results of elevated serum magnesium are related primarily to its membrane
effects. Magnesium slows or blocks neuromuscular and cardiac conducting system transmission, decreases smooth muscle contractility,
and depresses central nervous system irritability. The results include a desired anticonvulsant effect and undesirable effects such as
decreased uterine and myocardial contractility,
depressed respirations, and interference with
cardiac conduction. These effects occur at different serum magnesium concentrations (Table
41-7). Doses of magnesium sulfate sufficient
for anticonvulsant therapy cause little change
in blood pressure. Because the depression of
TABLE 41-7. Effects Associated with Various
Serum Magnesium Levels
EFFECT

Anticonvulsant prophylaxis
EKG changes
Loss of deep tendon reflexes
Respiratory paralysis
General anesthesia
Cardiac arrest

SERUM LEVEL
(mEq/liter)

4-6
~10
^
**
*'
>
^
5
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O l u d l . Boyle & H a t t r u p . Lee Olwell.
S3 \Vash.2d 514
Seattle, for petitioner.
Morrison P. HELLING and Barbara
Williams, Lanza, Kastner & Gibbs, HenHelling, his wife, Petitioners,
ry K. Kastner. Seattle, for respondent.
v.
C i t o u s . \V»i*li

Thomas F. CAREY and Robert C.
Laughlin, Respondents.
No. 42775.
Supreme Court of Washington.
Kn Kane.
March 14, 1!)74.

Malpractice action against ophthalmologists in which a patient claimed that she
suffered permanent visual damage due to
open angle glaucoma as a result of defenda n t s ' failure to diagnose and treat the condition. The trial court entered judgment
for defendants following a defense verdict,
the Court of Appeals, Division I, James, J.,
affirmed, and the patient petitioned for review.
The Supreme Court, Hunter, J.,
held that defendants were negligent as a
m a t t e r of law in failing to administer a
simple glaucoma test to the patient despite
uncontradicted expert testimony that it was
the universal practice of ophthalmologists
not to administer glaucoma tests to patients
under age 40 because the incidence of
glaucoma at younger ages was so small.
Reversed and remanded for new trial
on issue of damages only.
Utter, J., concurred and filed opinion
in which Finley and Hamilton, }]., concurred.

Physicians and Surgeons 0=18.80(8)
Ophthalmologists were negligent as
matter of law in failing to administer glaucoma test to patient under age 40, thus
failing to diagnose condition of primary
open angle glaucoma, despite uncontradicted expert testimony that it was universal
practice of ophthalmologists not to test patients younger than 40 for glaucoma because of low incidence of condition in
younger patients.

H U X T F . R . Associate Justice.
This case arises from a malpractice action instituted by the plaintiff (petitioner),
Barbara Helling.
The plaintiff suffers from primary open
angle glaucoma. Primary open angle glaucoma is essentially a condition oi the eye
in which there is an interference in the
ease with which the nourishing fluids can
flow out of the eye. Such a condition results in pressure gradually rising above the
normal level to such an extent that damage
is produced to the optic nerve and its fibers with resultant loss in vision.
The
first loss usually occurs in the periphery of
the field of vision. The disease usually
has few symptoms and, in the absence of a
pressure test, is often undetected until the
damage has become extensive and irreversible.
The
defendants
(respondents),
Dr.
T h o m a s F. Carey and Dr. Robert C.
Laughlin, are partners who practice the
medical
specialty
of
ophthalmology.
Ophthalmology involves the diagnosis and
treatment of defects and diseases of the
eye.
The plaintiff first consulted the defendants for myopia, nearsightedness, in 1959.
At that time she was fitted with contact
lenses. She next consulted the defendants
in September, 1963, concerning irritation
caused by the contact lenses. Additional
consultations occurred in October, 1963;
February, 1%7; September, 1967; October. 1%7: May. 1°6S; July. 1%S; August,
P o S ; September, 1%S; and October, 1968.
L'nnl the October 196S consultation, the
defendants considered the plaintiff's visual
problems to be related solely to complications associated with her contact lenses.
On that occasion, the defendant, Dr. Carey, tested the plaintiff's eye pressure and
field oi vision for the first time. This test
indicated that the plaintiff had glaucoma.
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The plaintiff, who was then 32 years of
age, had essentially lost her peripheral vision and her central vision was reduced to
approximately 5 decrees vertical by l«i degrees horizontal.
Thereafter, in August of 1(,69, after consulting; other physicians, the plaintiff filed
a complaint against the defendants alleging, among other things, that she sustained
severe and permanent damage to her eyes
as a proximate result of the defendants'
negligence. During trial, the testimony oi
the medical e x p e r t for both the plaintiff
and the defendants established that the
standards of the profession for that specialty in the same or similar circumstances
do not require routine pressure tests for
glaucoma upon patients under 40 years of
age. The reason the pressure test for
glaucoma is not given as a regular practice
to patients under the age of 40 is that the
disease rarely occurs in this age group.
Testimony indicated, however, that the
standards of the profession do require
pressure tests if the patient's complaints
and symptoms reveal to the physician that
glaucoma should be suspected.
The trial court entered judgment for the
defendants following a defense verdict.
The plaintiff thereupon appealed to the
Court of Appeals, which affirmed the
judgment of the trial court. Helling v.
Carey, Xo. I185-U91S-1 (Wn.App., filed
Feb. 5, 1973). The plaintiff then petitioned this Court for review, which we
granted.
In her petition for review, the plaintiff's
primary contention is that under the facts
of this case the trial judge erred in giving
certain instructions to the jury and refusing her proposed instructions defining the
standard of care which the law imposes
upon an ophthalmologist. As a result, the
plaintiff contends, in effect, that she was
unable to argue her theory of the case to
the jury that the standard of care for the
specialty of ophthalmology was inadequate
to protect the plaintiff from the incidence
of glaucoma, and that the defendants, by
reason of their special ability, knowledge

and information, were negligent ;n fading
to give the pressure test to the plaintiff at
an earlier point in time which, if given,
would have detected her condition and enabled the defendants to have averted the
resulting substantial los> in her vision.
We find this to be a unique case. The
tcstimotn oi the medical experts is undisputed concerning the standards of the profession for the specialty of ophthalmology.
It is not a question in this case of the defendants having any greater special ability,
knowledge and information than other
ophthalmologists which would require the
defendants to comply with a higher duty of
care than that "degree of care and skill
which is expected of the average practitioner in the class to which he belongs, acting in the same or similar circumstances."
Pederson v. Dumouchel. 72 Wash.2d 73, 79,
431 P.2d 973 (1967). The issue is whether
the defendants' compliance with the standard of the profession of ophthalmology,
which does not require the giving of a routine pressure test to persons under 40 years
of age, should insulate them from liability
under the facts in this case where the
plaintiff has lost a substantial amount of
her vision due to the failure of the defendants to timely give the pressure test to the
plaintiff.
The defendants argue that the standard
of the profession, which does not require
the giving of a routine pressure test to
persons under the age of 40, is adequate to
insulate the defendants from liability for
negligence because the risk of glaucoma is
so rare in this age group. The testimony
of the defendant. Dr. Carey, however, is
revealing as follows:
0. Now, when was it. actually, the
first time any complaint was made to
you by her of any field or visual field
problem : A. Really, the first time that
she really complained of a visual field
problem was the August 30th date.
[1%S] Q. And how soon before the
diagnosis wa> that? A. That was 30
days. We made it on October 1st. Q.
And in your opinion, how long, as vou
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nor have the whole history and analysis
and the diagnosis, how long had she had
this glaucoma?
A. I would think she
probably had it ten years or longer. <J.
Now, Doctor, there's been some reference to the matter of taking pressure
checks of persons over 40. W h a t is the
incidence of glaucoma, the statistics,
with persons under 40? A. In the instance of glaucoma under the age of 40,
is less than loo to one per cent. T h e
younger you get, the less the incidence.
It is thought to he in the neighborhood
of one in 25,000 people or less.
(J.
How about the incidence of glaucoma
in people over 40*
A. Incidence of
glaucoma over 40 gets into the two to
three per cent category, and hence, that's
where there is this great big difference
and that's why the standards around the
world has been to check pressures from
40 on.
J h e ' i n c i d t n c e ' o f glaucoma in one out of
!5,0o^persons under the age'of 40 ma\ appear J q u i t e minimal.
However, that one
cpersdtvthe"plaintiff in this instance, is enI t i t l e d j t o ^ h e ^ s a m e protection, as atrorded
iO,'essential for t i m e h detecJheieVidence of,glaucoma where it
iheSarrcstedUOvavoid the , g r a \ e and

f t t o W done - ^ i i x M J j v * ajStandar
sonab!e^p.niat$^^
x com plied with o r n o t ? ^ *
In The T. J. Hooper. 60 l\2d 757. on
page 74o (2d Cir. 1932). Justice Hand stated:
[ I ] n most cases reasonable prudence is
in fact common prudence ; but strictly it
is never its m e a s u r e ; a whole calling
ma\ have unduly lagged in the adoption
of new and available devices. It never
may set us own tests, however persuasive IK it^ u>agex^jTCJnr/i must JnJ lie '
>.-,\cnd sax wiwt is required;vthereare\fire_ ,
"cautions so impcrativc'ithat
ez'cnltneir -:<^r^
universal disregard will -not excuse their
^amission.
(Italics ours.)
Under the facts of this case reasonable
prudence required the timely giving ot the
pressure test to this plaintiff. T h e precaution of giving this test to detect the incidence of glaucoma to patients under 40
u a r s of age is so imperative that irrespective of it- disregard by the standards of
,thc opthalrnology profession, it is the duty
of the courts to say what is required to
'protect patients under 40 from the damaging restilt> of glaucoma.
/

We therefore hold, as a matter of law,
•devastating result of this disease. The t o t
that the reasonable standard that should
is a simple pressure test, relative!} m e \ h a \ e been followed under the undisputed
pensi\ e..„JTherc .ir^no^iuHgnfent factor' infacts of this case was the timely giving of
Jand there Ts no doubt that by givthis simple, harmless pressure test to this
ing the test the evidence of glaucoma can
plaintiff and that, in failing to do so, the
^ d e ^ e d .
T h e giving of the t e s t e s vdefendants were negligent," which proxi^^rmlesSxif the physical condition of the
mately resulted in the blindness sustained
eye permits. The testimony indicates that
by the plaintiff for which the defendants
although the condition of the plaintiff's
are liable.
eyes might have at times prevented the deThere are no disputed facts to submit to
fendants irom ctdnunlstcrinii the pressure
the
jury on the issue of the defendants'
test, there is an absence of evidence in the
liability.
Hence, a discussion of the plainrecord that the test could not have been
tiff's proposed instructions would be incontimely given.
sequential in view of our disposition of the
Justice Holmes stated in T e x a s & Pac
case.
Ry. v. Behymer. 1SV I'.S. 46S, 470, 23 S.Ct
The judgment of the trial court and the
622, 623, 47 l..Ed. (>o5 il<>03>:
deciMou of the Court of Appeals is re(\Vhat usually Ts dohe~may be. evidence of
versed, and the case is remanded for a new
- what "ought to be done, but what ought
trial on the issue of damages only.
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H A L E , C. J., and R O S E L L I X L S T A F FORD.
WRICHT
and
BRACHTFXB A C H . J J . . concur.
UTTF.R. Associate Justice ( c o n c u r r i n g ) .
I concur in the result reached by the majority. I believe a creator dut\ of cure
could be imposed on the defendants than
was established by their profession.
The
duty could be impused when a disease, such
as glaucoma, can be detected by a simple.
well-known harmless test whose results are
definitive and the disease can be successfully arrested by early detection, but where
the effects of the disease are irreversible if
undetected over a substantial period of
time.
T h e difficulty with this approach is that
we as judges, by using a negligence analysis, seem to be imposing a stigma of moral
blame upon the doctors who. in this case,
used all the precautions commonly prescribed by their profession in diagnosis and
treatment. Lacking their training in this
highly sophisticated profession, it seems illogical for this court to say they failed to
. exercise a reasonable standard of care. It
seem to me we are, in reality, imposing liability, because, in choosing between an innocent plaintiff and a doctor, who acted
reasonably according to his specialty but
who could have prevented the full effects
of this disease by administering a simple,
harmless test and treatment, the plaintiff
should not have to bear the risk of loss.
As such, imposition of liability approaches
that of strict liability.
Strict liability or liability without fault
is not new to the law. Historically, it predates our concepts of fault or moral responsibility as a basis of the remedy.
Wigmore,
Responsibilitv
for
Tortious
A c t s : Its History, 7 H a r . L . R e v . 315, 383,
441 (1394). As noted in \ \ \ Prosser, T h e
Law of T o r t s § 74 (3d ed. 1964) at pages
5<t7, 508:
T h e r e are m a i n situations in which a
careful person is held liable for an entirely reasonable mistake.
. . .
in
some cases the defendant may be held

liable, although he is not only charged
with no moral wrongdoing, but has not
even departed in any way from a reasonable standard of intent or care.
T h e r e is *'a strong and growing tendency, where there is blame on neither side,
to ask, in view of the exigencies of social justice, who can best bear the loss
and hence to shift the loss by creating
liability where there has been no fault."
i Footnote omitted.) T o r t law has continual!} been in a state of flux. It is "not always neat and orderly. But this is not to
<ay it is illogical. Its central logic is the
logic that moves from premises—its objectives—that are only partly consistent, to
conclusions—its rules—that serve each
objective as well as may be while serving
others too. It is the logic of maximizing
service and minimizing disservice to multiple objectives." Keeton, Is T h e r e a Place
for Negligence in Modern T o r t L a w : , 53
Va.L.Rev. 886, 897 (1967).
When types of problems r a t h e r than
number* of cases are examined, strict liability is applied more often than negligence
as a principle which determines liability.
Peck. Negligence and Liability Without
Fault m T o r t Law, 46 W a s h . L . R e v . 225,
239 (1971). T h e r e are many similarities in
this case to other cases of strict liability.
Problems of proof have been a common
feature in situations w h e r e strict liability is
applied. W h e r e events a r e not m a t t e r s of
common experience, a j u r o r ' s ability to
comprehend whether reasonable care has
been followed diminishes. T h e r e a r e few
areas as difficult for j u r o r s to intelligently
comprehend as the intricate questions of
proof and standards in medical malpractice
cases.
In a p p K i n g strict liability there are
many situations where it is imposed for
conduct which can be defined with sufficient precision to insure that application of
a strict liability principle will not produce
miscarriages of justice in a substantial
number of cases. If the activity involved
is one which can be defined with sufficient
precision, that definition can serve as an
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accounting unit to which the costs of the
activity may be allocated with some certainty and. precision. With this possible,
strict liability serves a compensatory function in situations where the defendant is,
through the use of insurance, the financially more responsible person. Peck, Negligence and Liability Without Fault in Tort
Law., supra at 240, 241.
If the standard oi a reasonably prudent
specialist is, in fact, inadequate to offer
reasonable protection to the plaintiff, then
liability can be imposed without fault. T o
do so under the narrow facts of this case
does not offend my sense of justice. The
pressure test to measure intraocular pressure with the Schiotz tonometer and the
Goldman applanometer takes a short time,
involves no damage to the patient, and
consists of placing the instrument against
the eyeball. An abnormally high pressure
requires other tests which would either
confirm or deny the existence of glaucoma.
It is generally believed that from 5 to 10
years of detectable increased pressure must
exist before there is permanent damage to
the optic nerves.
Although the incidence of glaucoma in
the age range of the plaintiff is approximately one in 25,0**0, this alone should not
be enough to deny her a claim. W h e r e its
presence can be detected by a simple, wellknown harmless test, where the results of
the test are definitive, where the disease
can be successfully arrested by early detection and where its effects are irreversible
if undetected over a substantial period of
time, liability should be imposed upon defendants even though they did not violate
the standard existing within the profession
of ophthalmology.
T h e failure -of plaintiff to raise this
theory at the trial and to propose instructions consistent with it should not deprive
her of the right to resolve the case on this
theory on appeal. W h e r e this court has
authoritatively stated the law. the parties
are bound by tho^e principles until they
have been overruled. Acceptance of those
principles at trial does not. constitute a
519 P 2a—62i i

waiver or estop appellants from adapting
their'" cau<e on. appeal to such a rule as
might be declared if the earlier precedent
is overruled.
Samuelson v. Freeman, 75
\Vash.Aj $04, 'HIM, 4 ; 4 pjd 4iw, , l% r )„
FLYLF.Y and II VMILTuN", If., concur.
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S3 Wash.2d 49S
INTERNATIONAL UNION OF OPERATING
ENGINEERS LOCAL NO. 286, A F L CIO (LOCAL 286),, et al.( Appellants,
v.
SAND POINT COUNT h i CUUL.. «~
POINT) et al.( Respondents.
No. 42691.
Sujuvnn • Court of Washington,
En Banc.
March 7, V. )T4.

Action, was brought by employee rep
resentatives seeking an injunction requiring golf club operators to engage in collective bargaining. The Superior Court, King
County, Shorett, J., entered summary judgment for defendants, and plaintiffs appealed. The Supreme Court, Rosellini, J., held
that under statute, golf club operators did
not have an affirmative duty to bargain
with representatives of maintenance employees.
J u d g m e n t affirmed.
Hale,
opinion.

C.

]

d'" r c ^ n ''

• ' nied

an

I. Labor Relations C=46
Purpose of labor statute was to facilitate achievement by employees of an effective b a r g a i n i n g position and not to provide
for
compulsory
collective
bargaining.
R C W A 40.52.011 et seq.
:

Lahor Relations C=I76
Under statute, golf club operators did
not have an affirmative duty to bargain
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Eclampsia
Marco A. ViUarL.,

M,D,tm

and Baha M. Sibai, M . D . t

Eclampsia is defined as the development of convulsions oi
or both, in p r e g n a n t patients with signs and symptoms o
eclampsia. It is mainly a disease of young primigravidas. Eclampsia
has been reported to occur in 0.05 to 0.2 p e r cent of all deliveries and
in 3.6 per cent of twin deliveries. 1 1 , 2 3 Maternal mortality rates of 0 to
14 per cent have b e e n attributed to eclampsia, as have perinatal mortality rates of 10 to 28 per cent. Eclampsia may be prevented by early
adequate prenatal care and by astute medical judgment.
PATHOPHYSIOLOGY
Ecuuiipsia is a syndrome characterized by functional derangement of nearly every organ system. Many hypotheses regarding the
etiology and pathophysiology of pre-eclampsia and eclampsia have
been proposed (Table 1), but none as yet has been confirmed conclusively. There is considerable evidence to suggest that the development of pre-eclampsia is associated with increased trophoblastic mass
(hyperplacentosis). This finding might explain the increased incidence of pre-eclampsia in patients with molar pregnancy, multiple
gestation, and nonimmune hydrops fetalis. In addition, there is an
increased incidence in patients with underlying renal disease, as can
be seen in chronic hypertension and lupus erythematosus.
Uteroplacental ischemia seems to play an important role in the
etiology of pre-eclampsia and eclampsia. The most widely accepted
hypotheses suggest an imbalance in the production of the two placental eicosanoids: prostacyclin and thromboxane. During normal
pregnancy, the placenta produces equivalent amounts of prostacyclin
and thromboxane, so that the biologic actions on vascular tone,
platelet aggregation, and uterine activity will be balanced. However,.
in pre-eclamptic pregnancy, placental production of these two eico-

* Fellow, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Tennessee, Memphis, Tennessee
fProfessor, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Tennessee, Memphis, Tennessee
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Table 1.

Mechanisms Suggested as Etiologies of Pre-eclampsia

Uteroplacental ischemia (uterine stretch)
Decreased placental perfusion
Abnormal progesterone metabolism
Oecieased MCRDS to estradiol
Immunologic dysfunction
Primarily a disease of primigravida
Immunologic complexes in kidney and liver
Multisystem involvement
Hematologic abnormalities
Thrombocytopenia
Disseminated intiavasculai coagulopathy
Renal ischemia
Impaired renal function
Hypertension
Proteinuria
Biochemical abnormalities
Magnesium metabolism
Calcium metabolism
Zinc deficiency
Dietary factors
Sodium intake
Protein intake
Caloric intake
Trace metals
Genetic factors
Increased incidence in daughters of eclamptic patients
Increased incidence in gianddaughters of eclamptic patients
Vasospasm
Increased sensitivity to vasoactive substances
Abnormal prostaglandin metabolism

sanoids is tipped heavily in favor of thromboxane. Therefore, the actions of thromboxane—increasing vasoconstriction, platelet aggregation, and uterine activity—will be exacerbated, whereas the actions
of prostacyclin—promoting vasodilation and inhibiting platelet aggregation and uterine activity—will be diminished. 30
Eclamptic patients exhibit an increased sensitivity to vasoactive
substances such as angiotensin II and catecholamines. Such patients
have generalized arteriolar vasospasm resulting in increased peripheral vascular resistance and an increased left-ventricular stroke work
index. Central venous pressure is usually low, and the pulmonary
capillary wedge pressure is in the low part of the normal range (0 to 7
mm Hg). The plasma volume is markedly reduced compared with
that of normal pregnancy (less than 48 ml per kg versus 63 ± 5 ml
per kg), resulting in hemoconcentration and increased blood viscosity. Renal function is frequently characterized by a reduced glomerular filtration rate, decreased renal plasma flow, and reduced
uric acid clearance. Liver damage is usually an autopsy finding in
patients who die from eclampsia. The typical lesion is periportal necrosis with hepatocellular damage.
Several pathologic mechanisms have been implicated as possible

ECLAMPSIA

Table 2.
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Possible Etiologic Factors Responsible for Convulsions
in Eclampsia
Cerebral vasospasm
Cerebral hemorrhage
Cerebral ischemia
Cerebral edema
Hypertensive encephalopathy
Metabolic encephalopathy

etiologic factors in the development of either convulsions or coma in
eclamptic patients (Table 2). Although a recent report suggests a possible association between decreased colloid osmotic pressure and the
development of seizures in eclamptic patients, 6 this idea has not
been confirmed in a study involving a larger patient population from
this institution.
DIAGNOSIS
Theacriteria for the diagnosis of eclampsia require the development,of convulsions in a patient with hvpertension>proteinnria;»*or
edema,after<the 20th week of gestation or.within ,4& hours postpartum.^Several risk factors may predispose to eclampsia (Table 3).
Development of convulsions during pregnancy and the puerperium
may also be the result of other medical and central nervous system
disorders (Table 4), which should be considered in the differential
diagnosis.
The>clinicaLcourse,of eclampsia is usually gradual and chronip;
howevei>the*onset of eclampsia.may be abrupt withoutany warning
signs-or^symptoms, as,occurs in about 15 to 20 p e r c e n t of casesi*A(i
the^University-of*Tennessee,- Memphis, > the authors .studied* 2JJB
eclampticcasesjsabrupt onset.was found in 34 (15.7 percent).
Abnormahweight gain (with or without clinical edema) in excess
of^pounds^per^week^during^the^third trimester, may be an eajjly
warning sign,*but*excessiveiweighhgain or edema during pregnancy*
is notnecessaryfonthe diagnosis^of eclampsia* In,a, report from-thist
institution,^}. (33.8 per*cent)*of.the eclamptic patients had convujj
sions without,edema,-and^intonly 52 (24 per.cent),was generalized
edema evicjjpnt.

Table 3.

Established Risk Factors for Eclampsia

Nulliparity
Multiple gestation
Molar pregnancy
Existing hypertension or renal disease
Previous severe pre-eclampsia and eclampsia
Nonimmune hydrops fetalis
Family history of pre-eclampsia or eclampsia
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Table 4.

Differential Diagnosis of Eclampsia

Cerebrovascular accidents
Cerebral venous thrombose
Cerebral arterial occlusion
Cerebral arteiial embolisn
Intracerebral hemorrhage
Hypertensive disease
Hypertensive encephalopathy
Pheochromocytoma
Space-occupying cential nervous system lesioi
Tumor
Abscess
Infectious disease
Meningitis

Encephalitis
Metabolic diseases
Hypoglycemia
Hypocalcemia
Water intoxication
Epilepsy

Hypertension is the lialu i i< ot eclampsia. This can be severe
(above 160 mm Hg systolic or • ive 110 mm Hg diastolic), as shown
in 42.6 per cent of our series, or mild (140 to 160 mm Hg systolic or
90 to ] 10 mm Hg diastolic), seen in 20.3 per cent. I n c o m e cases,,the^
hypertension is relative (120/80 mm Hg). In ; this-situation^hyperten r
sion is signified by any rise in blood pressure that is 30 mm Hg sys=
tolic or 15 mm Hg diastolic above mid-trimester blood pressure
readings.* Most young primigravidas have initial systolic pressures of
80 to 90 mm Hg and diastolic pressures between 50 and 60,mm Hg
during the second and early third trimester of pregnancy;-consequently, some of these patients may suffer convulsions with relative
degrees of hypertension.
T h e u s e of m e a n arterial p r e s s u r e d t :ng w e e k s ^ l 8 , t o 26j
(MAP-2) to identify patients destined to dev^ op pre-eclampsia has
been suggested by some authors. We have found that this*blood-*
pressure criterion is a poor predictor of eclampsia and might give the
clinician a false sense of security (Table 5)}3 This finding is in agreement with data reported by Moiler and Landmark, 15 who found that
'mly 39 per cent of patients having eclampsia before 37 weeks' and 16
per cent of those having eclampsia beyond 37 weeks' gestation had an
elevation of blood pressure 4 days before the first eclamptic seizures.
The diagnosis of eclampsia is usually associated with significant
proteinuria (more than 2 + on dipstick). The degree of proteinuria
may fluctuate widely over any 24-hour period, making quantitative
24-hour urine determinations more accurate than random assessment. However, the j u g s e n c e of proteinuria is not necessary for the
diagnosis of eclampsia, as about 20 per cent of eclamptic"patients'do
not have proteinuria (Fig. 1).
"
""""
~~
"
Several other Hinical signs and symptoms are potentially helpful
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Maximal Mean Arterial Pressure in Second Trimester in Two
Groups nf Eclamptic Patients
PERCENTAGE WITH

GROUP

NO. OFPATE-CTS

Nulliparas
Margaret-Hagu^
EH Crump
Total
Multiparas
Margaret Hague
EH Crump
total

8£
122
207
c

r
2(

MEAN ± S.D.

86.1
85.9
86.0

6,30
6T
-*- 6 2
-+•

-H

86.2 •+• 4
86 9 -h 4 I
86 6 ± 8.0

90-94

mm J/g

7*9% - :

* ^

28
20
23

a3
27
30

From Chesley LC, Sibai BM £ ^od pressure in mid-trimester and future eclampsia
Am J Obstet Gynecol 157:1259, 1QST

in e i t h e r e s t a b l i s h i n g the diagnosis of eclampsia or s e r v i n g awarnings before the onset of convulsions. These include severe a n d
persistentheadache, blurred vision, photophobia, epigastric pain oi
right upper^quadrTtTTt pain, and hyperactive deep tendon r e f l e t s
with clonus* Persistent occipital headache (80 per cent), visual disturbances (40 per cent), and epigastric pain (20 per cent) are the mc-s
frequent premonitory symptoms before convulsions. l£
The onset of convulsions can be antepartum, intrapartum, o
postpartum. About 50 per cent of cases develop antepartum, 25 p e r
cent during labor, and the rest in the postpartum period. Most cases
of antepartum eclampsia develop during the third trimester, a few
cases occur between 21 and 27 weeks' gestation, and rare cases have
been reported before 20 weeks* gestation. Figure 2 shows the distribution of gestational age at the time of onset of eclampsia among 216
cases studied by the authors. The development of eclamptic convul*21.76*

40.61%

29.63%
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Distribution of gestational age at the time of onset of eclampsia among

sions prior to the 20th week of gestation or more than 48 hours after
delivery in patients with clinical and laboratory findings consistent
with pre-eclampsia is termed "atypical eclampsia" by the authors.
This term has been viewed with skepticism by several other authors
because they consider that the convulsions are due to another disorder. These cases are extremely rare, especially those without associated hydropic or molar degeneration of the placenta; therefore,
most of the time, they may be misdiagnosed as hypertensive encephalopathy or a seizure disorder. Thus, the authors believe that women
in whom convulsions develop in association with hypertension, proteinuria, and elevated uric acid during the first half of pregnancy
should be treated as eclamptic. 1 9
'
Late-onset postpartum eclampsia is defined as convulsions more
than 48 hours after delivery. 21 Pre-eclampsia is not always recognized
before the onset of convulsions; consequently, education of physicians, n u r s e s , a n d p a t i e n t s on t h e subject of late p o s t p a r t u m
eclampsia may help identify the patient before the development of
convulsion. The seriousness of overlooking a persistent postpartum
blood pressure of 130/80 mm Hg or greater when previous constant
readings were 100/60 mm Hg intrapartum, or of a patient failing to
question and report severe headaches for 1 to 3 days or visual disturbances in the first week or two postpartum, cannot be overemphasized.
During the past 10 years, 33 cases of late postpartum eclampsia
(15.2 per cent of our series) have been managed in our institution.
Some of these patients had pre-eclampsia antepartum or during
labor. They received intravenous magnesium sulfate during labor and
for a minimum of 24 hours postpartum. There was clinical evidence
of improvement in the p r e e c l a m p t i c vrocess in all of them, yet con-
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vulsions developed either during hospitalization or a few days after
discharge. T h e other patients had normotensive gestations with
normal postpartum blood pressures. They had sudden onset of convulsions at home and then were readmitted. Headaches, visual disturbances, or both of 1 to 4 days* duration were reported by all patients before t h e onset of convulsions. Physical and laboratory
findings immediately after the convulsions were clearly consistent
with eclampsia in all patients, and brisk diuresis (urine output exceeding 4 L per day) for about 2 days was the rule in every patient.
None of them had a history of seizure disorder, and no patient had
neurologic deficits or seizures on follow-up.
Late-onset postpartum eclampsia should not be treated solely as
a diagnosis of exclusion, since immediate medical therapy should be
instituted for seizure control. Hence, when a postpartum patient is
admitted with a history of convulsions more than 48 hours after delivery and is hypertensive with proteinuria or e d e m a , late-postpartum eclampsia should be the primary diagnosis while ruling out
other possible neurologic or metabolic causes (Table 4).
LABORATORY F I N D I N G S
The diagnosis of eclampsia is not dependent on any specific laboratory data. T h e frequency of abnormal laboratory findings is influenced by multiple factors such as the presence of associated medical or obstetric complications, quality of obstetric care, and adequacy of compensatory physiologic mechanisms. Serum uric acid is
elevated (greater than 6.2 mg per dl) in most patients (69 per cent).
Other renal function tests such as serum creatinine and creatinine
clearance are abnormal in 50 to 70 per cent of the cases.
Hemoconcentration (increased hematocrit and reduced plasma
volume) and increased blood viscosity may be common in eclampsia.
Thrombocytopenia (platelet count below 150,000 p e r mm 3 ) is seen in
15 to 30 per cent of eclamptic patients. The full picture of disseminated intravascular coagulopathy may be seen in neglected cases or
in association with abruptio placentae and fetal demise (4.5 per
cent). 2 2
Conventional liver function tests such as alkaline phosphatase,
lactic dehydrogenase, serum transaminases, and bilirubin may be
elevated in 11 to 74 per cent of eclamptic patients. A syndrome of
hemolysis, elevated liver enzymes, and low platelets ( H E L L P syndrome) is encountered in about 10 per cent of eclamptic patients, and
its presence increases the risk of subcapsular hematoma of the liver
with or without rupture. This syndrome is usually seen late after
long-standing disease and in patients with associated medical disease. 2 6
Cerebral pathology in the form of edema, hemorrhage, or both
is a common autopsy finding in eclampsia. The diagnosis of eclampsia
is not d e p e n d e n t on^ any single clinical or diagnostic neurologic
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finding. Focal neurologic signs such as hemiparesis or tliose of asphyxia are rare. Neurodiagnostic tests such as electroencephalography (EEG), computed tomography (CT) scan, lumbar puncture,
and cerebral arteriography are rarely needed for the diagnosis, 25
The E E G is acutely abnormal in the majority of eclamptic patients. During eclampsia, the E E G pattern is usually a diffuse slow
activity (p or 8 waves), sometimes with focal slow activity and occasional paroxysmal spike activity. None of these findings is pathognomonic of eclampsia, as similar patterns are usually seen in other conditions such as hypoxia, renal disease, polycythemia, hypocalcemia,
and water intoxication. Such abnormalities may persist for as long as
6 weeks postpartum and return to normal within 3 to 6 months thereafter. We studied the E E G findings in 36 eclamptic patients during
the administration of magnesium sulfate (serum Mg 4.5 to 11.0 mg
per dl) and after magnesium sulfate had been discontinued (serum
Mg 1.8 to 2.5 mg per dl). 24 Seventy-five per cent of the patients had
abnormal E E G findings despite adequate serum magnesium levels.
In addition, the authors found no correlation between the degree of
maternal blood pressure elevation and the presence of E E G abnormalities.
There are very few data describing the CT scan findings in
eclamptic patients. The abnormal patterns found are either edema,
hemorrhage, or reversible diminished density of white matter scattered throughout the brain with or without reduced lateral ventricle
size. Cerebral arteriography and lumbar puncture should be restricted to the evaluation of patients with focal neurologic deficits or
late-onset postpartum eclampsia to rule out cerebrovascular pathology such as cerebral vascular accidents (cerebral venous thrombosis or intracerebral hemorrhage), cerebral edema, or cerebral infections (meningitis, encephalitis, or brain abscess).
Magnetic resonance imaging (MRI) is a recently d e v e l o p e d
neuroimaging technique that appears superior to other processes for
defining intracranial anatomy and pathophysiology. The technique
provides images in multiple planes, avoids the use of ionizing radiation, and is not associated with any known biohazards. Its application
in eclampsia has been reported by Crawford and associates, 7 who
found highest sensitivity relative to CT in its ability to detect central
nervous lesions. If their findings are confirmed by larger studies,
MRI might prove to be the method of choice in the management of
this kind of patient, especially the one in whom the diagnosis of
eclampsia is unclear.
.

MANAGEMEN

T h e basic p r i n c i p l e s in the mp c e m e n t of a n t e p a r t u m
eclampsia involve the following measin . (1) support of maternal
vital functions; (2) control of convulsions and prevention of recurrent
"MMvnk-mns-- i^) r n r r p r H n i i nl m a t e r n a l hvnnvnmia or a c i d e m i a : (4)
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control of severe hypertension; and (5) initiation of the process of
delivery.
Eclamptic convulsions constitute a life-threatening emergency.
The cardinal steps in management are to prevent maternal injury
during the convulsive episode, such as inserting a padded tongue
blade between the teeth, and to safeguard against potential maternal
morbidity following the convulsions. The most urgent part of therapy
is to ensure maternal oxygenation and to minimize the risk of aspiration.
The ideal anticonvulsant for pregnancy would be "one which is
rapidly effective, reliable, has a predictable duration of action, has a
wide safety margin, and is neither depressive nor toxic to either
mother or fetus." 2 7 Although it falls short of these ideals, parenteral
magnesium sulfate (MgS0 4 *7 H a O USP) has been the drug of choice
to control and prevent eclamptic convulsions. The drug does not
cliuse any significant maternal-neonatal central nervous system depression when used properly. During its administration, the mother
is awake and alert, and laryngeal reflexes are intact, which helps to
protect against aspiration. Fetal magnesium levels tend to equilibrate
with maternal levels after long-term administration; however, neuromuscular depression in the newborn is rare with proper use of the
drug.
The usual dose of magnesium sulfate given to arrest eclamptic
convulsions is 4 to 6 gm intravenously over 5 to 10 minutes. This
dose is followed by one of three commonly used regimens (Table 6).
If a patient has recurrent convulsions, then another bolus dose of 2 to
4 gm can be given over 3 to 5 minutes. If convulsions again recur,
then a short-acting barbiturate such as sodium amobarbital should be
given in a dose of up to 250 rng intravenously over 3 minutes. An
occasional patient will have recurrent seizures even with all the
above measures, necessitating the administration of a paralyzing
agent as well as intubation.
Maternal plasma levels of magnesium after parenteral administration of magnesium sulfate depend on the volume of distribution
and renal clearance of the M g + 2 ion. These are usually increased and
decreased, respectively, during pregnancy, especially in eclamptic
patients, The usual loading dose of 4 gm intravenously is likely to
Table 6.

Specific Recommended Regimens of Magnesium Sulfate to Treat
Eclamptic Convulsions
Pritchards intramuscular
regimen
4 gm IV over 3 - 5 minutes + 10 gm IM as loading dose
Maintenance dose of 5 gm IM every 4 hours
Zuspan's intravenous regimen
4 gm IV over 5 to 10 minutes as loading dose
Maintenance dose of 1-2 gm per hour
Sibai's intravenous regimen
6 gm IV over 10 minutes as loading dose
Maintenance dose of 2 - 3 gm per hour
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result in instant maternal plasma M g
levels of 5 to 8 mg per dl.
This increase is transient, and plasma levels fall rapidly within the
first 60 minutes. The regimen recommended by Pritchard will ordinarily keep maternal plasma M g + 2 levels between 5 and 8 mg per dl.
The maintenance dose of 1 gm per hour recommended by Zuspan
will produce plasma levels between 3 and 4 mg per dl, but even the
dose of 2 gm per hour produces plasma levels below 5 mg per dl in
about 50 per cent of patients. The recommended therapeutic levels
of Mg range from 4.8 to 8.4 mg per dl; however, the actual therapeutic level is unknown. An occasional patient develops convulsions
at plasma levels that are well in the therapeutic range.
Table 7 summarizes the physical findings consistent with elevated serum M g + 2 levels. Additional actions might include a transient and mild hypotensive effect when magnesium is given as an
intravenous bolus and mild reduction in uterine activity during active
labor. In addition, decreased fetal heart rate variability, neonatal
poor muscle tone, and low Apgar scores are associated with magnesium use. Because of the potential for significant morbidity during its
administration, it is mandatory to examine the patient at regular intervals for evidence of toxicity. Loss of patellar reflexes is the first
sign of magnesium intoxication; hence, any order for administration
of the drug should include checking these reflexes before continuing
the maintenance dose. It is important to keep an ampule containing 1
gm of calcium gluconate at the bedside for intravenous administration as an antidote in case of magnesium toxicity.
The mechanism of anticonvulsant action of Mg* 2 is unknown,
and there is considerable controversy surrounding its peripheral
versus central nervous system effects. Some authors suggest that
magnesium sulfate is a poor anticonvulsant on the grounds that it
controls convulsions by blocking peripheral neuromuscular transmission by interfering with the liberation of acetylcholine and reducing
the sensitivity to acetylcholine at the motor end-plate. This view is
supported by Hilmy and Somjen, 10 who induced hypermagnesemia
sufficient to paralyze skeletal muscles in two men, but they were
unable to induce significant depression of the central nervous
system. Based on these findings, they suggested that the central
nervous system is protected from high levels of serum magnesium by
a barrier mechanism that keeps the concentration in the brain within
physiologic limits. On the other hand, large clinical studies using
magnesium sulfate in patients with severe pre-eclampsia or
Table 7.

Signs of Magnesium Toxicity and Approximate Plasma Levels
SIGN

PLASMA LEVEL (MC/DL)

Loss of patellar reflex
Respiratory arrest
Paralysis
Cardiac arrest

10-12
14.6
15.0
30
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eclampsia have suggested that magnesium prevents convulsions
through a central nervous system effect, because the M g + 2 levels
reported as being adequate to control convulsions are well below the
levels needed to produce complete neuromuscular blockade.
The use of other anticonvulsants such as narcotics, sedatives,
tranquilizers (phenothiazine), and barbiturates can cause significant
maternal-neonatal central nervous system and respiratory depression. Barbiturates and phenytoin are good anticonvulsants when used
orally to treat epilepsy during pregnancy. Diazepam in high doses (20
to 50 mg) depresses both mother and fetus, causes loss of beat-tobeat variability in the fetal heart rate, delays the onset of neonatal
breathing, and is responsible for neonatal apnea, hypotonia, and poor
sucking. The use of intravenous phenobarbital has the potential for
producing laryngospasm as well as circulatory and respiratory depression. In dosages adequate to control seizures, intravenous phenytoin must be administrated slowly (no more than 25 mg per
minute). Because phenytoin is cleared from the brain rapidly, repeated intravenous injections are needed to maintain therapeutic
levels. In a very recent report by Slater and associates, 27 the use of
phenytoin infusion was adopted to avoid the difficulties mentioned
above. After an initial loading dose of 750 to 1250 mg, a 25 mg per
min infusion was started; 12 hours later, a second loading dose of 500
mg was given. Plasma phenytoin levels in the range of 7 to 20 mg per
L were obtained with this regimen, and no serious maternal or neonatal side effects were observed.
Correction of Maternal Hypoxemia or Acidemia
After controlling maternal convulsions, we obtain arterial bloodgas measurements and a chest radiograph to ensure the presence of
normal arterial P 0 2 and pH to rule out aspiration. Maternal hypoxemia or acidemia may result from repeated convulsions and respiratory depression from the use of multiple anticonvulsive agents, aspiration, or a combination of these factors. Correction of hypoxemia
and acidemia is necessary before administering either anesthetic or
anticonvulsive drugs in order to avoid toxic side effects.
Control of Severe Hypertension
The objective of treating severe hypertension is to prevent cerebrovascular accidents without compromising uteroplacental blood
flow, which is already reduced in eclampsia. Hydralazine is a safe
and effective drug for the management of severe hypertension during
pregnancy. The drug should be administered in intermittent bolus
injections of 5 to 10 mg every 20 minutes. Frequent close monitoring
of maternal blood pressure is necessary to titrate the dose of hydralazine. The ultimate goal is to keep the systolic blood pressure between 140 and 150 mm Hg, the diastolic blood pressure between 90
and 100 mm Hg, or both.
Labetalol hydrochloride is a new antihypertensive agent that
might augment the obstetrician's armamentarium. 14 It is available for
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hoih oral and intravenous use and produces nonselective betablockade and postsynaptic alpha-1-blockade, combining the effects of
propranolol and prazosin. Recent reports suggest the drug also has a
vasodilator action mediated by beta-2-receptor stimulation. Hemodynamic studies conflict, but overall, it appears that labetalol decreases
systemic vascular resistance with little or no change in cardiac
output. The drug was introduced in Europe in 1975 b u t did not receive Food and Drug Administration approval in the United States
until 1984. Serious rare side effects have not yet been quantified.
Other potent antihypertensive medications such as sodium ni~
troprusside or nitroglycerin are rarely n e e d e d in eclampsia. Diuretics are not indicated except in the presence of pulmonary edema.
Process of Delivery
Delivery of the fetus and the placenta is the primary treatment
of eclampsia. Once convulsions and severe hypertension are well
controlled and the patient has been stabilized, preparation for delivery should be initiated. All patients should have continuous fetal
heart rate and uterine activity monitoring during labor. Severe fetal
bradycardia and late decelerations are frequent during and immediately after eclamptic convulsions, which may be secondary to maternal hypoxia and acidosis. 17 Adequate correction of such conditions
is commonly followed by gradual recovery of the fetal heart rate pattern. If labor is not well established and no fetal malpresentation or
distress is noted, intravenous oxytocin may be used to induce labor in
all patients beyond 32 weeks' gestation irrespective of the extent of
cervical dilatation or effacement. A similar approach is used for patients at less than 32 weeks if the cervix is favorable for induction. All
other patients are usually stabilized with magnesium sulfate and then
delivered electively by cesarean section. This approach is based on
previous experience of a high incidence of intrapartum complications
such as abruptio placentae and fetal distress in eclampsia developing
before 32 weeks* gestation.
Maternal analgesia can be provided by the intermittent use of
small intravenous doses (25 to 50 mg) of meperidine. Local infiltration anesthesia with pudendal block may be used in most cases for
vaginal delivery. A balanced general anesthesia can be used for abdominal deliveries, b u t probably the anesthesia of choice is epidural.
It must be emphasized that epidural anesthesia in such patients requires the availability of central hemodynamic monitoring and perrunnel with special expertise in obstetrical anesthesia. Also, the use
of conduction anesthesia is contraindicated in patients with thrombocytopenia or prolonged bleeding time (greater than 12 minutes).
There has been controversy regarding the use of epidural anesthesia,
with some authors being against its use because of the potential maternal hypotension and r e d u c e d uteroplacental blood flow, but
others report no adverse maternal or fetal outcome. 9
All patients should have laboratory evaluation of urine protein
nwl specific eravifrv, creatinine, electrolytes, platelet count, and liver
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enzymes. The patient should be monitored closely during labor and
delivery, with special attention to fluid intake and output. Urinary
output should be monitored every hour, and fluid administration
should not exceed 150 ml per hour. Parenteral magnesium sulfate
should be continued through labor and delivery and for at least 24
hours postpartum. If the patient has oliguria (less than 100 ml per 4
hours), the rate of fluid infusion and the dose of magnesium sulfate
should be reduced.
After delivery, the patient should be monitored, including evaluation of reflexes, in the recovery room for at least 24 hours, during
which time maternal vital signs and intake and output should be
monitored hourly. Some of these patients may require invasive hemodynamic monitoring during labor and postpartum. Most patients
will show evidence of resolution of the disease process within 24
hours after delivery. However, some patients may require intensive
monitoring, including the administration of magnesium sulfate, for 2
to 4 days after delivery. Such patients are at risk for development of
pulmonary edema from fluid overload and compromised renal function.
Some authors recommend the use of short-term phenobarbital
w h e n p a r e n t e r a l m a g n e s i u m is d i s c o n t i n u e d in h o s p i t a l i z e d
eclamptic patients during the immediate postpartum period. This
recommendation would appear to be reasonable in view of the persistent E E G abnormalities in some of these patients. However, such
therapy will prevent early ambulation, and its efficacy has not been
studied in a controlled manner. In addition, some internists and neurologists prescribe long-term anticonvulsive therapy (as for epilepsy)
for the majority of patients with postpartum eclampsia. This therapy
is unwarranted, because most patients will have normal EEGs within
6 weeks after delivery. Most patients will be normotensive at the
time of discharge from the hospital, and no patient should have any
neurologic deficit at that time.
Some patients continue to have severe hypertension, whic 1
be controlled with a variety of drugs. Such patients should b*
evaluated within 1 week after discharge from the hospital. Mo
them will be normotensive on follow-up, at which time antihypertensive medication can be discontinued.

PERINATAL OUTCOME
,Eclampsia|is| r £|Significant cause of both maternal and perinatal?
deadifMHfmofBiHity worldwide. Most of the maternal deaths are associated with complicated or mismanaged cases of eclampsia. Potential maternal complications are summarized in Table 8. Some of them
are iatrogenic (pulmonary edema or aspiration), whereas others are
unavoidable (retinal detachment). Abruptio placentae is the most frequent complication; intracerebral hemorrhage i^ the m n ^ sorinn*:
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Table 8.

Maternal Complications in Eclampsia

Abruptio placentae
Disseminated intravascular coagulopathy
Intracerebral hemorrhage
Pulmonary edema
Aspiration pneumonia
Acute renal tubular necrosis
Retinal detachment
Ruptured liver
Transient cortical blindness

The reported perinatal mortality rate varies between 10 and 28
per cent. For fetuses alive on admission to perinatal centers, the neonatal mortality rate is about 4 per cent. 2 3 Most of the perinatal deaths
are related to prematurity, severe growth retardation, asphyxia, and
the increased incidence of abruptio placentae.
Factors relating to the perinatal mortality rate in eclampsia were
examined by L6pez-Llera and associates 12 in 327 infants born of
eclamptic Mexican women. The most important factor was the degree of fetal viability when the patient developed eclampsia. The
mortality rate in the 162 fetuses born to women with antepartum
eclampsia (mean gestational age 34.5 ± 4 weeks) was 37.0 per cent
compared with 12.2 per cent for the 107 fetuses born to women with
intrapartum eclampsia (mean gestational age 38.6 ± 3 weeks). When
fetuses weighing less than 1000 gm were excluded, the fetal deaths
were 22.2 per cent for women with antepartum eclampsia compared
with 6.5 per cent for women with intrapartum eclampsia. The corrected neonatal mortality rate was 9.6 per cent in the women with
antepartum eclampsia compared with 6 per cent in women with intrapartum eclampsia. Women who had eclampsia without any underlying medical condition had a perinatal mortality rate (16 per cent)
half that of women with eclampsia who had chronic hypertension
(34.9 per cent) or underlying renal disease (46.2 per cent). When
fetuses weighing less than 1000 gm were excluded, the corrected
fetal mortality rate in eclamptic women without any underlying medical condition was 6.7 p e r cent compared with 20.5 per cent in
eclamptic women with chronic hypertension and 23.1 per cent in
those with underlying renal disease. Corrected neonatal mortality
rates were 6 per cent for the eclamptic women without an underlying
medical condition, 9.7 p e r cent for the eclamptic w o m e n with
chronic hypertension, and 26.3 per cent for eclamptic women with
underlying renal disease. Most of the increase in the perinatal mortality rate in these women with chronic hypertension was attributable
to loss of fetuses weighing less than 1000 gm.
Of interest w e r e the findings of infants with r e t a r d e d fetal
growth as determined from standards derived by Gruenwald and
based on British data. 8 Before 35 weeks* gestation, 4.3 per cent of
fetuses had a birthweight two or more standard deviations below the
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British mean. This increased to 13.9 per cent for fetuses delivered
after 35 weeks' gestation. Retarded growth prior to 35 weeks' gestation was associated with a markedly increased fetal death rate. After
35 weeks' gestation, fetuses at or below two standard deviations
below the mean had five times the death rate of fetuses at or above
the mean. This study points out the increased death rate in undergrown fetuses.
Abruptio placentae is a significant risk in women who develop
eclampsia before delivery. Pritchard and associates 17 reported a 5.5
p e r cent incidence of abruptio placentae in women who develop
eclampsia before delivery. This was the contributing factor in the
death of three stillborn fetuses that weighed 2080, 2470, and 2670
gm. Abdella and associates 1 reported abruptio placentae in 13 of 55
women (23.6 per cent) with eclampsia prior to delivery at the University of Tennessee, Memphis. The birthweights for these 13 fetuses
were 1239.6 ± 601 gm with a mean gestational age of 29.9 ± 5.2
weeks. There were three stillbirths and three neonatal deaths, for a
perinatal mortality rate of 46 per cent. In addition, two other reports
have given rates of 60 per cent and 100 per cent in women who had
eclampsia and developed abruptio placentae.
Prematurity and intrauterine growth retardation (IUGR) are significant problems in the fetuses of eclamptic women. Sibai and associates 27 reviewed the outcome of the 68 women with eclampsia and
fetus alive on admission to the hospital for the period of August 1,
1977, to December 3 1 , 1981. Forty of the fetuses were less than 37
weeks' gestation with a mean gestational age of 32.4 ± 2 . 2 weeks and
a mean weight of 1496 ± 456 gm. Twelve of the preterm infants were
small for gestational age (SGA) at birth. Twenty-six of the 40 infants
were delivered by cesarean section, with fetal distress being the indication in 17 of the 26 (65.4 per cent). In comparison, cesarean section
was performed in 7 of the 28 women in the term group.
NEONATAL O U T C O M E
These same factors complicating the perinatal outcome are responsible for the increased neonatal morbidity in infants of eclamptic
mothers. Such complications, although more common in preterm antepartum eclampsia, occur as well as in eclampsia developing after 36
weeks' gestation.
Lopez-Llera and Herndndez 1 3 reported higher neonatal loss and
an increased incidence of fetal growth retardation in both antepartum
eclampsia and eclampsia developing early in pregnancy (27 per cent).
Brazy and associates 2 reported a high incidence of retarded fetal
growth (39 per cent below the 10th percentile and 96 per cent below
the 15th percentile) in 28 infants of severely hypertensive pregnancies, eight with eclampsia. In addition, 29 per cent of the infants
were SGA, showing an evident symmetrical growth retardation. The
same authors reported a high incidence of perinatal asphyxia, low
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Apgar scores, i
hematologic abnormalities in infants of hypertensive mothers c ipared with a matched group of infants of normotensive mothers. Some of the hematologic abnormalities were an increased incidence of thrombocytopenia, leukopenia, neutropenia,
and disseminated intravascular coagulopathy. The authors suggested
the presence of a common pathologic process (a humoral substance)
leading to the abnormal hematologic findings in both mother anc
infant.
The neonatal outcome in 72 infants of eclamptic mothers ha c
been recently reported by Sibai and cowoikers 22 Forty of the 7l2
infants (56 pei cent) were premature, and in 9 of these 40, the ptej;
nancy was complicated by abruptio placentae. Twelve of the 40 piematuie infants were SGA. Interestingly, none of the 32 mature infants had evidence of fetal growth retardation. Additionally, giowth
letardation was symmetrical in all seven infants of mothers who had
eclampsia before 32 weeks' gestation. H e n c e , t h e r e is no head
sparing when eclampsia develops early in the third trimestei
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PREVENTION

jgEcIampsisTisT generally considered a preventable c o m p l i c a t i o n ^
I pregnanc^T^
wlowef^ift^incidence.^However, some patients develop eclarriraid
^braptlyTwithout warning signs or symptoms.
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J a d m i t t e d , to t h e J h o s p i t a l . / T h e - s a m e ' a u t h o r s t r e s s e s n h a t i w h e j j j
^p^lnnip'iin dnf*Tfcnfmnri it iVhflc^ise o f - f a i l u r e t o - d i a g n o s e ^ p r ^
^eclampsia, lack of surveillance of women at risk for pre-eclampsia*an
._, and inadeauate
.vx^uuvv
yrj. >Tv/mou
at nais,
pre-eciampsiatand
^eclampsia,
trpafm^nf
r*«r»o
^****iur
^~1«—~:~
jl---i—i"'^'eclampsia, and inadequate treatment once, pre-eclampsia d e v e l o p s
i n e low incidence ot eclampsia in women managed with early long*7
~The low incidence of eclampsia in women managed with early long*
term hospitalization for mild pre-eclampsia has been documented bv
others. All factors that may have been involved in the development
of eclampsia are summarized in Table 10. Although a large numbej^pf #
cases^of, eclampsia are avoidable, there are some cases that»seeny
nonpreventable; factors associated with these cases are shownMn^

Table H *
LOM

T E R M NEONATAL O U T C O M E

Sibai and associates followed 28 premature infants and 14 fullterm infants of eclamptic mothers for up to 50 months. 2 2 Eight of the
12 infants who were SGA by weight at birth showed catch-up growth
at an average of 20.6 months (range 2 to 48 months). In all, only two
of the infants remained growth retarded by weight, height, and head
circumference; both were mentally retarded. A total of three infants
had seiious neurologic deficits resulting in cerebral palsy and mental
ietardation on follow-up evaluation. General health continued to be a
problem for the premature infants during the first year of life, and
several had repeated hospitalizations for either pulmonary or neurologic complications.
The information presented illustrates the importance of neonatal
and obstetric intensive-care facilities in the management of eclamptic
patients. If these facilities are not readily available, physicians cons e n t i n g eclampsia should b e familiar with the guidelines for appropi iate maternal transportation (Table 9).
Table 9,
1
2
3
4

Guidelines for Transport of F ^nts u i i

Table 10. fP^bWKs^iateWbith

»

Consultation with physician at perinatal center prior to transpc
Maternal records sent with patient
Stal)ili7e patient regarding blood pressute anil contiol of convulsion*
» ••••
Patient given adequate magnesium sulfate pnor to transport either -i *-• 1 IV i\
1M simultaneously or 6 gm IV over 15 minutes and 4 gm in 250
*> I
1
given at 125 ml per hour
^ Patient sent in an ambulance with medical personnel in attendance

Because various dietary and biochemical factors have been re
lated to the etiology of pre-eclampsia and eclampsia (Table 12), seeral investigations are being addressed to the use of such association^
in developing a preventive method. However, there is no clear evi
dence to suggest that either of these regimens reduces the incidence
of eclampsia.
T h e r e is some information from case reports and two r e c e r r
clinical studies that low-dose aspirin reduces the incidence of preeclampsia and thus eclampsia. This subject was recently reviewed h\
Wallenburg and associates. 29 The data relating to effectiveness in tinprevention of eclampsia are sparse and inconclusive.
Calcium supplementation during pregnancy has become the
most recent promising step in pre-eclampsia prevention. Villar and
coworkers 2 8 strongly suggest an association between the administration of calcium and the reduction of elevated blood pressure during
pregnancy. Using doses of as much as 1.5 gm per day after the 26th
gestational week, those authors were able to reduce the incidence of
pregnancy-induced hypertension.

i it
1r i
e

Eclampsy

Physician^rror JL ^
~" j "* Iriadequit^prenatal^r
__ Jire
kFailure of diagnosis*or*tr i nent
Patient error
No prenatal care
Failure to keep pienatal appointments
Failure of magnesium sulfate therapy
Convulsions while receiving magnesium sulfate
Magnesium levels helovv therapeutic range
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Table 11. ^Factors in Unavoidabl&Eclampsia
Abrupt onset
Late postpartum onset
Convulsion despite magnesium sulfate levels in therapeutic range
Mild pre-eclampsia with good response and normal blood piessure after
hospitalization
Early onset (before 21 weeks)

Unfortunately, the benefits of either low-dose aspirin or nutritional supplementation are not definite. Further large multicenter
trials are required.
COUNSELING WOMEN A N D RELATIVES OF WOMEN
WITH ECLAMPSIA
C h e s l e y and associates followed w o m e n who d e v e l o p e d
eclampsia at the Margaret Hague Hospital from its opening on October 15, 1931, through 1951. 5 They traced all but three of the
women who survived to 1974. The average annual death rate was
5.11 per 1000, with 31 deaths in the 187 white women who had
eclampsia during pregnancy. This was not significantly different from
the number of deaths expected. However, 33 of 59 white women who
had eclampsia as multiparas had died at an average rate of 21.3 per
1000, which was significantly higher than the number of deaths expected (11.6 per thousand). Twenty-nine per cent of the remote
deaths were the result of cardiovascular-renal disease in the women
who had eclampsia when nulliparas compared with 82 per cent in the
women who developed eclampsia as multiparas.
The prognosis for future pregnancies was good. Another 409
pregnancies occurred in the 158 women in whom eclampsia developed during their first pregnancy. One fifth of all pregnancies in 34.5
Table 12.

Drugs and Dietary Factors Being Tried for Prevention
of Pre-eclampsia
Pharmacologic manipulation
Diuretics
Antithrombotic agents
Low-dose aspirin
Dipyridamole
Heparin
Dietary manipulation
Low-salt diet
Iligh-protem diet
Nutritional supplementation
Calcium
Magnesium
Zinc
Fish oil

ECLAMPSL*
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per cent of the w o m e n resulted in pre-eclampsia. When preeclampsia was present in a subsequent pregnancy, it was usually
mild. Eleven of the women had pre-eclampsia classifed as severe.
Three of these women developed eclampsia for an overall incidence
of 0.9 per cent for pregnancies beyond 20 weeks' gestation, iipmgg^
gfc Chesley^and ^associates*aIso#evieweditheMncidence*of^rel«
^eclafnpsia^in^the first pregnancies of daughters of eclamptic*wtimerfrfM
^Preeclampsia developed in 63 of the 257 pregnancies (24.9 p e r '
"cent). Eclampsia occurred in seven of these pregnancies (2.7 per
cent). The outcome of the first pregnancy carried to viability of sisters
of eclamptic women was reviewed. Pre-eclampsia occurred in 54 (37
per cent) of first pregnancies, and six women (4.1 per cent) developed eclampsia. It is interesting that five other sisters who delivered
at other hospitals also developed eclampsia. Seventy-five of the first
pregnancies of the daughter-in-law of eclamptic women have also
been reviewed. Pre-eclampsia occurred in six (8 per cent). The outcomes of these pregnancies are summarized in Table 13.
~~ JThe Jong-term efFects„oCeclampsiavOnsmaterrial|bl6od pressure
_ _ ^ have.been,summarized by Chesley and associates. 5 The averageTnci^S
^ K «dence^dftchronic^hy^^
J ^ o w e d f o r 6 weeks'to 44 years was 23.8 per cent.' The^authbrs^rdeX^
amineii 197 mostly white women who had had eclampsia when^pri^
miparous'aWn?average *of*33 years'(range 1 to 43 years),iThe^
incidence of diastolic pressure 100 mm Hg or greater was 21.8 per
cent among patients having one subsequent viable pregnancy. However, the incidence was 10 per cent among patients who remained
normotensive in all pregnancies and 45 per cent among patients
having hypertension in at least one subsequent pregnancy. This observed incidence of hypertension was not higher than that expected
in a population of similar age and race. The incidence of diabetes at
an average follow-up of 25 years was 8.3 per cent, which was 2.5
times the expected incidence.
i* Recently, jjSibai andvassociates^analyzed^thefsubsequent p r e g ^
nancy outcomes and remote "prognosis in 406 young (11 to 25 years)]*
women who had had either severe pre-eclampsia (n = 287) or

L

Table 13.

Risk of Eclampsia in Relatives of Women with Eclampsia

RELATIONSHIP TO
ECLAMPTIC WOMEN

NO. WITH
PREGNANCIES
> 2 0 WEEKS

PRE-ECLAMPSIA

ECLAMPSIA

N

%

N

%

340
147
257

70
54
63

20.6
37.6
24.9

3
6
7

0.9
4.1
2.7

75

6

8 0

Eclamptic women
(all future pregnancies)
Sister (all future pregnancies)
Daughter (first pregnancy)
Daughter-in-law
(first pregnancy)

Modified from Chesley LC, Annittp JE, Cosgrove RA The familial factor in toxemia
of pregnancy. Obstet Gynecol 32-303. 1968
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eclampsia (n = 119) during their first pregnancies compared with a
group of 409 young (12 to 25 years) women who remained normotensive throughout their first pregnancies. 20 Each patient had at least
one subsequent pregnancy (range 1 to 11). The pre-eclamptic or
eclamptic group had a total of 815 subsequent pregnancies, whereas
the normotensive group had a total of 966 pregnancies. The preeclamptic and eclamptic group had significantly higher incidences of
both mild and severe pre-eclampsia in second pregnancies (Table 14).
Within this group, patients who had had pre-eclampsia or eclampsia
at 30 weeks' gestation or earlier had a significantly higher incidence
of pre-eclampsia in their second pregnancies than those who had
onset of pre-eclampsia after 30 weeks' gestation. The incidence of
pre-eclampsia in the second pregnancy in these patients was 76 per
cent, whereas it was 38 per cent in those who had had pre-eclampsia
or eclampsia at 37 weeks' gestation or later.
Table 15 compares the incidence of pre-eclampsia in subsequent
pregnancies (excluding second pregnancies) in the two groups.
Again, the pre-eclamptic or eclamptic group had significantly higher
incidences of both mild and severe pre-eclampsia. Within this group,
the incidence of pre-eclampsia in subsequent pregnancies was significantly higher in those who had pre-eclamptic second pregnancies (68
per cent) than in those who had normotensive second pregnancies
(12 per cent). Table 16 presents the subsequent pregnancy outcome
in the two groups of patients. It is obvious that the pre-eclamptic and
eclamptic group had significantly more obstetric complications in
their subsequent pregnancies than the normotensive group. Furthermore, the higher perinatal mortality rate in that group was mainly
related to the higher incidence of both premature delivery and
abruptio placentae.
All patients were followed up for a minimum of 2 years (range 2
to 24) and 90 patients in the pre-eclamptic group and 138 in the normotensive group were followed 10 years or longer. There was no
significant difference in the incidence of diabetes in the two groups
Table 14. Incidence of Pre-eclampsia in Second Pregnancies in Women
Normotensive (N = 409) or Pre-eclamptic-Eclamptic (N = 406) in
First Pregnancy
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Table 15. Incidence of Pre-eclampsia in Third or Subsequent
Pregnancies in Women Normotensive (N = 557) or Pre-eclampticEclamptic (N = 406)* in First Pregnancy
PRE-ECLAMPTICECLAMPTIC

NORMOTENSIVE

Mild pre-eclampsia
Severe pre-eclampsia
Eclampsia
Total

N

%

12
28
3

2.2
5.0
0.5
7.7

43

%

N

%

10
19
2
31

2.4
4.6
0.6
7.6

79
105
6
190

19.5
25.9
1.4
46.8

From Sibai BM, El-Nazer A, Gonzalez-Ruiz AR: Severe pre-eclampsia-eclampsia in
young primigravidas: subsequent pregnancy outcome and remote prognosis. Am J Obstet
Gynecol J55.I0I2, 1986.

%

28
50
7
85

6.8
12.2
1.7
20.7

(1.7 per cent in the pre-eclamptic and eclamptic group versus 1.5 per
cent in the normotensive). However, the respective incidences of
diabetes were 5.6 per cent and 3.5 per cent among patients followed
10 years or longer. The overall incidence of chronic hypertension was
significantly higher in the pre-eclamptic and eclamptic group (14.8
per cent versus 5.6 per cent). In the group followed less than 10
years, the incidence was 4.4 per cent versus 1.5 per cent. However,
in the subgroup that was followed 10 years or longer, the incidences
of chronic hypertension were 51 per cent and 14 per cent. This difference is very impressive considering that these two groups had
similar maternal age and duration of follow-up. It is apparent that the
risk of chronic hypertension in the pre-eclamptic and eclamptic
group becomes impressive after 10 years of follow-up.

Table 16. Pregnancy Outcome in All Subsequent Pregnancies
of Women Normotensive (N = 966)* or Pre-eclamptic-Eclamptic
(N = 815)* in First Pregnancy
PRE-ECLAMPTICECLAMPTIC

NORMOTENSIVE

N

N

•Number of subsequent pregnancies.
From Sibai BM, El-Nazer A, Gonzalez-Ruiz AR: Severe pre-eclampsia-eclampsia in
young primigravidas: subsequent pregnancy outcome and remote prognosis. Am J Obstet
.Gynecol 155:1012, 1986.

PRE-ECLAMPTICECLAMPT1C

NORMOTENSIVE

Mild pre-eclampsia
Severe pre-eclampsia
Eclampsia
Total

ECLAMPSIA

Pre-eclampsia
Abruptio placentae
Perinatal mortality
SGA infants
Preterm (<37 weeks)

N

%

N

74
7
29
32
91

7.7
0.8
3.0
3.3
8.4

275
21
48
58
122

%
33.7
2.5
5.9
7.1
15.0

*Total number of pregnancies.
From Sibai BM, El-Nazer A, Gonzalez-Ruiz AR: Severe pre-eclampsia-eclampsia in
young primigravidas: subsequent pregnancy outcome and remote prognosis. Am J Obstet
Gynecol 155:1013, 1986.

SUMMARY
The incidence of eclampsia has decreased over the past two decades. Proper prenatal care with early identification and hospitalization of patients with mild pre-eclampsia is responsible for this reduction. Modifications of current obstetrics teachings designed to
heighten awareness of the risk of both midtrimester and late-postpartum eclampsia could further reduce its occurrence. However,
there will always be a small number of women in whom eclampsia is
not preventable. Eclamptic patients should be counseled regarding
the increased risk of pre-eclampsia or eclampsia in their sisters and
daughters as well as their increased risk for both recurrence of the
disease and perinatal death in subsequent pregnancies.
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Deposition of:
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CLAYTON S, WILDE, M.D.
Defendant.
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BE IT REMEMBERED that on the 2 0th day of September, 1990,
the deposition

of CLAYTON

S. WILDE, M.D., produced

as a

witness herein at the instance of the plaintiff, in the aboveentitled action now pending in the above-named

court, was

taken before Rashell Garcia, a Certified Shorthand Reporter
and Notary Public in and for the State of Utah, commencing at
the hour of 9:50 a.m. of said day, at the offices of Robert B.
Sykes & Associates, 311 South State, Suite 240, Salt Lake
City, State of Utah.
That said deposition was taken pursuant to Notice.
-oOo-

CERTIFIED
COPY

RASHELL GARCIA
CSR No. 144

INDEPENDENT REPORTING
SERVICE
Certified Shorthand Reporters

1200 Beneficial Life Tower
36 South State Street
Salt Lake City, Utah 84171
(801)
538-2333

1

Q

Well, she eventually had eclampsia, didn't she?

2

A

But after her presentation with that, she was

evaluated and was normotensive.

4

Q

After h e r —

at

3

A

When I evaluated her, she was normotensive.

6

Q

Would you agree that she had a sudden weight gain?

7

A

Yes.

8

Q

The next sentence here, two down, says, "Sudden and

9

excessive weight gain is attributable almost entirely to

10

abnormal fluid retention and is demonstrable, as a rule,

11

before visible signs of nondependent edema, such as, swollen

12

eyelids and puffiness of the fingers."

13

that?

Do you agree with

14

A

Yes.

15

Q

Paragraph 10, right in the middle, says, "In early

16

preeclamp.sia,

17

lacking."

proteinuria

may

be

minimal

or

entirely

Do you agree with that?

18

A

I agree.

19

Q

I thought you told me earlier that proteinuria must

20

be present to have preeclampsia.

21

A

Correct.

22

Q

Well, this says that proteinuria does not have to

23

be present, it may be minimal or entirely lacking in early

24

preeclamp sia.

25

MR. WILLIAMS:

You're misquoting or quoting out of
199
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•

•

1

context.

2

making the diagnosis.

3

Q

This text clearly

(By Mr. Sykes)

identifies

the criteria

for

Go ahead and answer the question.

4

It says, "In early preeclampsia, proteinuria may be minimal

5

or entirely lacking."

6

A

I don't know what early preeclampsia is.

7

Q

Look at paragraph 11.

In the bold print there it

8

says, "In women who develop eclampsia, severe headache almost

9

invariably precedes the first convulsion."

10

that?

11
12

A

I do, but all eclamptic women are also hyperten-

Q

Do you admit that Tony and Brenda told you that she

sive.

13
14

Do you agree with

was having severe headaches?

15

A

No.

16

Q

Severe headaches on June 15th, 1989?

17

A

No.

18

Q

They didn't tell you she was having severe head-

19

aches?

20

A

No.

21

Q

Look at paragraph 15, if you would.

Do you agree

last

predisposing

22

with

23

factors?

the

sentence

talking

about

major

Do you agree with that statement?

24

A

I do.

25

Q

Did you ask at any time, either in your forms or
200
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CLINICAL SECTION
Clinical Opinion

Clinical significance of elevated mean arterial pressure in the
second trimester
Leon C. Chesley, PhD, and Baha M. Sibai, MD
Brooklyn, New York, and Memphis, Tennessee
Several reports suggested using the mean arterial blood pressure during the second trimester to predict
the future development of preeclampsia. The value of a second-trimester mean arterial blood pressure
^90 mm Hg was reviewed in 39,876 reported cases of preeclampsia and 207 cases of eclampsia. The
sensitivity ranged from 0% to 92% and the specificity vaned from 53% to 97% The predictive value of a
positive test ranged from 0% to 43% and the predictive value of a negative test ranged from 76% to 98%.
The predictive value of a positive test was not greatly higher than the incidence of hypertension in the
•.whole population studied in the majority of the reports. There was a strong association of higher
^second-trimester mean arterial blood pressure in nuliiparous women with eclampsia who had transient
hypertension in later gestations and ultimately developed chronic hypertension The data suggest that one
sign of future chronic hypertension, that is, transient hypertension, is often predicted by high
second-trimester mean arterial blood pressure, which may have the same significance. We think that if
Increased second-trimester mean arterial blood pressure levels predict anything, it is transient
hypertension rather than preeciampsia-eclampsia. (AM J OBSTET GYNECOL 1988;159:275-9.)

Key words: Second-trimester mean arterial blood pressure, preeclampsia, transient
hypertension

-In 1963, Fallis and Langford' reported that primigravid women developing "toxemia" in the third
trimester had had higher blood pressures earlier in
pregnancy when compared with women who remained
normotensive. T h e observation lay dormant for more
than a decade, until given impetus by Page and
Christianson 2 in 1976. In an analysis of data derived
from 14,833 pregnancies managed in the KaiserPermanente Health Plan, they found that the average
mean arterial pressure in the second trimester had
some predictive value for the later development of preeclamptic and nonpreeclamptic hypertensions in the
third trimester, in that the incidences of those complications were augmented progressively with increasing
levels of second-trimester mean arterial blood pressure,
Wltri
sharp increases at levels of ^ 9 5 mm Hg
rrovi the Department of Obstetrics and Gynecology, State University
°f \'ew York Downstate Medical Center, and the Division of
Maternal-Fetal Medicine, University.of Tennessee, Memphis
Reprint requests Baha M Sibai, MD, Division of Maternal-Fetal
Medicine, 800 Madison Ave , Memphis, TN 38163

Several later studies have purported to show that
preeclampsia often can be predicted from average
second-trimester mean arterial blood pressure levels of
2*90 mm Hg, although with high percentages of falsepositive and false-negative results. 37 Table I summarizes the sensitivity, specificity, and predictive values of
second-trimester mean arterial blood pressure as reported in a total of 39,600 cases plus 276 unpublished
cases T h e sensitivity ranges from 20% to 92% in the
reported studies, but it was 0% in the unpublished data
of Chesley T h e specificity varies from 53% to 97%
depending on the size and characteristics of the patients
studied T h e predictive value of a positive test ranges
from 6 4% to 4 3 % and the predictive value of a negative
test ranges from 76% to 98%. It is important to note
that the predictive value of a positive test was not greatly
higher than the incidence of hypertension in the whole
population studied in the majority of the studies.
In a retrospective analysis of average and maximal
second-trimester mean arterial blood pressure and
maximal diastolic pressure in the second trimester,

275

276

Chesley and Sibai

Table I. Summary of literature concerning predictive value of blood pressure in second trimester
Predict!ve value
Authors
Fallis and Langford
Page and
Christianson 2
Friedman and
Neff3*
Quass et al.4
Phelan 5
Oney and
Kaulhausen 6
Moutquin et al.7
Chesley (unpublished data)

No. of cases
1

Parity

Mean arterial
pressure
>9Q mm Hg

Sensitivity

Specifiaty

Positive

Negative

Pi e eclampsia

(%)

(%)

(%)

(%)

113
14,833

Nulliparous
All panties

41
2014

39
399

82
43

88
87

78
8.6

90
98

22,582

All panties

8807

888

64

62

64

98

801
96
200

All panties
Nulliparous
Nulliparous

207
7
85

213
15
21

65
20
90

88
95
62

15
43
20

70
87
98

808
175
174

Nulliparous
Nulliparous
Multiparous

56-71

66-78

11-14

96-98

9

46
3
2

97

0

99

1

0

*The data of Friedman and Neff are for maximal second-trimester mean arterial blood pressure.

we8 found but little relation to the later development
of eclampsia in 207 nulliparous women, and 20 multiparous women from two different eras, geographic regions, and racial distributions. Average secondtrimester mean arterial blood pressure levels of ^90
mm Hg have been observed in only 22% of the nulliparous women and 30% of the multiparous women.
Maximal second-trimester mean arterial blood pressure
levels of 2*90 mm Hg had occurred in 34% of the nulliparous women and 35% of the multiparous women,
incidences slighdy lower than the 39% seen by Friedman and NefP in the whole population of 22,983
women for whom relevant information was available in
the Collaborative Perinatal Project; that is, the women
later developing eclampsia cannot be identified in the
population by maximal second-trimester mean arterial
blood pressure. No nulliparous woman had a maximal
second-trimester diastolic pressure as high as 90 mm
Hg and only 8.7% had pressures 2*80 mm Hg.
T h e inefficacy of second-trimester mean arterial
blood pressure in the prediction of eclampsia prompts
a closer look at the data advanced as supporting its
value in the prediction of preeclampsia (almost always
of mild degree). Here the diagnostic criteria for mild
preeclampsia are crucial.
Problems In diagnosis of preeclampsia
Page and Christianson 2 found incidences of proteinuria, preeclampsia, and nonpreeclamptic hypertension
to be 1.8%, 2.7%, and 2.7%, respectively, among their
14,833 women. The identical incidences of preeclampsia and hypertension seem to indicate that the three
groups are mutually exclusive. They wrote that the diagnosis of preeclampsia "was based upon the combination of hypertension with proteinuria a n d / o r generalized edema" but gave no indication of how many

had had proteinuria. Accepting their diagnoses, it appears that the predictive value of average secondtrimester mean arterial blood pressure levels of 2*90
mm Hg is better for hypertension alone than for preeclampsia; the respective sensitivities are 6 1 % and 43%,
the respective specificities are 94% and 87%, the respective positive predictive values are 13.1% and 8.6%,
and the respective negative predictive values are 98%
and 99%.
Friedman and NefP published relevant data for
22,582 pregnancies in the Collaborative Perinatal Project but used the maximal rather than the average
second-trimester mean arterial blood pressure as a predictor. Their data together with those of Page and
Christianson 2 comprise 37,415 pregnancies and account for 94% of all cases reported. With maximal
second-trimester mean arterial blood pressure levels
2*90 mm Hg, for hypertension alone (transient hypertension) and for hypertension with proteinuria (preeclampsia?), the respective sensitivities were 78% and
64%, the respective specificities were 63% and 62%, the
respective predictive values of a positive test were
10.4% and 6.4%, and the respective predictive values
of a negative test were 98% and 98%.
Quass et al.,4 who included women of all panties,
made the diagnosis of preeclampsia in 213 of their 801
patients but remarked that 88% of them were assigned
a gestosis index of 1 or 2. That strongly implies that
mild rises in blood pressure may have been the only
basis for the diagnoses; that is, most of the women had
transient hypertension rather than preeclampsia.
Oney and Kaulhausen 6 found that 42% of 200 nulliparous women had an average second-trimester mean
arterial blood pressure of 2*90 mm Hg, but only 32%
of that group developed later hypertension. Eight-were
classified as pregnancy-induced hypertension and 19
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Table II. Average mean arterial pressures in second tnmestei ol nulhpaious eclamptic women in relation
to recurrence of hypertension in subsequent pregnancies
Margawl Hague series
Subsequent ptepuninrs

j

Average second-tnvwslei
mean arterial blood
pressure (mm Hg)

No. of women

No of pi egnanncs

//

55-64
65-74
75-84
85-89
5:90

2
4
14
20
6

2
9
22
29
23

0
0
3

Total

46

85

Ihptttnni,

E H. dump series
Subsequent pregnancies
Hype* tension*

i*

\ n of women No of p i egna ncies
<
—————

()

IM 4
M)

4
12
33
2<>

4

(><> 0

\b

7
24
59
46
30

13

2S J

91

166

n

%

0
1
8
9
10

8 3
24.2
34.6
62.5

28

30.8

•In at least one later pregnancy.

were termed preeclampsia. Only two of the 115 with
average second-trimester mean arterial blood pressure
<90 mm Hg developed preeclampsia. Their falsenegative rate is far below any other reported. T h e authors wrote that the blood pressures had been measured after the women had lain supine for 10 minutes.
Hence the higher second-trimester mean arterial blood
pressure levels might be attributable to the supine
pressor response that sometimes predicts pregnancyinduced hypertension. T h e 42% of patients with
second-trimester mean arterial blood pressure levels
2*90 mm Hg is far greater than the 13.6% reported by
Page and Christianson or by any other investigator.
• In the classification of the American Committee on
Maternal Welfare 9 and in Nelson's classification,10 which
b widely used in the British Commonwealth and elsewhere, the diagnosis of preeclampsia can be made on
the sole basis of rises of blood pressure, without proteinuria or edema. T h e diagnosis is erroneous as often
as not in primigravid women and usually is so in multiparous ones. T h e Committee on Classification of the
American College of Obstetricians and Gynecologists"
sought to improve the accuracy of the diagnosis of preeclampsia by relegating mere rises in blood pressure to
a new category designated transient hypertension
Sometimes transient hypertension is mild, incipient
preeclampsia but often, perhaps more often, it is latent
^essential hypertension brought to light by pregnancy
The clinically oriented classification of the Committee on Classification does not require proteinuria for
the diagnosis of preeclampsia because it usually is of
late onset in the course of the disorder, so late indeed
that the onset of convulsions may precede its appearance. The committee's criteria permit the diagnosis of
preeclampsia on the basis of acute hypertension together with edema of the hands or face in the latter
»aif of pregnancy-, but such edema is common in normal pregnancy and-some women with transient hyper-

tension must have such normal edema and be misdiagnosed as having preeclampsia, j
Dextei dnd Weiss' J examined~TDOconsecutive women
late in normal pregnancies and found digital or facial
edema, or both, in 64%. They were looking specifically
for edema and may have observed it in instances that
would escape detection in routine antepartum clinics.
Perhaps a more practical example would be in the data
of the Collaborative Perinatal Project, where significant
edema of the hands or face, or both, without proteinuria at any time, had been recognized at some stage of
pregnancy in 11,516 of 38,636 (30%) women. T h e frequencies were 39% in white women and 2 3 % in black
subjects n
In day-to-day management, acute hypertension and
edema in pregnancy must be regarded and treated as
preeclampsia, but in studies of preeclampsia more rigid
criteria are essential. Although often of late onset, proteinuria is the hallmark of preeclampsia and the charactenstic renal lesions of the disorder are rarely found
in the absence of proteinuria. 14 Many of the diagnoses
of preeclampsia in the relevant publications seem to
have been made in women without proteinuria.
Although preeclampsia does occur in multiparous
women, that diagnosis is usually erroneous, as demonstrated b\ findings in renal biopsy specimens. Fisher
et al ' retrospectively compared clinical diagnoses with
anatomic findings and "although most of the patients
have been considered preeclamptic prior to biopsy only
55% of them had the renal lesion of preeclampsia. . . ."
Of the 104 nulliparous women, 79 had the pure lesion
and eight others had it superimposed on nephrosclerosis or other renal disease; thus, 85% had anatomic
substantiation of the diagnosis and 15% did not.
Among the 72 multiparous women, 17 had the pure
lesion of preeclampsia and nine others had it superimposed on nephrosclerosis or other renal diseases,
thus, the clinical diagnosis of preeclampsia was not Sup-
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ported anatomically in 64% of cases; 37 (51%) had only
the lesions of nephrosclerosis or other renal diseases
and 8 (11%) had no renal lesion.
Gleicher et al,' 6 compared clinical presentation and
pregnancy outcome between 46 primiparous and 53
multiparous women with hypertensive disorders of
pregnancy. They found clear differences between the
two groups regarding time of onset of hypertension
(early in gestation in the multiparous women) and the
impact of maternal disease on fetal growth and development. They concluded that these differences suggest
different pathophysiologic features as the underlying
cause of hypertension in primiparous and multiparous
women.
It has been suggested that an average secondtrimester mean arterial blood pressure of ^ 9 0 mm Hg
has a good predictive value for future development of
preeclampsia. In their landmark study, Langford and
Watson recorded blood pressures of nulligravid high
school girls and analyzed them in relation to blood pressure observed throughout first pregnancies occurring
months to a few years later. Patients with "mild preeclampsia" had had higher pressures before conception, at every stage in pregnancy, and at io\k>w-up.TYie
study was based on first pregnancies of 186 women with
preeclampsia and 400 women without, with similar incidences of proteinuria, usually negative or present
only in trace amonts. T h e weight gains and incidences
of edema were similar in the two groups. The authors
wrote: "The diagnosis of preeclampsia appeared to be
based entirely on BP." In a word, most of the "preeclamptics" had had transient hypertension rather than
preeclampsia and the second-trimester mean arterial
blood pressure levels of =^90 mm Hg had predicted
transient hypertension.
Average second-trimester mean arterial blood
pressure and future pregnancies
Transient hypertension has a high rate of recurrence
in pregnancies, and it seems probable that it provides
the basis for the diagnosis of preeclampsia in many
multiparous women. If progressively higher levels of
second-trimester mean arterial blood pressure predict
transient hypertension, then they may also predict recurrence of hypertension in later pregnancies. We have
tested that hypothesis by relating second-trimester
mean arterial blood pressure in eclamptic pregnancies
to the nature of subsequent gestations, as shown in
Table II.
Among the women having had eclampsia in the Margaret Hague Maternity Hospital, in Jersey City, N.J.,
during the years 1931 through 1951, 47 nuliiparous
eclamptic women have had later pregnancies. Recurrent hypertension, usually mere rises in blood pressure
without proteinuria or edema (transient hypertension),

was observed in nine of 40 (22.5%) women whose average second-trimester mean arterial blood pressure
levels had been < 9 0 mm Hg and in four of the six
whose second-trimester mean arterial blood p c e ^ v ^
levels had been > 9 0 mm Hg during the eclamptic testation. Among the women having had eclampsia i n
Memphis, Tennessee, during the years 1977 through
1987, 91 nuliiparous eclamptic women have h.ul later
pregnancies. Recurrent hypertension was observed in
18 of 75 (24%) whose average second-trimester mean
arterial blood pressure levels had been <90 mm Hg
and in 10 of the 16 whose second-trimester mean arterial blood pressure levels had been ^ 9 0 mm Hg during the eclamptic gestation. It is interesting to note that
the incidence of recurrent hypertension in subsequent
gestations increases with increasing second-trimester
mean arterial blood pressure levels during the eclamptic gestation. When data from both studies are pooled
together, the presence of second-trimester mean arterial blood pressure ^ 9 0 mm Hg during the eclamptic
gestation is associated with a significantly higher incidence of hypertension in subsequent pregnancies
(p = 0.02, odds ratio 2.5:1).
Average second-trimester mean arterial blood
pressure and future chronic hypertension
Among the 81 nuliiparous eclamptic women surviving pregnancy in the Margaret Hague Hospital, average second-trimester mean arterial blood pressure values ^ 9 0 mm H g were associated with an increased
incidence of chronic hypertension at follow-up of 23
to 43 years. Hypertension was found in 13 of the 59
(22%) whose average second-trimester mean arterial
blood pressure value had been < 9 0 mm Hg as compared with nine of 22 (41%) whose levels had been 2*90.
If the dividing line is to be set at 85 mm Hg, the incidences are 13% and 38%, respectively, for secondtrimester mean arterial blood pressures <85 and ^ 8 5
mm Hg (p < 0.02, odds ratio 4 . 1 : 1).
Unifying concept
It has long been recognized that persons destined to
develop essential hypertension characteristically ha\e
blood pressures slightly increased over age-specific a\erages for some years before the onset of sustained
hypertension and possibly even in early childhood. The
higher pressures occur throughout pregnancy, including the second trimester. Is it not reasonable to suggest
that one sign of future chronic hypertension, ie, transient hypertension, is often predicted by high secondtrimester mean arterial blood pressure levels and that
both predict future essential hypertension, although
with some degree of fallibility? T h e data in Tables I
and II are consistent with that concept. We suggest that
second-trimester" mean arterial blood pressure may
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The sperm penetration assay: Can it discriminate between
fertile and infertile men?
Constance M a o , M D , a n d D a v i d A . G r i m e s , M D
Los Angeles,

California

The sperm penetration assay with zona-free hamster ova is widely used to evaluate male infertility
Despite a growing body of literature about this assay, its results remain difficult to interpret To evaluate
the clinical usefulness of this test, we reviewed the world s literature about this assay and analyzed the
test's performance Its sensitivity ranges from 0 00 to 1 00 and specificity ranges from 0 95 to 1 00 for
diagnosing male infertility For predicting in vitro fertilization failures, its sensitivity varies from 0 00 to 0 78
and specificity ranges from 0 51 to 1 00 The reproducibility of this assay is not clear, and there is little
standardization of methods between laboratories Until the validity and reproducibility of the sperm
penetration assay have been established, this expensive test should probably not be used to evaluate
infertile couples (AM J OBSTET GYNECOL 1988,159 279-86 )
Key w o r d s : S p e r m p e n e t r a t i o n assay, male infertility s e m e n , in vitro fertilization
Over t h e p a s t d e c a d e t h e s p e r m p e n e t r a t i o n assay,
also k n o w n as t h e z o n a - f r e e h a m s t e r ova assay, h a m s t e r
test, h u m s t e r test ( h u m a n p l u s h a m s t e r ) , a n d h e t e r o l ogous o v u m p e n e t r a t i o n test, h a s b e c o m e p o p u l a r in
From '^ Department of Obstetrics and Gynecology, University of
Southern California School of Medicine
Reprint requests Dr David Grimes Department of Obstetrics
tyd Gynecology, Women s Hospital, 1240 N Mission Road
Los *ngelesx CA 90033

t h e field o f infertility M a n y investigators c o n t e n d that
it p r e d i c t s m a l e infertility a n d c a n b e u s e d r o u t i n e l y in
t h e e v a l u a t i o n o f infertile c o u p l e s * O t h e r s use it t o
s c r e e n c a n d i d a t e s b e f o r e a t t e m p t i n g in vitro fertilization o f h u m a n e g g s 2 D e s p i t e a l a r g e b o d y o f l i t e r a t u r e ,
t h e basic q u e s t i o n r a i s e d by Y a n a g i m a c h i et a l s in 1976
r e m a i n s u n a n s w e r e d C a n t h e s p e r m p e n e t r a t i o n assav
d i s c r i m i n a t e b e t w e e n m a l e fertility a n d infertility^
Most i n v e s t i g a t o r s h a v e failed t o u s e a p p r o p r i a t e sci-
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MILD PREECLAMPSIA, POTENTIALLY LETHAL FOR WOMEN
AND FOR THE ADVANCEMENT OF KNOWLEDGE
Leon C. Chesley
Department of Obstetrics and Gynecology
State University of New York
Health Science Center at Brooklyn
Brooklyn, New York 11203
ABSTRACT
Acute increases in blood pressure of pregnant women must be regarded and
treated as preeclampsia, for if the patient really has preeclampsia it may
progress in severity and lead to eclampsia or even death.

In collecting cases

for the study of preeclampsia the working diagnosis cannot be accepted; far more
rigid criteria must be used because hypertension is common to several other
unrelated

disorders.

Erroneous diagnoses

lead

to erroneous

conclusions.

Examples cited concern (A) the renal distal tubular reabsorption of free water
during osmotic diuresis in hydropenia, (B) the concept that preeclampsia causes
chronic hypertension in women who otherwise never would have developed it, and
(C) the concept that higher levels of the mean arterial pressure in the second
trimester (MAP - 2) predict preeclampsia.

Many women bearing the diagnosis of

mild preeclampsia really have transient hypertension, which appears to be latent
essential hypertension brought to light by pregnancy.

Transient hypertension

often is predicted by higher levels of MAP - 2; it had a high rate of recurrence
in later pregnancies and often predicts ultimate chronic hypertension.
About a quarter of women with eclampsia have had apparently mild or even
barely diagnosable preeclampsia until the onset of convulsions.

Dieckmann (8)

reported that about 22% of eclamptics had not had recorded systolic pressures
exceeding 140mm Hg before seizures and that about 12% of that subgroup died of
eclampsia.

The experience of the Margaret Hague Maternity Hospital, in Jersey

City, N.J., was similar during the 19 years that I spent there.

3
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Moreover,
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proteinuria often is a late sign in the course of preeclampsia and may not appear
before convulsion in perhaps 5% to 10% of cases; in Sibai's (21) series of 67
cases of eclampsia, 21% had had no proteinuria prior to convulsion, and 21% had
had diastolic pressures below 90 mm Hg. One of Eden's (10) criteria for severe
eclampsia is the absence of edema.
These observations mean that in the day-to-day clinical management, any
rise in blood pressure in the latter half of pregnancy must be regarded and
I I treated as preeclampsia, with a potential for progression to eclampsia and even

1 -f

_

».

\ I to death.

Tf
it isdiagnosis
erroneousmust
in not
at least
half of
cases and several
I of preeclampsia,
The clinicalfor
working
be accepted
in publishing
studies
/

disorders are lumped together under the name "preeclampsia", especially "mild

\

preeclampsia".
In most classifications, including those of the American Committee on
Maternal Welfare (9) and Nelson (18), which is widely used in the British
Commonwealth and elsewhere, the diagnosis of preeclampsia can be and is made on
the sole basis of rises in blood pressure, without proteinuria or edema. The
Committee on Terminology of the American
Gynecologists

College of Obstetricians and

(14) sought to improve the accuracy of the diagnosis of

preeclampsia by setting aside mere rises in blood pressure in a new class called
transient, gestational, or late hypertension. Transient hypertension is defined
as rises in blood pressure in late pregnancy or early puerperium, without
significant proteinuria or edema, and a return to normotension within 10 days
after delivery./For the diagnosis of preeclampsia, the Committee requires the
acute onset of hypertension after the 20th week of gestation together with
^f'\\j

proteinuria or edema (facial, digital, or generalized), or both.

In their

/ clinically oriented classification, they do not require proteinuria because it
\ often is of late onset.
Edema is not a good criterion because it is so common in normal pregnancy.
Dexter and Weiss (7) examined 100 consecutive women in the third trimester of
normal pregnancies and observed facial or digital edema, or both, in 64. They
were looking for edema specifically and may have observed it in instances that
would have escaped casual examination. A more relevant datum might be in the
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Collaborative Perinatal Project; Vollman's (22) analysis showed 39% of 17,698
white women and 22% of 20,938 black women to have had edema of the hands or face,
or both during pregnancy.
Transient hypertension is called preeclampsia in most classifications and
there is no evident reason why it should not be accompanied by the normal,
physiologic edema of pregnancy but when it is, the erroneous diagnosis of
preeclampsia is likely to be made in accordance with the criteria proposed by
the Committee on Terminology.

Although transient hypertension sometimes is

incipient preeclampsia, and sometimes the reappearance of frank hypertension that
abated in midpregnancy, probably it more often is a manifestation of latent
essential hypertension unmasked by pregnancy.

O'Sullivan's (19) follow-up

studies have shown that the majority of women with gestational

diabetes

eventually develop overt diabetes, even though their glucose tolerance tests had
reverted to normal after delivery.

There is good evidence to support the

hypothesis that transient hypertension in pregnancy often predicts ultimate
essential hypertension.
To cite only one of several studies, in 1936 Herrick and Tillman (13)
reexamined 188 women with what is now called transient hypertension; at an
average of 7.5 years after pregnancy, half were hypertensive; 33% had retinal
angiosclerosis; 55% were not yet aged 40, which means that more would become
hypertensive; significantly, 88% of those having had later pregnancies had had
recurrence of hypertension during their later gestations.

The frequent

recurrence of transient hypertension has been the basis for many erroneous
dignoses of preeclampsia in multiparas.
Probably all of us interested in hypertensive pregnancy look to the Chicago
Lying-in Hospital as the paragon, so recognized for more than half a century.
The staff there has assessed the reliability of their clinical diagnoses of
preeclampsia and I cite two papers.

Fisher et al (11) blindly reviewed renal

biopsies that had been obtained from many of their hypertensive patients between
1958 and 1976, and then compared the anatomic findings with clinical diagnoses.
They wrote:

"Although most of the patients had been considered preeclamptic

prior to biopsy only 55% of them had the renal lesion of preeclampsia".

That

does not seem to mean that many preeclamptics do not have the lesion, for 40%
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of all patients had the lesions of chronic renal disease without the preeclamptic
changes:

glomerulonephritis,

pyelonephritis,

and

nephrosclerosis,

a scattering

of

several

interstitial

others.

The

nephritis,
hypertension,

proteinuria, and edema associated with renal diseases, singly or in combinations,
had simulated preeclampsia.
The consequence of erroneous diagnosis must be erroneous conclusions, as
exemplified in a paper by McCartney et al (17). They assessed the renal tubular
handling of water during osmotic diuresis and hydropenia in 22 women with the
clinical diagnosis of preeclampsia, but obtained renal biopsies from each. Only
six

of the

22

had

the

renal

lesion

cf preeclampsia;

six

had

chronic

glomerulonephritis, five had nephrosclerosis, and five had no renal lesion. The
tubular handling of water was different from group to group and if the overall
findings had been based upon the clinical diagnoses, the erroneous conclusions
would have been that there is a wide range, averaging out close to normal in
preeclampsia. Actually the women with proved preeclampsia had a depressed rate
of glomerular filtration, but an increased tubular capacity ( T ^ Q ) for the
reabsorption of solution free water: 7.5 ml/lOOml of glomerular filtrate as
compared with 5.3 ml in normal pregnant women.

An earlier study (2) in women

with clinical diagnoses of preeclampsia had come to the opposite conclusion, that
there is a renal concentrative defect in preeclampsia.
The almost innumerable follow-up studies of women thought to have had
preeclampsia led to the erroneous conclusion that preeclampsia could and often
did cause hypertension in women who otherwise never would have had it. That view
has been disputed and, I hope, discredited in an earlier review (3).

Since

publication of the review, Fisher, Luger, Spargo and Lindheimer (11) reexamined
53 women who had had preeclampsia as proved by renal biopsies and found that the
prevalence of hypertension (9.5%) at follow-up was slightly lower than that in
matched, unselected women in the National Health Survey (10%).

They also had

matched the preeclamptic women with others having had normotensive pregnancies;
in that group the prevalence of hypertension at follow-up (0.5%) was only 1/20
of that expected. Thus, as had been suggested by Chesley, Annitto, and Cosgrove
(4),

pregnancy

is

a

screening

test

for

future

essential

hypertension:

normotensive pregnancies predict a low likelihood, and transient hypertension
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a high probability of ultimate hypertension.

Preeclamptic and eclamptic

hypertension is an intercurrent disorder that predicts nothing, although the
women will have a higher prevalence of later hypertension than will those having
had normotensive pregnancies. That is not because preeclampsia-eclampsia causes
chronic hypertension but because the women have not been screened, whereas
normotensive pregnancies have selected out women at low risk for essential
hypertension.
Studies of "mild preeclampsia" seem to have led to another erroneous
concept, namely, that higher blood pressures within the normal range in the
second trimester are predictive of later preeclampsia. Mean arterial pressures
are calculated by adding 1/3 of the pulse pressure to the diastolic reading and
it has been alleged that levels of 90 or higher in the second trimester (MAP 2) often precede preeclampsia (almost always mild), with a sensitivity ranging
from 20% to 90%, specificity from 62% to 95%, and a positive predictive value
from 6.4% to 78% (6). Chesley and Sibai (5) put the concept to the acid test
in a retrospective analysis of MAP - 2 in the eclamptic pregnancies of 207
nulliparas.

They found no predictive value and that the distribution of the

levels of MAP - 2 were not much different from that in whole populations of
pregnant women.
In seven papers purporting to show a predictive value for MAP - 2, 39,608
women were screened. Fortunately, Page and Christianson (20), with 14,833 women,
specified the numbers who developed preeclampsia and of those who developed
hypertension alone (transient hypertension ?), as did Friedman and Neff (12) with
22,852 women.

Page and Christianson used the average MAP - 2 whereas Friedman

and Neff used the maximal MAP - 2 and specified separately the numbers developing
hypertension with and without proteinuria.

The two series represent 94.5% of

all cases. Clearly, most of the published data point to the higher levels of
MAP - 2 as being a better predictor of what usually is transient hypertension
than of "true" preeclampsia.

Table I, based upon the data of Page and

Christianson, shows that the sensitivity, specificity, and positive predictive
value of the average MAP - 2 aro better for hypertension alone than for what they
call preeclampsia. Similarly, Table 1 shows the same thing for the maximal MAP 2.

CHESLEY

3

TABU I
Predictive Values of the Average MAP 2 in 14,833 Women
Oerived from Data of Page and Christianson (20)

Predictive Values
Diagnosis

Sensitivity

Specificity

Positive

Negative

Preeclampsia

43%

87%

8.1%

98%

Hypertension

61%

94%

13.1%

99%

alone

TABLE 2

Predictive Values of the Maximal MAP - 2 in 22,582
Women Derived from the Data of Friedman and Neff (12)
Predictive Values
Diagnosis

Sensitivity

Specificity

Positive Negative

Hypertension
with
Proteinuria

65%

62%

6.4%

78%

63%

10.4%

98%

Hypertension
alone

98%

Transient hypertension has a high rate of recurrence in later pregnancies
and it probably is the usual basis for the misdiagnosis of preeclampsia in
multiparas.

Also, transient hypertension often predicts ultimate chronic

hypertension (2, 3, 13).

For those reasons, Chesley and Sibai (6) tested the

relation between levels of MAP - 2 in eclamptic pregnancies of nulliparas and
(A) the recurrence of hypertension in later pregnancies and (B) the prevalence
of hypertension at from 23 to 43 years after eclampsia. Figure 1 shows increases

MILD PREECLAMPSIA
70

55

65

75

85

95

Average MAP-2 in eclamptic pregnancies of nulliporas

F1g. 1. Relationship between MAP - 2 in eclamptic pregnancies of
nulliparas and (A) recurrence of hypertension 1n at least one of
later gestations (triangles and broken line) and (B) ultimate chronic
hypertension (circles and solid line).

in the recurrence of hypertension in later pregnancies and in the prevalence of
later chronic hypertension with each increment in MAP - 2.
For the recurrence of hypertension, the difference between incidences with
M A P - 2 below and above 90 has a Chi 2 of 18.0, p<0.001. Using 85 as a dividing
line, the development of ultimate chronic hypertension has a Chi 2 of 5.92,
p<0.02.
Langford and Watson (16) published an epochal study that seems to have
escaped the attention of many obstetricians. They recorded the blood pressures
of nulligravid high school girls and analyzed their first pregnancies occurring
months to a few years later; there were 400 normotensive gestations and 186 in
which the obstetricians had made the diagnosis of preeclampsia.

Proteinuria

usually was absent or present in only trace amounts and the incidences and
degrees of proteinuria and edema were similar in the two groups, as were the
gains in weight. The authors wrote: "The diagnosis of preeclampsia appeared to
be based entirely on BP".

That is, many probably had transient hypertension
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rather than preeclampsia. The patients with "preeclampsia" had had higher blood
pressures before conception and at every stage of pregnancy (MAP - 1 and MPA 2), and at follow-up than did those with normotensive pregnancies.
It has long been known that persons who develop essential hypertension
characteristically have blood pressures in the upper range of age-specific
normals before the onset of hypertension, perhaps with such levels even in
childhood (15). Women in the childbearing age who are destined for essential
hypertension might then be expected to have increased blood pressures within the
"normal range" before conception, to carry the higher pressures through pregnancy
(higher levels of MAP - 2), to develop transient hypertension, and ultimately
to become chronically hypertensive. Thus, higher levels of MAP - 2 and transient
hypertension
hypertension.

appear

to

be

stages

in

the

natural

history

of

essential

Inasmuch as future hypertensives are not immune to preclampsia,

higher levels of MAP - 2 may predict preeclampsia in them, purely by chance.
Of course, we should study incipient and mild preeclampsia, but how are
we to identify it and exclude simulating disorders?

Ernest Page used to talk

about founding a journal to be called Recent Setbacks in Medicine; he had a
specific contributor in mind, but I am sure that he would have agreed that many
of the contemporary papers on mild preeclampsia belong there.
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Pregnancy Outcome as Related to
Hypertension, Edema, a n d Proteinuria
Toxemia of pregnancy, although recognized
to be a devastating condition in terms of its
effects on both mother and fetus, is at best
ill-defined. The diagnostic criteria have been
vague and arbitrary in all the systems of
classification devised thus far. Not only are
such criteria poorly defined, but they also
tend to be inconsistent in their application to
clinical situations, and therefore are inadequate for continued use. It was felt necessary
to try to determine instead the specific
adverse effects of the clinical diagnostic
components of toxemia, namely blood
pressure, proteinuria, and edema, concentrating especially on the potentially deleterious results associated with combinations
of these factors and their patterns of change
during the course of pregnancy. In this way,
Supported by funds from Contract NOI-NS-3-2320
from the National Institutes of Health, U.S. Public
Health Service. The Collaborative Study of Cerebral
Palsy, Mental Retardation and Other Neurological and
Sensory Diseases of Infancy and Childhood is supported
by the National Institute of Neurological Diseases and
Stroke. The following institutions participate: Boston
Lying-in Hospital; Brown University; Charity Hospital,
New Orleans; Children's Hospital of Buffalo; Children's
Hospital of Philadelphia; Children's Medical Ccnl
cr, Boston; Gofumbia University; Johns Hopkins
University; University of Minnesota; Medical College
of
Virginia; New York Medical College; Pennsylvania
Hospital; University of Oregon; University of Tennessee; and the Perinatal Research Branch, National Institute of Neurological Diseases and Stroke.

one might be able to develop objective,
meaningful, and critical criteria for making
appropriate diagnoses of significant disease.
Such a study has been undertaken and is
currently in progress, utilizing data collected
for the Collaborative Project of the NINDS,
under whose auspices it has been pursued actively.
DATA

BASE

The Collaborative Study of Cerebral Palsy,
Mental Retardation and Other Neurological
and Sensory Disorders of Infancy and Childhood is a joint endeavor of 14 medical
centers and the Perinatal Research Branch
of the NINDS. Its prime objective is to determine relationships between factors that
affect women during pregnancy and the
development of neurological and sensory
disorders in their offspring. To this end,
since 1957 a total of 58,806 obstetrical
patients have been studied on a prospective
basis.
The relevant data were collected on structured and prccoded study forms by specially
trained, highly skilled interviewers and
examiners. A wide range of information was
recorded, including history of x-ray exposure, drug intake, minor and major illnesses, socioeconomic and genetic background, physical examination on each visit,
13
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various laboratory studies, labor and delivery events in great detail, examination of
the placenta, etc. Moreover, the neonate was
studied extensively, beginning with Apgar
scoring and information concerning the
onset of respiration and resuscitation.
Pediatric examinations, together with relevant laboratory determinations, were carried
out at specified intervals. A psychological
examination was conducted at eight months
of age for the assessment of the child's
mental and motor development. A neurological examination was performed at the
age of one year. The speech, language, and
hearing status was determined at three years.
A detailed Stanford-Binet intelligence test
was carried out at age four to assess the fine
and gross motor development. A behavioral
profile was included at this time, also.
Another neurological examination was done
at age seven. A psychological evaluation was
also carried out at this time, using the
Wechsler Intelligence Scale for Children and
the Bender Visual Motor Gestalt Test.
Throughout this time, periodic interval histories were obtained. Detailed descriptions of
the collaborative project, its functional
components, data collection forms', and
population characteristics have been
published previously (1,2).
Our data base was selected from the
enrolled study population to include only
those with single, viable pregnancies who
registered prior to 28 weeks* gestational age
and had a sufficient number of antepartum
visits (four or more) to permit us to investigate the relevant clinical variables. Patients
were excluded from the data base if they had
a multiple pregnancy, no antepartum care,
an abortion, or a hydatidiform mole, or if
the date of their last menstrual period was
unknown; in addition, data were excluded
on pregnancies after the gravida's first
registered study pregnancy. This procedure
yielded 38,636 gravidas for study. For them
there were 269,668 blood pressure recordings
and like numbers of proteinuria, edema, and
weight observations for analysis.

Early in the course of our study, it became
essential to determine the reliability of the
available data. A series of editing operations
was undertaken, together with error analysis,
which revealed a high level of accuracy in
the data file under surveillance, with error
rates of 1% or less, based on 14,245 verified
items.
Of considerable interest to us, as others
had found before, was the recognition that
the blood pressure data represented a discontinuous variable throughout its range,
with a pooling of the readings primarily at
the zero end-digit values. Thus, we felt justified in grouping the blood pressure readings
into 10 mm Hg incremental groups centered
at the zero end-digit figure, i.e., 55-64, 6574, etc.
As for the pressure distribution according
to gestational age (Fig. 1), it was observed
that the discontinuous distribution of
pressure recordings persisted, but with a
characteristic shift to lower readings as pregnancy advanced into the second trimester
and with a return toward higher readings in
late pregnancy. A plot of cumulative
pressure frequencies for each week of gestation (Fig. 2) defined the zones of pressure,
for purposes of appropriate grouping, as well
as logical intervals of gestational age according to the homogeneity demonstrated for the
pressure readings during those intervals.
Thus, we obtained a utilitarian (rather than
arbitrary) series of epochs of gestational age
in week intervals (a) 13-16, (b) 17-23, (c)
24-27, (d) 28-32, (e) 33-34, (/) 35-36, (g)
37-38, and (h) 39-41. This arrangement provided a coding for blood pressure readings
by the gestational epoch in which the recording was obtained for the purpose of designating patterns of sequential change with
advancing pregnancy.
Since the blood pressure readings did not
follow a continuous distribution but were, in
fact, naturally clustered around the zero enddigit values, they were to some degree already grouped. A further condensation into
10 mm Hg incremental groups simplified the

£- S
DiASTOUC BLOOD PRESSURE READINGS,

mm. Hg

Figure I Distnbution of diastolic blood pressure recordings in 2 mm Hg increments for each 2-week gestational
age interval from 12 weeks to term. Note the zero end-digit clustering and the trend toward lower pressure distribution as pregnancy advances, as term approaches, the distribution returns to that observed in early pregnancy
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Figure 2 Distribution of diastolic pressure recordings by gestational age epoch. The cumulative percentages of all
recordings obtained during each week of gestational age arc plotted to illustrate trends with advancing pregnancy
*nd to form the basis for meaningful gestational age epoch divisions.
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analysis of dynamic trend patterns of blood
pressure. However, the issue was then raised
of how efficient this grouping was in terms
of the loss of information. The efficiency was
assessed by taking the ratio of the variance
of the grouped data to the variance of the
ungrouped data. For data with a gaussian
(normal) distribution, the theoretical optimal
efficiency for five groups is 92.01% (3). Our
data showed very nearly optimal efficiency
rates for each gestational age epoch.
The outcome factors which were investigated included 12 scored items: (a) fetal
death, (b) neonatal death, (c) perinatal
mortality, (d) depressed one-minute Apgar
score (less than 6), (e) depressed five-minute
Apgar score (less than 6), (/) low fetoplacental weight ratio (less than 5), (g) low
birth weight (less than 2500 g), (h) abnormal
eight-month Bayley mental score (less than
56), (0 abnormal eight-month Bayley motor
score (less than 20), (J) abnormal eightmonth global evaluation, {k) abnormal oneyear neurological examination, and (/) defective four-year intelligence quotient (less than
70). Subsequently, the small-for-gestationalage-infant was designated as one who fell
below the fifth percentile of his/her appropriate birth weight distribution, which was
produced for each gestational age and for
two races (white and black). Similarly, a
birth-weight score was established for each
infant as the standardized deviation from the
mean (the deviation expressed in units of
standard deviation); again, the distributions
were stratified jointly by race and duration
of pregnancy at delivery. The most critical
outcome factors among these 14 items, with
regard to the effects of the risk factors under
surveillance, included fetal death (and as a
consequence, perinatal mortality), low birth
weight, smallness-for-gestational-age, and
abnormal four-year intelligence quotient. In
this chapter, because of space constraints,
we will concentrate primarily on fetal death
data.

ANALYTIC A P P R O A C H E S

Single-Factor Effects by Epoch
The data base was partitioned into 40 cells
for studying blood pressure according to the
gestational-age epoch (five diastolic pressure
groups in 10-mm Hg increments in each of
eight gestational-age epochs during which
the recordings were obtained). The numbers
of subjects in these cells ranged from 224 to
10,139. Where there was more than one
reading in a given epoch, only the maximum
was considered. Within each cell, the population was studied to determine the various
outcome incidence rates. Fetal mortality, for
example, was seen to rise abruptly in each of
the epochs in association with diastolic
pressure levels exceeding 84 mm Hg (Table
1). The relative overall mortality levels fell
progressively with advancing gestational age
on the basis of the self-selecting nature of the
data; those women who delivered previable
or premature infants earlier in pregnancy
could no longer present pressure recordings
as term approached. Similar trends were encountered for neonatal death, perinatal
mortality, neonatal depression at one and
five minutes, low birth weight, and smallness-for-gestational-age. Long-term adverse

Table 1: Rates of Fetal Mortality (per 1000) for
Diastolic Blood Pressure by Gestational
Age
Diastolic Blood Pressure, mm Hg
Gestational
Age (Weeks) <65 65-74 75-84 85-94 95+
13-16
17-23
24-27
28-32
33-34
35-36
37-38
39-41

9
8
6
6
6
7
2
4

8
8
8
7
6
4
5
5

12
11
10
8
6
6
4
3

13
12
9
9
8
6
5
5

18
16
26
21
19
16
9
9
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Table 2:

Rates of Fetal Mortality (per 1000) for
Degree of Proteinuria by Gestational
Age
Proteinuria

Gestatior i s l
Age (Weieks)
13-16
17-23
24-27
28-32
33-34
35-36
37-38
39-41

None Trace 1+ 2 ^ 3-h
13

9
\14

*5^
<•

6
5
4

11
10
8
10

30
10
,14
6
10
16
11
6

0
37
26
40
44
17
25
41

(0)«
71
71
58
56
24
19
22

4+
(0)
(0)
(91)
(176)
(200)
45
(0)
(71)

a

Parentheses indicate rates based on a small
sample size.

effects did not seem to be associated with
high levels of diastolic pressure; on the
contrary, only the very lowest levels seemed
to be related to poor long-term results. This
is a matter for consideration elsewhere.
Similarly, proteinuria of 2+ or greater
was associated with an adverse outcome for
each gestational age epoch under surveillance (Table 2). This relationship held for
essentially all the outcome factors studied.
The apparent influence of edema on outcome was negligible, as determined by history or by physical examination. Also, the
maternal weight change did not appear to affect the outcome appreciably. It was
recognized that this approach did not take
into account potentially confounding factors
having to do with the coexistence of other
deleterious effects and the possibility that the
various subgroups were not constituted
homogeneously insofar as patient makeup
(actuarial as well as obstetrical) was
concerned.
Doublet Combinations
In order to approach the dynamic study of
the effects of blood pressure on the outcome
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of pregnancy, our first thrust was to investigate doublet groupings based on blood
pressure transitions between adjacent epochs
of gestational age. A total of 175 such
groupings existed (35 epoch-pressure cells
for epochs 1-7, inclusive, multiplied by the
five possible blood pressure level transitions
in the next succeeding epoch). The data
derived from analyses of outcomes in each of
these cells showed that a pairwise transition
involving a jump of three levels upward (for
example, a rise in diastolic pressure from the
65-74 mm Hg level to the 95 + mm Hg level)
had an adverse effect in general (Table 3).
More important, specific sequences of
diastolic pressure change could be shown to
be deleterious. By virtue of the fact that
some of the pattern cells contained relatively
few cases, so that the outcome data derived
therefrom were not likely to be meaningful
from the statistical point of view, the data in
each cell were subjected to a "filtering"
process for the purpose of establishing
relevance and appropriately suppressing any
potentially spurious or chance observations.
This operation permitted us to simplify the
evaluation involving the data obtained from
the doublet (and later the triplet) sequences
by tabulating only those doublet sequences
which were based on data showing statistically significantly increased or decreased
rates of abnormal outcome (p < 0.01). It
was felt that they might serve tentatively for
purposes of prognostication. In all, 45 doublet sequences of diastolic pressure were
identified as being particularly hazardous in
terms of fetal and infant outcome. Most of
these sequences involved high levels (over 84
mm Hg) in one or both members of the pair.
As for proteinuria, it was clear that its abrupt appearance—that is, a positive shift of
two or more levels (for example, from negative to 1+ or from trace to 2+)—was
associated with increased stillbirth rates, as
well as other short- and long-term adverse
outcomes. Ninety significant doublets of
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Table 3: Effect on Fetal Mortality Rates of Direction and Degree of
Diastolic Change by Gestational Age
Gestational
Epoch Pairs
(Weeks)

-3

-2

-1

No Change

+1

4-2

4-3

13-16 to 17-23
17-23 to 24-27
24-27 to 28-32
28-32 to 33-34
33-34 to 35-36
35-36 to 37-38
37-38 to 39-41

0
20
54
0
11
18
0

22
24
17
16
9
19
5

29
22
13
16
10
10
6

25
21
18
13
13
11
11

31
25
18
15
13
10
10

26
26
16
7
15
9
14

71
31
23
9
25
22
8

?<lirwise Transit ion in Pressure Levela

"Observations grouped in 10mm Hg increments: +1 indicates a positive
jump to the next higher pressure level between gestational age epochs; 4-2 a
jump of two levels, upward, etc.

proteinuria were identified. Comparable
pairwise transitions of edema showed little in
the way of a reliably consistent effect, although 28 significant patterns were found.
The paired interepochal weight change had
no material influence, but large weight losses
were associated with increased fetal
mortality, as shown in 42 pattern pairs.
Sequence Patterns
The same operational principle was applied
to the study of triplet combinations in dynamic sequences of diastolic blood pressure
levels. In all, there were 750 groupings (30
epoch-pressure cells for epochs 1-6, multiplied by five possible blood pressure level
transitions in the next succeeding epoch, and
by five again for the possible transitions in
the third epoch of the triplet sequence). The
previously described statistical filtering
process identified 108 triplet sequence patterns of diastolic pressure which could be
considered as indicators of fetal risk. Similarly, there were 176 triplet sequences of proteinuria, 43 of edema, and 179 of weight
change.
It soon became clear that the prospect of
investigating all possible sequences involving
up to eight epochs was unworkable. The

numbers of permutations of blood pressur
patterns increased exponentially for each ac
ditional epoch examined, and all possibi
combinations and permutations totaled ovc
2 million sequence patterns. The problem
therefore, was approached more empirically
From a detailed listing of all patterns ot
served to be actually associated wit
specific, unfavorable outcomes, it was sec
that the number of possible theoretical pa
terns at risk could be reduced considerable
The complexity of the analysis was reduce
further, in order to-make the data momeaningful for practical utilization I
clinical situations, by studying only sequent
patterns for the last five gestational ai
epochs, beginning at the 28th week. While!
total of 7776 such patterns were theoretical
possible for diastolic blood pressure, on
1669 were actually encountered; son
represented in terms of patterns we;
particularly sparse in the number of subjec
recognized. All sequencing possibility
including quadruplet and quintuplet grou
ings, totalling 3334 subsets, were studied.
A total of 46 actual high-risk diastolic s
quence patterns significantly associated wi
perinatal mortality were uncovered by stat
tical analysis. It should be emphasized t j |
the study of these specific patterns includ
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a provision for determining the gestational
age at delivery and was confined to observations made from 28 weeks to delivery, exclusive of observations made during labor.
When similar procedures were carried out
on proteinuria sequences, 26 patterns significantly associated with perinatal mortality
were found. Edema sequences yielded 39 and
weight change 118 additional pattern combinations. Thus, in spite of our efforts to
reduce the inherent complexity of the investigation, we were still left with more than 5
million theoretical pattern combinations to
consider in our search for a clinical
constellation of risk factors involving just
these four parameters (there are about
5,504,000 possible combinations involving 46
pressure, 26 proteinuria, 39 edema, and 118
weight change patterns). Moreover, this
investigation in no way considered other
variables that might be relevant and
contributory.
Cluster Analysis
Large numbers of high-risk patterns were
seen to occur, each of which had a relatively
low incidence and accounted for only a small
number of affected fetuses. The task of
grouping them meaningfully in order to simplify and classify diagnostic criteria for use
by the practicing clinician seemed impractical, therefore, by the approach
described above. Moreover, the summary
variables we used (that is, epoch-specific
maximum blood pressure, edema, proteinuria, and weight recordings and their
various changes) may well have missed or
suppressed much detailed information in the
visit-by-visit observations, particularly with
regard to rapid fluctuations at various times
during pregnancy. Accordingly, we cmbarked on exploratory analyses in which a
large number of derived blood pressure,
edema, proteinuria, and weight variables
w
cre examined. These analyses covered as
completely as possible the material judged
potentially significant by the use of combina-
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tions of measurements from the available
data. The variables fell into three main
groups: (a) level variables, measurements of
absolute values by epoch (mean, maximum,
minimum, first, last), and (b) change variables, measurements of change in magnitude
or rate (range, maximum rate of increase,
etc.), and (c) shape variables in terms of
specified patterns of change with advancing
gestational age. Thus, a total of 196 variables were identified which might conceivably
be related to the disorder under study. These
variables included relevant actuarial data on
race, age, and parity, and fetal variables
dealing with gestational age, birth weight,
placental weight, outcome, and the birth
weight score, as defined earlier.
Cluster analysis was used to identify
analytic variables which were so highly
similar in information content, that when
studying just one of them, one would be using information on all of those with comparable degrees of similarity. Thus, for
example, a very compact cluster of weight
variables allowed us to conclude with some
assurance that we could discard all but one
weight variable for future analysis without
any appreciable loss of information.
The reduced set of variables was then
used in other cluster analyses, using several
subsets of gravidas, in an effort to discover
natural subgroups of gravidas with distinctive profiles that could be related to the incidence of outcome abnormalities. The
clustering of gravidas based on their blood
pressure variables was carried out. It was
found that several of the variables seemed to
carry relatively little information; for
example, a set of variables that were standard deviations of determinations within
epochs and over the course of pregnancy
(which may be taken as measures of lability)
conveyed very little that was not also
contained in the average rates of change.
Clusters of cases with low maxima and small
ranges were associated with low rates of abnormality, and clusters with high levels
(maxima) or large variability (ranges) were
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associated with high abnormality rates. Patterns of blood pressure change over the
course of pregnancy were sought, particularly those related to a high risk of abnormal
outcome. High blood pressure levels with
and without extreme variability were found
to have high abnormality rates. We also
found clusters of blood pressure patterns
over the course of pregnancy that could be
characterized as (a) relatively constant and
low, (b) high and variable, and (c) low in
early epochs and higher later. We did not
observe any association between high abnormality rates and specific patterns of change.
The possibility remained that there were
regularities in our data that we missed or
that there were patterns of blood pressure
change in pregnancy that our data did not
reflect (for example, phenomena involving
blood pressure changes on the scale of a few
days). Despite an exhaustive effort to find
such regularities, employing a number of different techniques, none was revealed.
Linear Discriminant Analysis
We have utilized linear discriminant analysis
to identify potential combinations of risk
factors among the variables under study,
taking into account the potentially confounding variables, such as the actuarial
variables of age, race, and parity, as well as
the institution in which the observations were
made. This technique permitted us to
identify variables that contribute information significant for identifying fetuses and infants with the potential for an adverse outcome from unaffected ones.
It was determined that age, race, parity,
institution (with the exception of a single
unit), maternal weight and edema did not
provide significantly more information related to distinguishing unaffected survival
from fetal death (or other outcomes studied
in like manner) than was provided already by
such clearly verified factors as maximum
proteinuria and diastolic blood pressure, as
observed during or after the 28th week of
pregnancy. It was verified clearly that

neither edema nor maternal weight change
contributed meaningfully to the adverse outcome. Moreover, there appeared to be only
negligible confounding effects from the actuarial and institutional variables.
Analysis of Rate Ratios
Diastolic pressure and proteinuria levels
were examined simultaneously to determine
which combinations yield the highest incidence of adverse outcomes. When the levels
were examined without regard for the gestational age at which the observations were
made or for the delivery date, it became
quite clear that each was associated independently with adverse outcomes and were
synergistic (Table 4). Compared to patients
with diastolic pressures of 75-84 mm Hg and
no proteinuria, fetal death rates, for example,
increased about fourfold in conjunction with
diastolic pressures of 95 mm Hg or greater
(and proteinuria less than 2-f) and increased
by the same amount in association with 2+
proteinuria or more (but with diastolic
pressures of under 95 mm Hg). Pressures of
95 mm Hg or more which occurred in conjunction with proteinuria of 2+ or more
showed fetal mortality rate ratios far exceeding the sum of their independent rate ratios
(almost tenfold). Indeed, "subliminal" levels
of both factors (that is, levels that were not
associated with a recognizably increased risk
when observed alone) which occurred in combination yielded elevated mortality data as (
well. This phenomenon was seen in gravidas
with 1-f proteinuria and diastolic levels of
85-94 mm Hg, who had a fourfold increase in
fetal deaths. Rate ratio zones thus were identifiable, based on levels of relative hazard as
related to various proteinuria-diastolic!
pressure combinations, and these remained
remarkably intact when the independent effects and synergistic effects were examinee
according to the time during pregnancy a*
which the observations were made.
A continuum of hazard is seen to begin a |
a low level in the reference group (diastolic
pressure 75-84 mm Hg with no proteinuria

ANALYTIC APPROACHES

Table 4:
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Rate Ratios for Fetal Death by Diastolic/Pressure and Proteinuria
Combinations
Diastolic Blood Pressure (mm Hg)

Proteinuria

<65

65-74

75-84

None
Trace

4+

2.5°
2.2
1.0
0.0
0.0
0.0

1.5
1.3
0.9
5.3"
6.7 a
0.0

^h01_
1.2
1.0
3.1°
0.0
0.0

Total

2.0

1.3

1.0*

1-h

2+
3-f

95-104

105 +

Total

3.1°
2.8°
4.3°
9.0°
18.6°
23.1°

3.3°
4.5°
10.1°
11.1°
20.2°
17.9°

I.O*

1.5
3.8°
0.0
36
0.0
1.5

3.7°

6.1°

85/94

iW

1.1
1.4
2.7°
5Aa
6.6°

° Statistically significant,/? < 0.01.
b
Referent rate 0.62%.
c
Referent rate 0.86%.
d
Referent rate 0.68%.

and to rise multidirectionally to compose
three moderately high mortality areas and
one severe mortality area. Four groups were
identifiable, as follows: (a) Gravidas presenting with the single factor of a diastolic
pressure elevation of 95 mm Hg or greater
were associated with a moderate increase in
the incidence of adverse effects on the fetus
(rate ratio for fetal mortality, 4.1). (b)
Gravidas manifesting comparable magnitude
of mortality were associated with the single
factor of proteinuria of 2+ or greater (rate
ratio 4.0). (c) Gravidas shown to possess
synergistic combinations of the two factors
(diastolic pressures of 85 mm Hg or greater
together with proteinuria of 1+ or greater)
provided the greatest hazard to their unborn
offspring (overall rate ratio, 7.2). (d) The
fourth group is composed of gravidas with
low diastolic blood pressures (less than 65
rnm Hg and without proteinuria) who have
significantly high rates of fetal loss (rate
fatio 3.0). While it is clear that the infants of
these gravidas experience significant excess
mortality, it is hypothesized that this syndrome represents a condition separate from
">e hypcrtensive-proteinuric state which we
*** ttudying here.

Wili
notcd that the group with thc
vii
*
*
**I&est excess mortality (group 3, above) in-

cluded gravidas with less intense clinical
risk factors (diastolic blood pressure of 8594 mm Hg and proteinuria of 1 + ), in whom
the fetal peril was shown to equal that of
patients with diastolic pressures exceeding 94
mm Hg and proteinuria of 2+ or more.
Thus, this group may be considered to be
composed of three subdivisions: (a) those
with a diastolic blood pressure of 85 mm Hg
or more with 2+ proteinuria or greater, the
subset at highest risk (rate ratio, 9.6); (b)
cases with diastolic pressures of 95 mm Hg
or greater and 1+ proteinuria (rate ratio,
8.0); (c) patients with borderline pressures of
85-94 mm Hg and borderline proteinuria of
1+ level (rate ratio, 5.1). Together, these
three subdivisions represent a moderately
homogeneous group of gravidas whose
fetuses have a very great chance of being
damaged.
Group 1 (hypertension only) comprised
5.2% of the study population but encompassed 10.4% of all fetal deaths. Group 2
(proteinuria only) included 1.9% of the
patients and 3.6% of the deaths. Group 3
(hypertension plus proteinuria) accounted
for 4.3% of the gravidas and an impressive
14.7% of the fetal deaths. The fourth group
(low diastolic pressures, without proteinuria)
constituted 3.0% of the gravidas studied and
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4.4% of the fetal deaths. Thus, one-third of
all fetal deaths were accounted for by these
four* groups of definable disorders, even
though the women in these groups all
together comprised only one-seventh of the
whole study group.
Similar analyses of rate ratios for combinations of diastolic pressure by weight
change, diastolic pressure by edema, proteinuria by weight change, proteinuria by
edema, and weight change by edema confirmed the earlier conclusions, based on the
aforementioned analytic techniques, that
neither edema nor weight change (other than
weight loss) affected the outcome in such a
way as to make these variables useful for the
purpose of identifying gravidas at risk of a
potentially adverse fetal outcome.

stitute of Neurological Disease and Stroke: The
Women and Their Pregnancies.
Philadelphia:
Saunders, 1972, p. 6.
3. Cox, D. R.: Note on grouping. J. Am. Statist.
Assoc. 52:543, 1957.

DISCUSSION
DR. R. A. CHEZ: YOU stated that the weight
gain factor was not significant. Could you elaborate on this?
DR. FRIEDMAN: We were unable to show any
effect of excessive weight gain. On the other hand,
when we analyzed weight loss, we noted clear
relationships to unfavorable outcome.
<T~
D R . C H E Z : Were y o u referring t o total weight
gain during the gestation o r i n j ^ m c j i t a l weight
incrcases^xspecially those occurring over a short
period of time.
D R . F R I E D M A N : Incremental.

SUMMARY
Clinical variables of blood pressure, proteinuria, edema, and maternal weight have
been studied extensively, with particular
reference to associated adverse fetal and infant outcomes. The levels of these variables,
as well as their relative patterns of change
with advancing pregnancy, were investigated
by several analytic methods. It was determined that diastolic blood pressure and
proteinuria, alone and in combination, provided sufficient information about their effect on fetal and infant outcomes to enable
us to create an empirical classification of
^gravidas whose fetuses were probably at risk.
_The results must be considered preliminary
4n viciwl^f^thefact tFat the wofiris stilHn
^progress.
"
"
^
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D R . N . S . A S S A L I : It seems odd that one has to
analyze o u t c o m e t o define the disease, and I was
wondering about the rationale of such an approach. A s an example, y o u included "small-forgestational-age" babies as a criterion for defining
preeclampsia, yet preeclampsia is an acute disease
which occurs in the last trimester and does not
produce ( a s far as I know) a small-for-gestational-age baby. T h e latter is characteristic of
chronic hypertensive disease. I wonder if y o u were
really able to separate acute preeclampsia and
chronic hypertensive diseases.
D R . FRIEDMAN: I agree that a small-for-gestational-age baby usually indicates the presence of
long-standing hypertension, but it is also seen
with acute toxemia. From our point of view, w e
were looking for means whereby w e would be able
to determine signals that would predict those
patients w h o would b e c o m e hypertensive. W c felt
that by using o u t c o m e w e would not fall into t h e
trap that everyone w h o has preceded us (including
ourselves) has fallen into; that is, wc would n o t
utilize any preconceptions a n d merely determine
criteria based o n bad effects. This is a wellrecognized device in screening programs. That is
what w c were trying t o d o — s e t up a means
whereby the disease could be determined t o exist
on the basis of a constellation of factors that
heretofore had not been recognized. But, note^
that w e were unable t o find a n y constellation of
(cither acute or) rapid changes that were critical
in defining the disease.
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IN THE THIRD JUDICIAL DISTRICT COURT FOR SALT LAKE COUNTY
STATE OF UTAH
BRENDA RIVERA,
Plaintiff,

AMENDED FINDINGS OF FACT AND
CONCLUSIONS OF LAW

v.
Civil No. 900902630
CLAYTON S. WILDE, M.D.,
Judge Michael R. Murphy
Defendant.
ANTONIO R. RIVERA, by and
through his Guardian Ad
Litem
TONY RIVERA, also known as
Antonio R. Rivera,
Civil No. 910907496
Plaintiff,
v.
CLAYTON S. WILDE, M.D.,
Defendant.
The above-entitled matter having come on for trial before
the Honorable Michael R. Murphy, one of the judges of the aboveentitled court, on the 22nd day of September, 1992, Plaintiff
Brenda Rivera having been present in person and represented by
her attorneys of record, Robert B. Sykes, James D. Vilos and
Tamara J. Hauge of and for Sykes & Vilos, Defendant having been

present in person and represented by his attorneys of record,
Elliott J. Williams and Bruce H. Jensen of and for Williams &
Hunt, the Court having received the Stipulation of the parties
that the claims of Plaintiff Antonio R. Rivera shall be decided,
as to a finding of liability, upon the evidence presented and the
judgment of the Court as to the claims of Plaintiff Brenda
Rivera, having heard the testimony of the witnesses, having
reviewed the exhibits entered into evidence, having heard the
arguments of counsel, having considered proposed findings and
conclusions submitted by the parties and the memoranda of counsel
submitted therewith, and with good cause appearing therefore,
does now enter its:
FINDINGS OF FACT
1.

In early February 1989, Plaintiff Brenda Rivera sought

the services of Defendant, a specialist in obstetrics and
gynecology, to care for her in conjunction with her first
pregnancy.
2.

At the time, Plaintiff was 25 years old.

At the time of Plaintiffs first pre-natal visit to

Defendant on March 1, 1989, Defendant determined on the basis of
Plaintiff's medical and family history and physical examination
that she was a low risk obstetrical patient, that the estimated
gestational age of the fetus was 11 % weeks, and that the
estimated date of confinement (for delivery) was September 17,
1989.

Defendant provided information to Plaintiff and her

husband about what they could expect during the pregnancy and
assured them that they could, and should, call him anytime they
- 2 -

had any concerns or problems.

During her pregnancy, Plaintiff

had the following blood pressure and weights at the times
indicated
Date

Weeks

Weight

3/1/89
4/24/89
5/22/89

11%
19
24-5

157
170
173

6/15/89

26

181

3.

B.P. (Systolic/
Diastolic)
98/64
110/72
120/68
(110/88
110/84
LllO/80

Plaintiff was seen monthly by Defendant for routine pre-

natal care. During these visits she complained to Defendant about
persistent headaches, which were relieved with Tylenol, and
nausea and vomiting.

These symptoms are common during pregnancy

and Defendant reassured Plaintiff and her husband that she should
soon begin to feel better.
4.

On June 12, 1989, Plaintiff's husband spoke with

Defendant's nurse by telephone and reported that Plaintiff was
experiencing some swelling in her feet and legs after being on
them all day.

After questioning him about other complaints and

learning of none, the nurse recommended that Plaintiff elevate
her legs as much as possible and increase her water intake.

If

her condition worsened she was to come in before her next
scheduled visit.
5.

When Plaintiff visited Defendant on her next scheduled

visit on June 15, 1989, the estimated gestational age of the
fetus was 26 weeks.

Plaintiff's blood pressure was measured as

110/88 and a urine test revealed no protein in her urine.
- 3 -

Defendant repeated the blood pressure measurement, which was
found to be 110/84, and rechecked the urine specimen to confirm
the absence of proteinuria•
6.

During that visit, Plaintiff repeated her complaints of

having headaches, which were still relieved with Tylenol, and
some nausea and vomiting.

She also complained of some fatigue.

The symptoms of which Plaintiff complained were consistent with a
flu-like illness that many of Defendant's patients had recently
reported.

At the request of the Plaintiff's husband, Defendant

also carefully examined Plaintiff's feet, ankles, legs and face
and found no pathologic edema.

Defendant instructed Plaintiff to

take breaks at work so that she could have her legs elevated, to
rest and keep off her feet when at home and to take care of
herself.

Defendant told Plaintiff that she should start feeling

better in a few days, but, if she did not or got worse, she
should come in to be checked.

Defendant asked Plaintiff to come

back for another pre-natal visit in two weeks, rather than at the
regular interval of one month.

Plaintiff's blood pressure was

taken a third time and was measured at 110/80.

During this

office visit the Defendant considered the possibility of preeclampsia and upon examination and evaluation ruled out the
diagnosis of pre-eclampsia in accordance with the accepted school
of thought to which he adhered.
7.
1989.

Plaintiff experienced an eclamptic seizure on June 23,
She had no contact with Defendant between the time of the

last office visit on June 15, 1989, and the eclamptic seizure.
- 4 -

8.

Plaintiff and Defendant called expert witnesses to

provide testimony in support of their respective positions.

The

Plaintiff's expert, Dr. Maclyn Wade, had limited obstetrical
experience and his testimony was equivocal, unpersuasive and
lacking in credibility.

Dr. Wade gave away on cross-examination

most of the points he made on direct and redirect examination.
9.

The expert testimony adduced during trial and the

medical literature to which reference was made by the witnesses
clearly established that there is no uniform standard of care
followed by all competent practitioners, but rather a cacophony
of opinion, on the subject of the criteria for diagnosing preeclampsia.
10.

Based upon the expert testimony and medical literature

presented, the Court finds that Defendant's treatment of
Plaintiff complied with an acceptable school of thought which is
within the standard of care.

It was appropriate for Defendant to

adopt and adhere to the school of thought that:

(1) defines pre-

eclampsia as a blood pressure of equal to or greater than 140/90
in the presence of proteinuria; and (2) considers edema (even of
the face and hands) and weight gain as so common in pregnancy
that they are useless for the diagnosis of pre-eclampsia.
11.

The school of thought Defendant followed in his

diagnosis and treatment of Plaintiff is well-supported in the
medical literature and by competent and qualified experts as an
approved method of diagnosis and treatment recommended and
followed by a respectable portion of the medical community in the
- 5 -

specialty of obstetrics and gynecology.

The Plaintiff has not

demonstrated by a preponderance of the evidence with credible
expert testimony that the school of thought Defendant followed is
unaccepted, insufficient or unsafe.
12.

During Defendant's examination and evaluation of

Plaintiff on June 15, 1989, the possibility of pre-eclampsia was
raised, but there was nothing in Plaintiff's medical or family
history, course of pregnancy, complaints, or examination and test
findings which was diagnostic of pre-eclampsia or developing preeclampsia.

To the contrary, Plaintiff did not have hypertension

or proteinuria.

Her symptoms of headache, nausea, and vomiting

were not caused by pre-eclampsia or developing pre-eclampsia.
The amount of edema and weight gain observed was not unusual.
Moreover, the risk of pre-eclampsia and/or eclampsia is extremely
low in gravid patients at 2 6 weeks gestational age.
13.

Defendant acted appropriately on June 15, 1989, in

changing his usual procedure and instructing Plaintiff to return
in two weeks rather than the usual four week interval.

The

standard of care did not require Defendant to take any further
action or to have the patient return sooner than two weeks.
14.

Plaintiff has failed to meet her burden of proof to

establish a claim for medical malpractice or negligence against
Defendant and the more credible evidence received convinces the
Court that Defendant clearly complied with an applicable and
acceptable standard of medical care in his treatment and care of
Plaintiff during her pregnancy.
- 6 -

15.

Plaintiff suffered eclamptic seizures on June 23, 1989.

The eclampsia caused Plaintiff physical and mental injuries.

The

Court makes no findings on the categories or items of damage.
From the foregoing Findings of Fact, the Court now enters its:
CONCLUSIONS OF LAW
1.

In order to recover upon a claim for medical

malpractice, Plaintiff has the burden of proving by a
preponderance of the evidence that Defendant deviated from the
standard of care applicable to physicians specializing in
obstetrics and gynecology practicing in Salt Lake City, Utah, or
similar communities, in 1989, and that said deviation from the
standard of care was a proximate cause of the injuries and
damages claimed by Plaintiff.
2.

Plaintiff Brenda Rivera has failed to meet her burden of

proof on the elements of her medical malpractice claim against
Defendant and Defendant is therefore entitled to a judgment in
his favor of no cause of action upon the claims of Plaintiff
Brenda Rivera and, based upon the Stipulation of the parties
herein, and with good cause appearing, is further entitled to a
judgment in his favor of no cause of action upon the claims of
Plaintiff Antonio R. Rivera.
5.

Defendant is entitled to be awarded his Court costs

incurred herein.
DATED this

'^

day of

lu-^-*' BY THE COURT:

h^^l/2
MICHAEL R. MDRPHY
District Court Judge
- 7 -

, 1993.
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APPENDIX 13
VIOLATIONS OF STANDARD OF CARE
CHART USED AT TRIAL

VIOLATIONS OF STANDARD OF CARE
Dr. WUde -

6-15-89

I. FAILURE TO RECOGNIZE CONSTETXATION - of
signs and symptoms (s/s) that would alert reasonable OB/GYN to existing or developing
preeclampsia (P.E.),
A. HIGHER RISK
- 1st pregnancy
- family hx of hypertensive disorders
— mother: hypertension (HTN)
— sister: stroke
— sister: pregnancy-induced hpt (PIH) or P.E.
- lower socio-economic class

B. DANGEROUS DIASTOLIC BLOOD PRESSURE fDBP)
- increasing trend in DBP
- acute increase (t) in DBP
— > 15 mm Hg t (actually, t of 24)

C. WEIGHT GAIN -

SIGNIFICANT

- 8 lbs. in Vh weeks
- rapid

D. EDEMA (swelling
- face
- generalized

E. HEADACHES - SEVERE
- persistent
- unresponsive to tylenol

F. NAUSEA AND VOMITING
- still having at 3rd trimester

n . IMPROPER DTAGNQSIS (dxl
A. Used "research dx"
- "must have BP of 140\90" (SBP/DBP)
- "must have proteinuria"

B. Should have used: "clinical dx" (treating)
-

ffl.

constellation of s/s
acute HTN = t > 15 mm Hg DBP
edema, non-dependent (face), or generalized
proteinuria not necessary

FAILURE TO TREAT
A. Needed close observation
-

m

come back: 24 - 48 hours
not two weeks
frequent BP and proteinuria readings
increased vigilance due to risk factors

g
I

I

B. Not "continue working" as custodian
C. Should have ordered
- bed rest (+ hospitalize if no improvement), px
- hospitalization (until stable)

IV. FATT JIRF, TO EXPLAIN AND WARN
A. Explanation of s/s of P.E.
B. High DBP = significant P.E. risk
- "Dangerous" condition

C. How to avoid future injury
- progression of symptoms
- call immediately if s/s worsen

D. Allayed fears: "just pregnant"

in

